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Summary
The ʻlower dimer  ʼand its role in actin patterning:
Studying different forms of actin by
electron microscopy, biochemistry
and tailor-made antibodies
2                     Summary
At the onset of actin polymerization, a transient species termed ʻlower dimer  ʼ (LD) is 
incorporated into growing filaments, but disintegrates during filament maturation. Because 
two actin subunits assume an antiparallel orientation in the LD, it is inherently polymerization-
incompetent and its subunit contacts do not occur in F-actin filaments at steady state. 
However, by copolymerizing G-actin and previously cross-linked LD in the presence of 
phalloidin, we were able to produce a novel type of actin hybrid filaments, which contained 
the LD at steady state. The presence of LD in hybrid filaments was verified by high-speed 
sedimentation and subsequent SDS-PAGE analyses as well as by conventional and scanning 
transmission electron microscopy (CTEM and STEM). Copolymerization of mixtures 
containing G-actin and increasing amounts of LD depicted that the LD was incorporated into 
hybrid filaments at corresponding ratios. One subunit of the LD contributed to the hybrid 
filament backbone whereas the other jutted out from the filament surface, thereby causing 
numerous lateral protrusions. Occasionally, these protrusions initiated the branching of lateral 
emanating daughter filaments. Hybrid filaments revealed also a high degree of structural 
variation. Frequent local unraveling of the two hybrid filament strands and perturbation of 
crossover spacings indicated that the presence of incorporated LD also strongly interfered 
with interstrand subunit contacts. It seems that particularly in highly disordered filament 
sections, the intersubunit contacts needed for phalloidin binding were not established. As a 
consequence subunits were released and/or exchanged at steady state. 
Contrary to the biochemical evidence and CTEM analysis which clearly demonstrate 
the co-polymerization of LD and actin into hybrid filaments, STEM data did not reveal 
any difference between mass-per-length (MPL) and full-width half-maximum (FWHM) in 
hybrid versus conventional F-actin filaments.
Our findings corroborate that actin has the intrinsic ability for branching in vitro, and that 
the LD substantially contributes in the formation of branching sites. 
In the second part of this study we tested the immunogenic potential of a novel type of 
self-assembled peptide nanoparticles. According to the design principles, 60 copies of a 
computationally designed and recombinantly expressed coiled coil polypeptide self-assemble 
to form highly organized regular dodecahedrons of defined size.
In order to elucidate whether the nanoparticles (NP) can be functionalized to potent 
immunogens, we genetically engineered a 13mer corresponding to the amino acid residues 
239 - 251 of human β-cytoplasmic actin onto the C-terminus of the NP.
The resulting nanoparticles were termed NP-Gly. Corresponding nanoparticles containing 
the same actin sequence but with a single point mutation from Gly to Asp at the original 
position 245 were termed NP-Asp. A 13mer peptide containing this mutation has previously 
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been used to produce a monospecific polyclonal antiserum in rabbits. CTEM analysis 
revealed that neither epitope interfered with the formation of homogenous populations of 
nanoparticles. Moreover, immunochemical analyses with the antisera against wild type and 
G245D mutant actin demonstrated the accessibility of the corresponding epitopes on NP-
Gly and NP-Asp. Subsequent immunization of rabbits with NP-Gly and NP-Asp yielded 
individual polyclonal antisera that were shown to react with wild type and mutant actin, 
respectively.
In order to examine the immunogenic potential of a distinct structural element that is exposed 
on the nanoparticles surface, we grafted 12mers corresponding to the so-called ʻ hydrophobic 
loop  ʼof human β-cytoplasmic actin onto the C-terminus of NPs. Since the ʻhydrophobic 
loop  ʼis buried within the F-actin filaments, but is exposed to the surface of monomeric actin, 
we assumed that immunization with nanoparticles containing the ʻ hydrophobic loop  ʼepitope 
would yield antibodies that detected only non-filamentous actin.
In a first construct, an additional Cys residue was introduced downstream of the nanoparticle 
core polypeptide in order to stabilize the propensity of the grafted actin epitope to assume a 
loop structure by a disulphide bond with the Cys residue contained in the epitope sequence. 
The resulting nanoparticles were termed NP-L/C and extensively aggregated as displayed 
by electron micrographs. In a second construct termed NP-L/S, both cysteines were replaced 
by Ser residues in order to eliminate the random formation of disulphide bonds between 
polypeptides. CTEM analyses confirmed that NP-L/S assembled into a disperse population 
of spherical particles rather than forming aggregates.
Following immunization of mice with NP-L/C, six individual hybridoma clones were 
selected, all of which produced IgGs of the subclass 2b. Immunoblot experiments under 
native and denaturing conditions revealed that the monoclonal antibodies (mAbs) specifically 
reacted with NP-L/C ND NP-L/S. In addition, the mAbs reacted with purified skeletal muscle 
actin and detected actin in a number of total cell extracts. Fluorescence cross-correlation 
spectroscopy further demonstrated the binding specificity of selected antibodies with NP-
L/S.
The in situ reactivity of the mAbs was further characterized by immunofluorescence on Rat2 
fibroblasts and immunogold labeling on ultrathin sections of different cell lines and tissues. 
These experiments showed that the mAbs which were raised against loop nanoparticles, also 
recognized the ʻhydrophobic loop  ʼof actin in its native context throughout the cytoplasm 
and in the the nucleus. The presence of the antigenic determinant in the nucleus and the 
absence of a filamentous staining pattern in the cytoplasm indicated that the epitope was 
readily detected in non-filamentous actin, but hidden in F-actin filaments. Consistently, the 
mAbs did not cosediment with F-actin filaments from purified skeletal muscle actin in high-
speed cosedimentation assays.
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In conclusion, the data show that self-assembling peptide nanoparticles are a suitable 
platform for the immunogenic surface display of actin-related epitopes, which because of 
their high conservation are poor antigens. Presenting the refractory antigenic determinants in 
an ordered, repetitive array significantly increased the immune response of the host animal, 
resulting in specific poly- and monoclonal antibodies. 
The third part of this study addresses the interaction of actin with Raver1. This ubiquitously 
expressed hnRNP protein resides primarily in the nucleus, where it colocalizes with the 
polypyrimidine-tract binding protein PTB. During skeletal muscle differentiation, raver1 
translocates to the I-Z-I-band of sarcomers, where it colocalizes with its ligands metavinculin, 
vinculin and α-actinin. In order to obtain a more detailed view on the potential role of raver1 
in muscle, we investigated its distribution and localization in murine striated and smooth 
muscle using three monoclonal antibodies that recognize distinct epitopes at the N- and 
C-terminus of raver1. Immunofluorescence and immunoelectron microscopy showed that 
cytoplasmic raver1 is an integral part of the sarcomers of skeletal muscle, heart and smooth 
muscle, and is not restricted to costamers like its ligands vinculin and metavinculin. A closer 
look at isolated myofibrils and ultrathin sections of skeletal muscle revealed that raver1 
mainly concentrated at sarcomeric I-Z-I band. Moreover, a minor fraction of raver1 was 
present in the nucleus of the three muscle types tested.
Pre-embedding immunolabeling of isolated Xenopus nuclei with all three antibodies 
revealed that raver1 at the nucleoplasmic periphery is preferentially located at the distal ring 
of the nuclear pore complex, where actin has also been described.
Cosedimentation assays and electron microscopy with recombinant full-length raver1 
protein and a C-terminal deletion fragment revealed that both proteins induce bundling of F-
actin filaments in vitro. In addition, preliminary data suggest that raver1 might also interact 
with monomeric actin.
Our data indicate that during muscle differentiation raver1 might link gene expression with 
structural functions of the contractile machinery of muscle. Moreover, due to the common 
localization of raver1 and actin in the cytoplasm and in the nucleus, one can assume that 
both proteins might translocate as complexes to the cytoplasm, possibly accompanied by 
proteinous cargo.
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1.1 Introduction
1.1.1 Actin in vivo
Actin, a protein of 375 amino acids, is one of the most abundant proteins in nature. It is 
encoded by an evolutionary highly conserved gene family (Gallwitz and Sures 1980) and 
ubiquitously expressed in nearly all eukaryotic cells. Actin is known to be involved in a fast 
growing number of essential protein-protein interactions and actin represents also a key 
player of the highly dynamic eukaryotic cytoskeleton. 
The intrinsic ability of actin monomers (G-actin) to reversibly assemble into filamentous 
polymers is the driving force for a multitude of motile cellular functions which are spatially 
and temporarily precisely orchestrated by a myriad of regulatory actin binding and actin 
related proteins (reviewed by (Pollard and Borisy 2003). Despite the vast number of accessory 
proteins, the basis of actin-based motility remains the interaction of actin with itself.
Depending on its actual task, cytoplasmic actin occurs in different forms, such as G-
actin, individual filaments, filament bundles and supramolecular filament assemblies. This 
polymorphism provides the basis for the diversity of actin functions including muscle 
contraction, maintenance of the cell shape, cell migration, cytokinesis, phagocytosis, 
intracellular transport, subcellular organization and definition of embryonal polarity 
(reviewed by (Pollard 2003; Rafelski and Theriot 2004; Disanza et al. 2005; Dormann and 
Weijer 2006; Kaksonen et al. 2006).
Other than the established cytoplasmic conformations, actin can assume unconventional 
forms, which are sometimes transient. For instance, the transiently formed ‘lower dimer’ 
described below (see Chapter 1.1.3), is assumed to trigger the formation of distinct actin 
assemblies (Schoenenberger et al. 1999; Pope et al. 2000; Pelham and Chang 2001; 
Schoenenberger et al. 2002; Ono 2003; Pollard and Borisy 2003; Schmid et al. 2004; Disanza 
et al. 2005).
Over the past decades, various studies have reported the presence of actin in the nucleus in 
addition to the cytoplasm. However, the existence of nuclear actin was a matter of dispute for 
many years because it was regarded as artifact. Although the discovery of nuclear functions 
associated with actin has settled the dispute, the form of nuclear actin remains an enigma. 
Only few authors report on distinct forms of nuclear actin (Gard 1999; Kiseleva et al. 2004; 
McDonald et al. 2006). But there is increasing evidence that distinct pools of unconventional 
forms of actin, which have so far been undervalued, might contribute to the functions carried 
out by nuclear actin (Pederson and Aebi 2005; Schoenenberger et al. 2005; Jockusch et al. 
2006).
Only little is known of the role of actin in the nucleus. But there is increasing experimental 
evidence that nuclear actin might be involved in essential nuclear processes such as chromatin 
remodeling, initiation of RNA polymerase activity during transcription, RNA processing, 
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nucleo-cytoplasmic transport and assembly and maintenance of the nuclear envelope 
(reviewed by (Jockusch et al. 2006; Percipalle and Visa 2006; Chen and Shen 2007)). 
1.1.2 Structural characteristics of actin
To achieve both a mechanistic understanding of the actin function and its interactions 
with other proteins, it is crucial to know the atomic structure of G-actin as well as the 
subunit contacts in F-actin filaments. Initially, crystallization of unbound or unmodified G-
actin failed, because conditions favoring 3-D crystallization induce the formation of F-actin 
filaments. These, in turn, are essentially incompatible with the growth of 3-D crystals. To 
overcome these difficulties, 2-D crystals of skeletal muscle actin were grown in the presence 
of the trivalent lanthanide gadolinium (Dos Remedios and Dickens 1978). However, the 3-
D structure from tilted views of negatively stained 2-D crystals were only resolved at low 
resolution (Aebi et al. 1980; Aebi et al. 1981; Smith et al. 1983; Steinmetz et al. 1998).
The first crystal structures of monomeric actin at atomic resolution were determined 
from a number of complexes with actin binding proteins that prevent polymerization, such 
as DNase I (Kabsch et al. 1990), profilin (Schutt et al. 1993; Chik et al. 1996), gelsolin 
fragments (Mannherz et al. 1992; McLaughlin et al. 1993; Irobi et al. 2003; Vorobiev et al. 
2003) and vitamin D-binding protein (Otterbein et al. 2002). Based on crystal structures 
of a nonpolymerizable tetramethylrhodamine-labeled monomeric actin (TMR-actin) with 
ADP (Otterbein et al. 2001) or with the non-hydrolyzable ATP analog AMPPNP (Graceffa 
and Dominguez 2003) at the active site, structural differences between ADP and ATP actin 
have been revealed (see also (Rould et al. 2006)). More recently, the atomic structure of pure 
polymerization-competent G-actin was solved (Klenchin et al. 2006).
Today, the structure of the monomeric actin is understood in considerable detail. Most 
of the atomic structures of monomeric actin display striking similarities except for some 
very flexible regions, such as for instance the C-terminus and the DNase I binding loop 
in subdomain 2. In addition, depending on the crystallization conditions, the nucleotide-
binding cleft has been found in an open or closed conformation (Otterbein et al. 2001; Sablin 
et al. 2002; Klenchin et al. 2006; Rould et al. 2006).
The asymmetric actin molecule consists of four subdomains that fit into a box measuring 
5.5 x 5.5 x 3.5 nm. The polarity of actin, which is of great importance in actin dynamics, is 
determined by mass differences of the subdomains (Kabsch et al. 1990; Bremer and Aebi 
1992). In the center of the molecule and embedded by all subdomains, there are both a single 
high affinity binding site for a nucleotide (ATP/ADP-P
i
/ADP) and for a divalent cation 
(Mg2+/Ca2+). The cohesion of all subdomains is mainly supported by chemical interactions 
between the phosphate groups of the nucleotide and the divalent cation.
The first structural model of the F-actin filament was published by Holmes and colleagues 
(1990), who determined the approximate orientations and positions the atomic structure of 
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G-actin in the filament by using fiber-diffraction data from oriented gels of actin filaments 
(Holmes et al. 1990). A large number of studies using different analytical techniques 
confirmed the basic features of the ʻHolmes  ʼmodel and have led to its structural refinements 
(e.g. (Milligan et al. 1990; Bremer and Aebi 1992; Lorenz et al. 1993; Lorenz et al. 1995; 
Hoenger 1996; Kim et al. 2002; Holmes et al. 2003; Holaska et al. 2004)).
There is a general agreement that an F-actin filament consists of two intertwined right-
handed long-pitch helical strands, which cross each other, dependent on the experimental 
conditions, approximately every 36 nm. A helical turn is assumed to contain 13 actin subunits 
with an axial subunit repeat of 5.5 nm, and the two helical strands are axially staggered by 
half the axial subunit spacing (described in more detail by (Steinmetz et al. 1997). 
However, due to averaging, the highly ordered assembly of subunits in these models 
disregards the flexibility of subunit interactions and subunits-subunit interfaces that occur 
in F-actin filament (Egelman et al. 1982; Sablin et al. 2002). For instance, as seen for the 
conformational transitions of nucleotide binding cleft during ATP hydrolysis and P
i
-release, 
structural changes of subunits in actin filaments are essential characteristics for the regulation 
of their polarity and dynamics (Sablin et al. 2002). 
Structural plasticity of F-actin filaments was also described in the ʻlateral slipping  ʼmodel 
by Bremer and colleagues (1991), which revealed that both long-pitch helical filament strands 
are capable to independently move along each other (Bremer et al. 1991). This depicted 
that the subunit contacts along the two long-pitch helical strands are continuous and much 
stronger than those between them (reviewed by (Holmes and Kabsch 1991; Bremer and Aebi 
1992)). The two filament strands were also found to be locally unraveled at random sites 
(Aebi et al. 1986; Bremer and Aebi 1992; Steinmetz et al. 1997), which in turn changed the 
screw angle of the filaments.
Although many different studies revealed an astonishingly similar structure of G-actin at 
atomic resolution and to a large extent, there is an agreement concerning the model for the 
F-actin filament, the orientation and position of the subunits in the filament is so far only 
resolved to 8 - 10 Å resolution at best (Holmes et al. 1990; Schmid et al. 2004). Thus, many 
questions concerning the arrangement of actin subunits in polymeric actin assemblies are 
still open.
1.1.3 Actin polymerization and the actin ʻlower dimer  ʼ(LD)
G-actin has the intrinsic ability to polymerize into F-actin filaments in the presence of 
salts. For a long period of time, the basic principle of actin polymerization was described 
as reversible, single pathway reaction that includes the three major steps i) fast monomer 
activation, ii) rate-limiting formation of trimeric nuclei and, iii) fast and linear elongation 
of the filament until a steady state without net filament growth is reached (reviewed by 
(Schoenenberger et al. 2002). 
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When G-actin polymerization is monitored by time-resolved conventional transmission 
electron microscopy (CTEM), it was shown that actin growing filaments undergo remarkable 
morphological changes. Shortly after the onset of polymerization, actin filaments appear 
ragged and branched, whereas at steady state they emerge smooth and linear, without lateral 
protrusions (Steinmetz et al. 1997; Schoenenberger et al. 2002). The formation of lateral 
protrusions at early stages of polymerization, even if transient, does not fit with the simple 
three-step model of polymerization described above.
A new understanding of the actin polymerization pathways and the molecular architecture 
of the actin filament was established by chemical cross-linking experiments using the 
bifunctional sulfhydryl reagent N,Nʼ-1,4-phenylenebismaleimide (1,4-PBM) (Knight 
and Offer 1978). The addition of 1,4-PBM immediately after the salt-induced onset of 
polymerization yields an initial dimeric actin species with an apparent molecular mass of 86 
kDa (Millonig et al. 1988). The production of this so-called ʻlower dimer  ʼ(LD) is transient 
and in its place an ʻupper dimer  ʼ(UD) with an apparent molecular mass of about 120 kDa 
by SDS-PAGE, is subsequently formed. Isolated cross-linked LD is not able to form F-
actin filaments or nucleate filament formation, whereas UD will assemble into filaments 
indistinguishable from those polymerized from unmodified G-actin (Elzinga and Phelan 
1984; Millonig et al. 1988; Steinmetz et al. 1997). 
Given the appropriate experimental conditions, the transient production of the LD at 
early stages of polymerization can be sustained, leading to the presence of cross-linked LD 
at steady state (Steinmetz et al. 1997). The resulting filaments exhibit a ragged phenotype 
similar to that seen shortly after the initiation of polymerization without cross-linker and 
display an increased incidence of lateral protrusions and branches at steady state (Figure 
1).
Thus, a correlation seems to exist between the detection of LD by chemical cross-linking 
experiments and the ragged morphology observed during maturation of F-actin filaments.
Of particular interest is the antiparallel orientation of the subunits in the LD. Crystallography 
revealed comparable atomic structures of actin dimers with subunits in antiparallel orientation 
(Bubb et al. 2002; Reutzel et al. 2004; Klenchin et al. 2006; Lassing et al. 2007).
Figure 2 exemplarily exhibits the structure of a polylysine-actin-latrunculin A dimer at 
3.5 Å resolution, which is likely to be consistent with the antiparallel LD described above 
(Bubb et al. 2002). 
At the interface of the actin monomers within the ribbon-and-strand representation there is 
a disulfide bond between the C-terminal Cys-374 residues of the individual subunits (Figure 
2). It is conceivable that these Cys-374 are covalently cross-linked (Elzinga and Phelan 
1984) by the 1,4-PBM linker which measures 11.1 ± 0.5 Å in length (Green et al. 2001). In 
addition, each subunit contributes two parallel helices to the specific interface that stabilize 
the corresponding helices of the adjacent monomer by intersubunit salt bridges between 
residues Glu-361 and Arg-372 in the model. 
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Figure 1. LD-containing ragged actin filaments. Arrowheads indicate lateral protrusions and branching 
sites that are most likely mediated by incorporated LD in actin filaments at steady state. Scale bar, 30 nm. 
Adapted from Schoenenberger et al. (2002).
Figure 2. Ribbon-and-strand representation of an antiparallel actin dimer. The individual actin subunits are 
colored purple and green. On the left, the disulfide bond connecting the subdomains 1 are depicted as ball-
and-stick and indicated with an arrow. The arrowhead indicates the DNase I binding loop (subdomain 2). On 
the right, a close-up view of the dimer interface at the barbed ends of both subunits reveals the disulfide bond 
between the residues Cys-374 and the four salt bridges between residues Glu-361 and Arg-372 that stabilize 
the helices of the adjacent subunits. Adapted from Bubb et al. (2002).
Further biochemical characteristics of LD and UD are summarized in Table 1 (Millonig 
et al. 1988; Hesterkamp et al. 1993; Steinmetz et al. 1997).
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LD UD
Electrophoretic mobility on SDS-PAGE [kDa] ~ 86 ~ 120
Appearance after onset of actin polymerization early stages later stages
Life span transient persisiting
Compatibility with F-actin filament geometry no yes
Orientation of subunits antiparallel parallel
Cross-linked residues
Self-assembly into F-actin filaments no yes
Table 1. Biochemical und structural characteristics of the actin LD and UD
In conclusion, time-resolved CTEM analysis and chemical cross-linking of polymerizing 
actin with 1,4-PBM revealed that actin is not only capable to assemble into linear filaments, 
but also has the intrinsic ability for branching in vitro. The experimental data suggest that the 
transiently formed LD represents a so far undervalued player in the dynamic assembly and 
turnover of actin networks. Hence, branching and networking of actin in motile cells may 
not be entirely mediated by actin-associated proteins such as the Arp2/3 complex (Mullins 
et al. 1998; Pollard et al. 2000; Pantaloni et al. 2001) but might involve transient actin 
intermediates. It is possible that transiently incorporated LD constitute a platform for the 
binding of Arp2/3 to commence the formation of daughter filaments in vivo (Lassing et al. 
2007). Therefore, the principle function of actin-binding proteins could be to act as catalyst 
or stabilizer for the assembly of suprastructures (Schoenenberger et al. 2002).
1.1.4 Actin polymerization follows a dual pathway
The correlation of LD formation and ragged filament morphology at early stages of 
polymerization has prompted a refined model for the polymerization of actin (Steinmetz et 
al. 1997; Schoenenberger et al. 2002). As shown in Figure 3, this model postulates a dual 
pathway that G-actin can undergo during polymerization into mature F-actin filaments. 
The conventional pathway, also termed the ʻUD pathwayʼ, includes a slow nucleation 
step during which three activated G-actin moieties assemble to form a nucleus (colored 
dark grey) that encompasses all the actin–actin contacts present in mature F-actin filaments 
(Barden et al. 1987).
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Figure 3. Dual pathway for actin polymerization. The bulk of activated G-actin assembles in a slow reaction 
to form a nucleus onto which monomeric actin, UD and LD are added. The latter is formed along the fast 
pathway. At the site of LD incorporation, the growth of a daughter filament might be initiated. However, the 
integrated LD is not stable and will rapidly dissociate. Finally, both pathways converge and the disperse actin 
filaments at steady state exhibit an unbranched and smooth morphology. Adapted from Schoenenberger et al. 
(2002).
Subsequently, the filaments elongate relatively fast through the addition of monomers, 
small oligomers or UD until elongation of unbranched and smooth filaments ends at steady 
state. 
Following the unconventional pathway, termed the ʻLD pathwayʼ, which is restricted to 
a short period of time immediately after the onset of polymerization, G-actin dimerizes in a 
fast reaction to LD (colored red). When transiently incorporated into growing filaments, the 
LD subunits which are not involved in filament formation, jut out from the filaments, thereby 
causing their ragged appearance (Millonig et al. 1988; Steinmetz et al. 1997).
Consistent with this notion, Reutzel and colleagues (2004) suggested that one of the 
LD subunits is integrated into the growing actin filament, causing a rotational movement 
between the two monomers of the LD. Moreover, these subunits could serve as origin for the 
formation of branching daughter filaments (colored light grey). In the absence of accessory 
proteins, LD are labile and dissociate possibly as a result of a conformational change with 
ongoing polymerization. In this process, protruding subunits and emerging filament branches 
would be released. Finally, both pathways converge and all F-actin filaments at steady state 
exhibit a smooth and unbranched morphology (reviewed by (Schoenenberger et al. 2002)).
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1.1.5 LD-like contacts are established in unconventional actin arrays
Because of the transient nature of the LD and because of the lack of suitable tools, it has 
not been possible to detect this actin species in the complex environment of a cell. However, 
the existence and functional importance of LD in vivo have gained support from a number 
of studies which show that several actin binding proteins interact with an antiparallel LD-
like actin dimer with high affinity (Hesterkamp et al. 1993; Bubb et al. 1994). Studying the 
nature of the LD in detail would be greatly facilitated by structures with a stable, native 
arrangement of subunits in LD conformation.
As illustrated in Figure 4, purified muscle actin can form a number of unconventional 
assemblies given the adequate experimental conditions. For example, two-dimensional 
crystalline ʻsheets  ʼ (panel A) and ʻtubes  ʼ (panel B) form in the presence of the trivalent 
lanthanide gadolinium (Dos Remedios 1978; Aebi et al. 1980). Moreover, polymerization 
in the presence of magnesium concentrations above 10 mM will result in tightly packed 
two-dimensional paracrystalline arrays of actin filaments (panel C; (Fowler and Aebi 1982; 
Millonig et al. 1988).
Figure 4. Unconventional actin arrays including LD-like contacts. The formation of actin 2-D crystals (A) 
ʻsheets  ʼand (B) ʻtubes  ʼfrom purified rabbit skeletal muscle actin was induced by gadolinium(III)chloride and 
KCl. (C) Actin paracrystalline arrays were formed by adding 50mM MgCl
2
 to G-actin. Inserts display close-
up views of the ultrastructural patterning of 2-D crystals. Bars, 200 nm.
Similarly, paracrystalline arrays of F-actin have been formed on positively charged lipid 
layers composed of phosphatidylcholine (PC) and quaternary ammonium surfactants (Taylor 
and Taylor 1992).
Interfilament contacts between actin subunits in antiparallel orientation, reminiscent of 
those occurring in LD, are made possible by the lateral alignment of F-actin filaments with 
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opposite polarity. Consistent with this notion, 1,4-PBM cross-linking of paracrystalline 
arrays yields a substantial amount of LD and polymerization in the presence of 50 mM 
magnesium reveals that cross-linked LD persists at steady state (Millonig et al. 1988).
Similar results were obtained when gadolinium-induced actin 2-D crystals were cross-
linked (Millonig et al. 1988), suggesting that some of the contacts in sheets represent the LD 
conformation. 
By fitting the atomic structure of the G-actin monomer (Kabsch et al. 1990) into an EM-
based 3-D reconstruction obtained from negatively stained actin ʻtubesʼ, Steinmetz and 
colleagues (1998) confirmed that actin crystals include antiparallel packing of subunits into 
dimers which are reminiscent of the LD, and that the LD is compatible with the unit cell 
structure and symmetry of the crystals. Moreover, similar to LD, most of the intersubunit 
contacts within or between the dimers in a 2-D crystal are not compatible with the F-actin 
filament symmetry (Aebi et al. 1980; Aebi et al. 1981; Smith et al. 1983; Steinmetz et al. 
1998; Schoenenberger et al. 1999).
Because these unconventional synthetic actin polymers represent stable arrays of LD-like 
subunit arrangement they lend themselves to further characterization of the structure and 
function of the LD.
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1.2 Aims of project
The fundamental idea of this study was to gain insight into the role of the LD in actin 
patterning. Moreover, we aimed at overcoming the transient nature of LD and producing 
supramolecular actin structures with persisting LD subunit contacts. These structures should 
prove useful to test the specificity of antibodies raised against the LD conformation of 
actin.
1.3 Materials and methods
Preparation of monomeric actin (G-actin)
Rabbit skeletal muscle actin was extracted from acetone powder (Spudich and Watt 
1971). The resulting F-actin filament pellet was resuspended in monomer buffer A (2.5 mM 
imidazole, 0.2 mM CaCl
2
, 0.2 mM ATP disodium salt, 0.005% NaN
3
, 0,2 mM DTT, pH 
7.2 - 7.4) and dialyzed with vigorous stirring against buffer A at 4°C for 72 hrs with daily 
buffer changes. The G-actin was centrifuged at 100.000 g for 2 hrs to remove oligomeric 
actin and the upper 3/4 of the supernatant was separated by gel filtration chromatography on 
an equilibrated (buffer A) SuperdexTM 200 prep grade HiLoadTM 26/60 column (Amersham 
Biosciences) at a flow rate of 1 ml/min in buffer A. Eluted fractions of 2.5 ml were collected 
and the peak fractions were analyzed by SDS-PAGE. The protein concentration of monomeric 
peak fractions was determined by measuring the absorbance at 280 nm. Monomeric G-actin 
was stored in buffer A at 4°C and used within 2 weeks. 
Intermolecular cross-linking of G-actin with N, Nʼ-1,4-phenylenebismaleimide 
Intermolecular cross-linking of G-actin with sulfhydryl reagent N,Nʼ-1,4-
phenylenebismaleimide (1,4-PBM) was carried out essentially as described (Millonig et al. 
1988; Steinmetz et al. 1997). All reagents were freshly prepared and kept at 4°C. Briefly, 1,4-
PBM was dissolved in dimethylformamide (DMF) at 5 mM and diluted in 20 mM sodium 
borate, pH 9.5, containing 100 mM KCl and 0.2 mM CaCl
2
, prior to use. 
To optimize the yield of LD, polymerization of freshly isolated G-actin (1 - 1.5 mg/ml) 
was induced by the addition of CaCl
2
 to a final concentration of 20 mM, and cross-linking 
was immediately initiated by the addition of an equal volume of 1,4-PBM diluted in 20 mM 
sodium borate, 20 mM of CaCl
2
, pH 9.5, to achieve a final molar ratio of 0.5:1 1,4-PBM/
actin. The reaction was quenched after 20 min at room temperature by the addition of 0.001 
v/v β-mercaptoethanol. The efficiency of cross-linking was monitored by SDS-PAGE and 
subsequent Coomassie Brilliant blue staining (Figure 5).
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Figure 5. Purification of cross-linked LD by gel filtration chromatography. SDS-PAGE of consecutive fractions 
indicates that an efficient separation of the intermolecularly cross-linked LD from the intramolecularly cross-
linked actin moiety requires repeated runs on a Superdex 200 column. After the first run, fractions containing 
mostly LD were combined, concentrated and re-chromatographed. After the 2nd run (right panel), peak fractions 
contained only small amounts of monomeric actin (> 1%). The molecular masses in kDa of standard proteins 
are indicated on the right.
Purification of the actin ʻlower dimer  ʼ(LD)
The covalently cross-linked actin solution was dialyzed against buffer A at 4°C for at 
least 36 hrs with several buffer changes and then centrifuged at 100.000 g for 2 hrs in a 
swing-out rotor. To purify LD, the upper 3/4 of the solution was separated by gel filtration 
chromatography on a Superdex 200 (26/60) column equilibrated in buffer A at a flow rate of 
1 ml/min. The eluent was collected in 2 ml fractions.
The peak fractions were analyzed by SDS-PAGE (Figure 5). Fractions containing > 80% 
LD were pooled and re-chromatographed to further reduce contaminating, intramolecularly 
cross-linked monomeric actin. Finally, fractions containing ~ 95% pure cross-linked LD 
were used for copolymerization assays with G-actin. The protein concentration of the LD 
was determined by measuring the absorbance at 280 nm.
Copolymerization of cross-linked LD and G-actin
Different ratios of purified cross-linked LD and monomeric G-actin were mixed and 
then polymerization was induced at room temperature by the addition of salt to a final 
concentration of either 100 mM KCl or 2 mM MgCl
2
/50 mM KCl, and a twofold molar 
excess of phalloidin over actin where indicated. After 2 hrs, the polymerization reaction 
was analyzed by a standard pelleting assay as schematically illustrated in Figure 6. Briefly, 
the total polymerization reaction ʻT  ʼwas centrifuged at 100.000 g at 4°C for 1 hr yielding a 
supernatant (S) that contains non-polymerized actin and small oligomers and a pellet fraction 
(P) with filamentous actin.
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Figure 6. Schematic representation of the standard pelleting assay.
The supernatant was removed and the pellet was washed in the one volume of 
polymerization buffer F (buffer A containing either 100 mM KCl or 2 mM MgCl
2
/50 mM 
KCl). After washing, the pellet was gently resuspended in one volume of buffer F and 
incubated for at least 1 hr at 4°C. 
Corresponding aliquots of the total protein input ʻTʼ, the high-speed supernatant ʻS  ʼand 
the resuspended pellet ʻP  ʼwere analyzed on 12% SDS-PAGE gels by Coomassie Brilliant 
blue staining. In addition, aliquots of ʻP  ʼwere examined by CTEM and STEM (see below).
Preparation of actin 2-D crystals
The preparation of two-dimensional actin crystals has been previously described (Dos 
Remedios 1978; Aebi et al. 1981). Briefly, G-actin (1.0 - 1.5 mg/ml in buffer A) was dialyzed 
in a 0.25-inch diameter dialysis tubing with a molecular weight exclusion limit of 12.000 Da 
against ʻ prepolymerization buffer  ʼ(2.5 mM imidazole, 0.5 mM CaCl
2
, 0.25 mM dithiothreitol, 
0.005% NaN
3
, pH 7.25) for 5 hrs at 4°C. The dialysis bag was then carefully transferred to 
two liters of ʻcrystallization buffer  ʼ(2.5 mM PIPES, 0.25 mM dithiothreitol, 0.005% NaN
3
) 
containing 25 mM KCl and a 5:1 molar ratio GdCl
3 
over actin (ʻsheet  ʼconditions) or 75 mM 
KCl and a 9:1 molar ratio GdCl
3 
over actin for (ʻtube  ʼconditions) for at least 6 hrs at 4°C 
with minimal agitation. The 2-D crystals were processed within 24 hrs.
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Conventional Transmission Electron Microscopy (CTEM)
For specimen preparation, carbon-coated 200 mesh/inch copper grids for CTEM were 
rendered hydrophilic by gentle glow discharge in air at low pressure. 5 µl sample droplets 
were then adsorbed to the grids for 30 - 60 s, washed four times with double-distilled water 
to remove salts, and subsequently negatively stained with 2% uranyl acetate, pH 4.5, for 
10 s according to standard protocols (Harris and Agutter 1970; Aebi et al. 1981). Analogue 
high resolution micrographs were taken at a nominal magnification of 50.000x on Hitatchi 
H 7000 and H 8000 microscopes at acceleration voltages of 100/200 kV. Low-resolution 
images were taken on a fully digitalized FEI Philips Morgagni 268D at an acceleration 
voltage of 80 kV.
Scanning Transmission Electron Microscopy (STEM)
STEM analysis of negatively stained specimens was performed as described previously 
(Muller and Engel 1998; Muller and Engel 2001). Briefly, aliquots of the resuspended pellet 
fractions from copolymerization experiments were adsorbed for 1 min to freshly glow 
discharged thin carbon film that spanned a thick fenestrated carbon layer covering a gold-
plated copper microscopy grid. The specimens were washed on four drops of quartz bi-
distilled water, negatively stained with 0.75% uranyl formate, pH 4.25, and air dried. Images 
were recorded with the STEM (STEM HB5; Vacuum Generators, East Grinstead, England) 
operated at an accelerating voltage of 100 kV and a nominal magnification of 500.000x.
Mass determination by STEM
For mass-per-length measurements (MPL), 5 µl aliquots of the sample were adsorbed for 
1 min to glow discharged STEM microscopy films; thin carbon films that spanned a thick 
fenestrated carbon layer covering 200-mesh/inch, gold plated copper grids. The grids were 
then blotted and washed on four drops of quartz bi-distilled water to remove buffer salts, and 
freeze-dried at -80°C and 5·10-8 Torr overnight in the microscope.
Tobaccco mosaic virus (TMV) particles served as mass standard. These were similarly 
adsorbed to separate microscopy grids, washed on four droplets of 10 mM ammonium 
acetate, air-dried and placed in the microscope together with the sample.
Digital STEM dark-field images were recorded using a Vacuum Generator HB-5 STEM 
interfaced to a modular computer system (Tietz Video and Image Processing Systems GmbH, 
D-8035 Gauting) operated at an accelerating voltage of 80 kV and a nominal magnification 
of 200.000x. Mass loss induced by the electron beam was experimentally determined as 
described previously (Engel 1978; Muller et al. 1992).
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The mass analysis was carried out using the IMPSYS program package as detailed in 
(Engel and Reichelt 1988; Muller et al. 1992). Accordingly, filament segments were manually 
selected in square boxes and tracked. The total scattering of each filament region was then 
calculated and the scattering of the supporting carbon film deducted. Division by the filament 
length gave the MPL. The resulting values were scaled according to the mass measured for 
TMV and corrected for beam-induced mass loss (Muller et al. 2001). The mass values were 
then displayed in histograms and described by Gauss curves.
Width measurement of actin filaments
The widths of actin filaments were measured manually from uncompressed digital STEM 
electron micrographs of negatively stained specimens (see above) using the image processing 
and analysis software ImageJ. Width measurements were carried out on both, conventional 
F-actin filaments that were polymerized from G-actin and hybrid actin filaments that were 
copolymerized from G-actin and LD. The filament widths were measured perpendicular 
to the filament axis at the sites of maximal width between two consecutive crossovers of 
the two long pitch helical strands. In the case of laterally protruding protein, the maximum 
widths of the filaments with and without the protrusion were measured.
20
Chapter 1        The actin ʻlower dimer  ʼmodulates the structure of actin filaments
1.4 Results
1.4.1 Copolymerization of G-actin and cross-linked actin ʻlower dimer  ʼ(LD)
In the present study we copolymerized G-actin and covalently cross-linked LD in varying 
ratios in the presence of 100 mM KCl and a twofold molar excess of phalloidin. Phalloidin, 
a bicyclic heptapeptide toxin of the toadstool Amanita phalloides (Wieland and Faulstich 
1977; Wieland and Faulstich 1978) blocks actin subunits in F-actin filaments and prevents 
monomer release from the filaments ends (Estes et al. 1981; Coluccio and Tilney 1984). The 
incorporation of LD into filamentous structures was biochemically analyzed by high-speed 
pelleting assays and subsequent SDS-PAGE and visualized by CTEM.
1.4.2 G-actin and cross-linked LD cosediment in high-speed pelleting assays
G-actin and cross-linked LD mixed at different ratios were copolymerized for one hour 
at room temperature and then centrifuged at 100.000 g in order to separate unpolymerized 
(supernatant) from polymerized or aggregated protein (pellet). Subsequently, aliquots of 
the total protein input (T) at the onset of polymerization and the supernatant (S) and the 
resuspended pellet fraction (P) at steady state were separated on a 12% SDS-PAGE gel and 
stained with Coomassie Brilliant Blue.
As documented in Figure 7, at steady state, the native actin pool was entirely pelleted 
in the absence, but also in the presence of LD. Copolymerization of native actin and LD at 
a molar ratio of 10.5:1.8 [µM] yielded pellets that contained LD in addition to the native 
actin with virtually no protein in the supernatant. Increasing the fraction of LD lead to a 
higher amount of LD in the pellet. At the same time, the amount of LD that remained in the 
supernatant slightly increased. In the absence of native actin (panel on the far right), addition 
of 100 mM KCl and phalloidin did not induce significant amounts of LD-structures that 
pelleted at high speed, and most of the LD stayed in the supernatant.
In conclusion, the high-speed pelleting experiments suggest that cross-linked LD is able 
to copolymerize with native actin into filamentous structures. Considering that the LD might 
interfere with the formation of actin filaments, we cannot rule out that the pellets represent 
unstructured aggregates rather than filaments, although the control experiment with purified 
LD alone indicates that LD does not form aggregates under the given salt conditions. Hence, 
in Chapter 1.4.3 the pellet factions containing cosedimented actin and LD were further 
examined by CTEM.
Corresponding pelleting experiments were carried out in the absence of phalloidin. In 
contrast to the experiments with phalloidin, SDS-PAGE analysis revealed that the initial G-
actin fraction was not entirely polymerized and pelleted in the presence of the LD (data not 
shown).
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1.4.3 The incorporation of cross-linked LD alters the morphology of actin filaments
For CTEM analysis, aliquots of the resuspended pellet fractions from copolymerization 
of G-actin with different amounts of cross-linked LD were adsorbed to EM-grids and 
negatively stained with 2% uranyl acetate. Micrographs representing the cosedimented 
fraction from different actin:LD ratios are shown in Figure 8. As expected, high-speed 
centrifugation of G-actin polymerized without LD (Figure 8 A) yielded the highly ordered, 
smooth F-actin filaments that are described in the literature (Millonig et al. 1988; Milligan 
et al. 1990; Schoenenberger et al. 1999). Typically, crossovers are spaced regularly along the 
filaments and subunits appear well-aligned within the helices. Figure 8 B displays filaments 
from copolymerization of G-actin and LD at a molar ratio of 10.5:1.8. Consistent with the 
biochemical analysis that suggested a copolymerization of LD and actin (Figure 7), these 
filaments appear less straight and slightly irregular compared to bona fide F-actin filaments 
in panel A. In particular, regular crossover spacings are less evident. With increasing 
amounts of LD present at the onset of copolymerization, the subtle alterations of the filament 
architecture became more pronounced. At a molar ratio of 7.0:3.5 actin:LD (Figure 8 C), the 
overall contour of the filaments appeared to be more ragged. 
Figure 7. Cosedimentation of native actin and cross-linked LD. Different ratios of G-actin:LD (indicated 
in the top line) were copolymerized by the addition of salt to a final concentration of 100 mM KCl and a 2:1 
molar excess of phalloidin over actin. After centrifugation at 100.000 g, samples were washed and resuspended 
in the initial volume with filament buffer. Aliquots of the total protein input (T), the supernatant after high-
speed centrifugation (S) and the resuspended pellet fractions (P) were separated on a 12% SDS-PAGE gel 
and stained with Coomassie Brilliant Blue. In the presence of native actin, LD was predominantly found in the 
pellet fraction whereas without actin, LD remained mostly in the supernatant. The molecular masses in kDa of 
standard proteins are indicated on the right.
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Typically, small lateral protrusions were jutting out from the filaments and disruptions 
occurred along the filament axis. At a slight molar excess of LD over actin (5.3:4.8), lateral 
protrusions were more frequent  (Figure 8 D - Dʼʼ ) and the regular substructure of F-actin 
filaments (Figure 8 A) was no longer detectable. Remarkably, several cases of junctions where 
two filaments are linked were observed. In most instances, one of the filaments terminated at 
the junction, which might indicate that this structure represents a branching site rather than 
two random filaments crossing each other. 
Together, biochemical and electron microscopic studies showed that copolymerization of 
G-actin and cross-linked LD in the presence of phalloidin lead to the stabile incorporation 
of LD into actin filaments. With increasing amounts of LD, the filament morphology was 
significantly altered. In particular, the substructure characteristic for F-actin filaments was 
perturbed and small lateral protrusions were prominent.
Figure 8. CTEM micrographs of copolymerized native actin and cross-linked LD. Varying ratios of G-actin:
LD were copolymerized by adding 100mM KCl and a 2:1 molar ratio of phalloidin over actin. Negatively stained 
specimens of resuspended high-speed pellet fractions are shown. F-actin filaments (A), copolymerization of 
G-actin and LD at molar ratio of 10.5:1.8 (B), 7.0:3.5 (C) and 4.8:5.3 (D - Dʻʻ ). Arrowheads in (C) point to 
disruptions of the filament structure. Arrow in (D) marks a possible branching site. Bar, 50 nm.
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Moreover, at high levels of LD, the fraction of un-incorporated LD increased, indicating 
that LD-incorporation is only tolerated to a certain extent. Consistently, filamentous structures 
were no longer observed in mixtures with a large excess of LD over actin. This finding 
suggests that a minimal number of proper actin subunit interactions are needed to allow for 
filament formation in the presence of LD. Moreover, numerous cases of filaments ending at 
the side of other filaments suggest that LD incorporation is conducive to branching. 
For a more detailed structural analysis of the effects of LD incorporation on F-actin 
filament architecture, we processed the hybrid filaments for scanning transmission electron 
microscopy (STEM) analysis.
1.4.4 Scanning transmission electron microscopy (STEM)
In STEM technology, a field emission gun produces an electron beam with a narrow 
energy distribution allowing the electrons to be focused to a sharp point. The rastering of the 
beam over the sample in combination with a high-angle detector capable of counting single 
electrons allows for mass measurements and the generation of mass maps. Moreover, the 
highly sensitive detector system and thin carbon support films used, result in a high signal 
to noise ratio allowing even unstained protein to be detected and quantitatively measured 
(Muller et al. 1996). Because STEM simultaneously provides images and quantitative 
data, it is invaluable for structure determination. Its most successful application is the mass 
determination and mass mapping of protein complexes and supramolecular structures.
We used STEM to compare the morphology of conventional F-actin filaments with that of 
hybrid filaments containing actin and LD subunits. The specific focus was to investigate the 
mass-per-length (MPL) of hybrid filaments and compare it to that of conventional F-actin 
filaments. Based on previous findings, we assumed that the incorporation of dimeric actin 
protomers in hybrid filaments should result in a higher MPL, and that the MPL difference 
between both filament types would provide more information of the actual incorporation rate 
of LD in hybrid filaments. 
Moreover, by analyzing digital STEM images of negatively stained specimens we 
intended to obtain a more detailed picture of the morphological changes brought about by 
the LD incorporation.
1.4.4.1 Mass-per-length measurements of unstained F-actin and hybrid filaments
For mass-per-length measurements (MPL) of unstained specimens, a droplet of the 
resuspended pellet fractions from copolymerization of actin and cross-linked LD in the 
presence of phalloidin (see Chapter 1.3) was adsorbed to glow discharged STEM grids. After 
removal of buffer salts, the specimens were freeze-dried in the microscope.
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To examine the effect of LD incorporation in actin filaments, we compared the MPL of 
unstained F-actin filaments and hybrid filaments, which were copolymerized from G-actin 
and LD. We mainly focused on hybrid filaments, which were copolymerized from G-actin 
and LD at a molar ratio of 4.8:5.3 µM, because they frequently exhibit lateral protrusions. 
For analysis, square boxes (80 pixel2) containing filament segments were manually 
selected from digital STEM dark-field images and the MPL and the full-width half-maximum 
(FWHM) of the filament segments were calculated computationally. MPL-data describe the 
calculated entire signal curve of an object, whereas the FWHM-data depict the width of 
the signal curve at its half maximum value. For circular and tubular objects, the analysis of 
the FWHM is a valid alternative to the MPL, because by excluding the information at the 
periphery of the objects measured inaccurate data analysis at the blurred and noisy edges is 
avoided.
Table 2 displays the data obtained from STEM analysis for both conventional F-actin and 
hybrid filaments.
Table 2. MPL and FWHM of F-actin filaments and hybrid filaments determined by 
STEM
F-actin 
filaments
(n = 65)
Hybrid 
filaments
(n = 69)
Average MPL [kDa/nm] 14.7 14.6
SD 1.4 1.3
Gaussian peak MPL [kDa/nm] 14.6 14.6
SD 1.3 1.3
FWHM [nm] 7.8 8.0
SD 0.7 0.8
n, number of measuring points; MPL, mass-per-length;
SD, standard deviation; FWHM, full-width half-maximum
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The average MPLs of F-actin filaments (14.7 kDa/nm) and hybrid filaments (14.6 kDa/
nm) were similar. Surprisingly, a slight MPL decrease was recognized for hybrid filaments. 
In related experiments using different conditions for F-actin filament and hybrid filament 
polymerization (data not shown), we observed a similar tendency for MPL values to decrease 
as a result of LD incorporation. 
Figure 9 depicts that the MPL of both filament types distribute almost congruent within 
the Gaussian curve. Depending on the X-axis scale factor used, the Gaussian peak for hybrid 
filaments fits between 14.50 - 14.55 kDa/nm. For F-actin filaments, the Gaussian peak was 
always 14.60 kDa/nm. Moreover, the FWHM of hybrid filaments (8.0 nm) and F-actin 
filaments (7.8 nm) is almost identical.
Contrary to the biochemical evidence and CTEM analysis which clearly demonstrate the 
co-polymerization of LD and actin into hybrid filaments with an altered geometry, STEM 
data did not reveal any difference between MPL and FWHM in hybrid versus conventional 
F-actin filaments.
It appears that those two parameters are not suitable to characterize the consequences of 
LD incorporation on filament geometry.
Figure 9. MPL analysis of F-actin filaments and hybrid filaments. MPLs of (A) native F-actin filaments and 
(B) hybrid filaments that were copolymerized from G-actin monomers and LD in a molar ratio of 4.7:5.3 µM. 
The Gaussian fits (indicated by the dotted lines) reveal no MPL differences between the two types of filaments. 
The ordinate displays the number of boxes; MPL, mass-per-length.
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1.4.4.2 Highly ordered F-actin filaments versus morphologically altered hybrid 
filaments visualized at high magnification
In order to evaluate the structural impact of LD in hybrid filaments in detail, we examined 
negatively stained specimens from resuspended pellet fractions of copolymerized actin and 
cross-linked LD and actin (see Chapter 1.3) at a nominal magnification of 500.000x by 
STEM. A gallery of highly magnified, inverted STEM micrographs is shown in Figure 10.
The highly ordered structure of conventional F-actin filaments assembled from native 
G-actin is presented in panel A. The smooth appearance and the constant diameter of the 
filaments, as well as the regular crossover repeats and homogenous staggering of subunits 
along the longitudinal filament axis, confirm the proper assembly of monomers into bona 
fide F-actin filaments.
In contrast, the hybrid filaments resulting from copolymerization of G-actin and LD at 
a molar ratio of 4.8 µM:5.3 µM, characteristically displayed some unique features, namely 
lateral protrusions (Figure 10 B) and branching (Figure 13). The hybrid filaments revealed 
irregular staggering of subunits and numerous prominent lateral protrusions that were 
irregularly spaced along the filament axis and resulted in a ragged appearance accompanied 
by an increase of the average filament diameter. Although some of the protrusions seemed 
to be associated with the filament rather loosely, the majority were actual constituents of the 
filament structure. 
1.4.4.3 Width measurement of negatively stained F-actin and hybrid filaments on highly 
magnified STEM images
To determine the width at different sites of hybrid and conventional F-actin filaments, 
the image processing and analysis software ImageJ was used. In particular, the width at 
individual sites between two recognizable crossovers of the long-pitch helical strands was 
measured perpendicular to the filament axis. Only filament sections that lacked morphological 
disruptions such as breaks, were considered.
At the sites selected, filaments exhibited either a smooth morphology or a laterally 
protruding structure. In the latter case, a corresponding hypothetical filament width excluding 
the protrusion was also determined. Occasionally, the prevailing smooth morphology of 
the conventional F-actin filaments also appeared to be interrupted by a protrusion. Based 
on several earlier studies which demonstrate conventional F-actin filaments at steady state 
exhibiting a smooth morphology (Steinmetz et al. 1997), we concluded that the lateral 
protrusions in our F-actin filament preparation represent an artifact caused by free protein 
that randomly associated with the filaments. For this reason, the particular data points were 
not considered in the statistical calculations of the width of conventional F-actin filaments.
27
Chapter 1        The actin ʻlower dimer  ʼmodulates the structure of actin filaments
Figure 10. STEM analysis of negatively stained specimens from copolymerization of cross-linked LD with 
native actin. Copolymerization of cross-linked LD with native actin was induced by the addition of salt to a 
final concentration of 100 mM KCl in the presence of a 2:1 molar ratio of phalloidin over actin. The filaments 
were centrifuged at high speed (100.000 g), resuspended and then processed for STEM analysis. In (A), F-actin 
filaments from polymerization of pure G-actin exhibit a smooth morphology with a highly ordered substructure. 
(B) If native actin and LD were copolymerized at a molar ratio of 4.8:5.3, filaments display abundant lateral 
protrusions. Bars in A, B, 20 nm; in galleries, 10 nm. The individual sites of width measurements are marked 
with lower case letters and shown at higher magnification in the adjacent galleries. Note the lateral protrusions 
that eminate from hybrid filaments in (B)a, e and g. 
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As illustrated in Table 3, 152 individual measurements were collected for conventional 
F-actin filaments and 165 for hybrid filaments. The width of hybrid filaments ranged from 
4.76 to 17.90 nm. As a result of LD incorporation, width variability of hybrid filaments is 
significantly larger compared to smooth F-actin filaments, which range from 7.98 to 16.23 
nm in width.
Table 3. Width measurements of conventional F-actin filaments and hybrid actin 
filaments
F-actin
filaments
(n = 152)
Hybrid
filaments
(n = 165)
Filament width [nm] 7.98 - 16.23 4.76 - 17.90
Average filament width [nm] 10.58 11.63
SD 1.25 1.86
n, number of measuring points; SD, standard deviation
Moreover, consistent with a high frequency of lateral protrusions, a 9.9% increase in 
the average width was detected in hybrid filaments (11.63 nm) compared to that of F-actin 
filaments (10.58 nm). Statistical analysis using the unpaired t-test revealed this increase to 
be statistically extremely significant (p < 0.0001).
Figure 11 displays the width distribution at 0.3 nm intervals for both types of filaments. 
Note that for hybrid filaments only the data from width maxima at sites containing lateral 
protrusions were included, not the hypothetical filament width lacking these protrusions.
The width distribution measured from F-actin filaments ranges predominantly from 8.71 - 
12.90 nm, with a maximum frequency between 9.01 - 11.40 nm. In contrast, hybrid filaments 
exhibited a more even width distribution over the entire range with a slight clustering between 
9.01 and 13.80 nm.
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In the following we evaluated the width of the lateral protrusions in hybrid filaments. 66 
individual protrusions were analyzed (Table 4).
Table 4. Width measurements of lateral protrusions from hybrid filaments
Figure 11. Width distribution of F-actin and hybrid filaments. Width frequencies were plotted at 0.3 nm 
intervals. White bars represent F-actin filaments; black bars, hybrid filaments.
Lateral
protrusions
(n = 66)
Width [nm] 1.54 - 6.92
Average width [nm] 3.66
SD 1.35
  n, number of measuring points; SD, standard deviation
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The average width of the lateral protrusions measured 3.66 nm. Although the maximal 
distance from the filament surface was 6.92 nm, 90.9% of the protrusions did not extend more 
than half of the average diameter of hybrid filaments without protrusions (10.87 nm/2=5.44 
nm). The dimension of the average protrusion corresponds well with the dimensions of an 
actin subunit. Thus, it is conceivable that the protrusion represents the free actin subunit of 
the incorporated LD that is jutting out from the filament.
A comparison of the width of F-actin filaments and hybrid filaments measured at sites 
without lateral protrusions (Table 5) revealed only a minor difference between the two 
diameters, which was not significant according to unpaired t-test (p = 0.860).
Table 5. Width measurements of conventional F-actin filaments and hybrid filaments 
without lateral protrusions
F-actin
filaments
(n = 152)
Hybrid
filaments
(n = 99)
Width [nm] 7.98 - 16.23 8.37 - 17.25
Average filament width [nm] 10.58 10.87
SD 1.25 1.38
n, number of measuring points; SD, standard deviation
This finding supports the notion that the LD incorporation along hybrid filaments occurs 
at random: some filament segments frequently exhibit laterally protruding LD subunits 
whereas others have a smooth contour and highly ordered substructure comparable to that 
of F-actin filaments.
Another striking effect of LD incorporation was the perturbation of the crossover repeats 
of the long-pitch helical strands in hybrid filaments. An extreme example of a hybrid filament 
segment lacking any evidence of a crossover is shown in Figure 12. It is conceivable that the 
absence of helical structure in this filament segment prevented phalloidin from binding the 
hybrid filament. As a result, both monomeric (asterisks) and dimeric (arrowheads) protomers 
possibly dissociated, leading to a high background staining.
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Figure 12. Perturbation of crossover repeats in hybrid filaments. Native actin and LD were copolymerized 
at a molar ratio of 4.8:5.3. The filament displays a perturbed morphology lacking axial repeats. Dissociated 
protein moieties cover the EM-grid. Potential actin monomers and antiparallel dimers are indicated by asterisk 
and arrowheads, respectively. Bar, 10 nm. 
Because the axial repeats in hybrid filaments often could not be localized, a general 
comparison with the regular repeats in F-actin filaments is not possible. However, segments 
of hybrid filaments that are devoid of lateral protrusions, exhibited axial repeats comparable 
to those of F-actin filaments.
Another noteworthy feature of hybrid filaments is the occurrence of ʻdaughter  ʼfilaments 
that appear to emanate from the ʻmother  ʼfilament at different angles. An example of such 
a filament that seems to be branching off another filament at an angle of approximately 
90° is shown in Figure 13. At the interface of the two filaments, a prominent horseshoe-
like subunit, which is reminiscent of the shape of an actin monomer, encompassed a lateral 
protuberance of the adjacent filament. Although the exact origin of the protomers at the 
contact site is unclear, they evidently establish contacts between two filaments, which is 
consistent with the notion of branching. We cannot rule out that mechanical forces during 
sample preparation have destroyed many of these delicate structures, rendering a detailed 
examination of the branching rate unfeasible.
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Figure 13. Branching of hybrid filaments. At the interface of the two filaments (circle), a prominent horseshoe-
like subunit, which is reminiscent of the shape of an actin monomer, encompasses a lateral protuberance of 
the adjacent filament. Prominent lateral protrusions (asterisks) approximately extend to half of the filament 
diameter. Bar, 20 nm.
In summary, ultrastructural analysis by electron microscopy showed that the 
copolymerization of cross-linked LD with actin produced filamentous structures with 
randomly incorporated LD. STEM data revealed that incorporated LD on one hand perturbed 
the spatial packing of the actin subunits in the filaments, and on the other hand, their laterally 
protruding free subunits led to a ragged appearance of the hybrid filaments. Consistent with 
the notion that the protruding LD subunit might trigger a branching event, we observed an 
increased incidence of hybrid filaments that were linked at different angles. In addition, 
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hybrid filaments displayed an overall increase of the average filament width compared to 
conventional F-actin filaments. However, the extent of LD incorporation is limited and a 
minimum amount of monomeric actin subunits that establish the corresponding filament 
contacts are required to form hybrid filaments. The presence of LD in the filaments also 
affected the crossover spacing of the two long-pitch helical strands: crossovers varied 
considerably, provided crossovers were detected at all.
The finding that the LD incorporation did not increase the mass-per-length in hybrid 
filaments was somewhat unexpected. A likely explanation for the absence of the mass 
increase can be found in the large structural heterogeneity of hybrid filaments. Clearly, more 
extensive data sets are required to establish the relation of incorporated LD and actin filament 
geometry.
34
Chapter 1        The actin ʻlower dimer  ʼmodulates the structure of actin filaments
1.5 Discussion
LD incorporation alters the appearance of actin filaments
Time resolved CTEM analysis of polymerizing actin has shown that filaments at early 
stages of polymerization appear ragged on account of numerous protrusions that jut out from 
the filament surface, and mature into smooth F-actin filaments over time (Millonig et al. 1988; 
Steinmetz et al. 1997). Following the polymerization reaction by chemical cross-linking 
with 1,4-PBM revealed the kinetics of LD formation to concur with the ragged filament 
appearance, suggesting that transient incorporation of a native LD via one of its subunits into 
growing F-actin filaments might be the origin of the ragged morphology. Consistent with 
this notion, polymerization in the presence of 1,4-PBM cross-linker and phalloidin yielded 
ragged filaments even at steady state and the presence of cross-linked LD in these filaments 
was biochemically confirmed (Steinmetz et al. 1997)(reviewed by (Schoenenberger et al. 
2002)). However, the amount of incorporated LD and the effects on the filament geometry 
were not elucidated.
The experiments described above were designed to test whether cross-linked LD could 
be stably incorporated into F-actin filaments and how the incorporation affected standard 
filament geometry. In contrast to an earlier study, where polymerization was initiated in 
the presence of 1,4-PBM and phalloidin was added immediately to prevent dissociation 
of cross-linked moieties (Millonig et al. 1988; Steinmetz et al. 1997), we chose a slightly 
different approach. We copolymerized monomeric G-actin and previously cross-linked LD 
at defined ratios and removed unpolymerized moieties by high-speed centrifugation. This 
approach offers the advantage that the incorporation of the LD can be quantitatively assessed 
by SDS-PAGE analysis of pellet and supernatant fractions after high-speed centrifugation. 
Accordingly, biochemical analysis showed that the amount of LD incorporation correlated 
with the amount of LD present at the onset of polymerization over a certain range. This 
data is consistent with the notion that preformed LD can be incorporated into growing actin 
filaments. At the same time, the amounts of unincorporated LD in the supernatant also 
increased while the monomeric G-actin fraction had entirely polymerized (see Figure 7). 
This finding indicates that the ratio between LD and monomeric subunits in structures found 
in the pellet is limited and that subunit-subunit contacts as they occur in F-actin filaments are 
required for the overall integrity of the filament structure.
The morphological effects of LD incorporation were similarly influenced by the amounts 
of LD. Ultrastructural analysis by CTEM and STEM revealed that the protrusions that jut out 
from the filament axis in hybrid filaments become more frequent at higher LD concentrations 
(see Figures 8 and 10). Overall, hybrid filaments displayed a ragged morphology similar to 
the appearance of F-actin filaments during early stages of polymerization (Steinmetz et al. 
1997; Schoenenberger et al. 2002). Our data support the earlier notion by Steinmetz and 
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colleagues that the transient incorporation of LD via one of its subunits is part of the early 
polymerization process and gives rise to a ragged morphology in growing filaments.
Interestingly, hybrid filaments resulting from copolymerization of equal amounts of G-
actin and LD, exhibit segments with a ragged morphology, but also segments that show the 
smooth, well-ordered appearance of native F-actin filaments (see Figure 10). It is conceivable 
that the conventional subunit interactions of monomeric actin in these segments are essential 
to maintain a filamentous structure in the presence of persisting LD. Consistently, when LD 
is present at a large excess over G-actin in the polymerization reaction, the number of hybrid 
filaments is reduced. High-speed cosedimentation assays (see above) provide further support 
for the limited tolerance of LD incorporation. Moreover, although the irregular morphology 
of hybrid filaments suggests a random incorporation of LD, the constant ratios of LD and 
monomeric actin observed in independent high-speed cosedimentation assays suggest that 
the LD incorporation must be somehow regulated.
Furthermore, the orientation of the incorporated LD within the hybrid filament is not 
yet resolved. The incorporation via on of its subunits, leaving the second subunit freely 
projecting from the filament surface, represents only one possible orientation. One could 
also imagine alternative orientations, for example along the filament axis, which are even 
less compatible with the conventional filament geometry and thus significantly perturb the 
molecular filament architecture. Consistent with this notion, hybrid filaments were found 
to display local disruptions along the filament axis, irregular axial subunit arrangement, as 
well as deviations from the mean actin filament crossover spacing (see Figures 8, 10, 12 and 
13).
LD as an initiator of filament branching
It has previously been speculated that actin has the intrinsic ability to initiate the branching 
of filaments even in the absence of the Arp2/3 complex (reviewed by (Schoenenberger et al. 
2002), which is generally believed to mediate the formation of actin branches (for a recent 
review see Pollard 2007). The working hypothesis for role of the LD in the polymerization 
pathway suggests that during the transient incorporation of an LD, the protruding subunit that 
is not involved in filament contacts, might act as an initiator of filament branching. Under 
experimental conditions that overcome the transient nature of the LD incorporation during 
F-actin polymerization, the probability for branching was 25-fold higher than in normal 
F-actin filament preparations (Steinmetz et al. 1997). A similar observation was made for 
LD containing hybrid filaments. Although the incidence of branching appeared significantly 
higher in hybrid filaments compared to F-actin filaments, we did not quantify the number of 
branches mainly for two reasons: (i) many filament branches may have detached from their 
‘mother’ filaments during the processing for electron microscopy, and (ii) the resolution of 
CTEM images of negatively stained hybrid filaments, even at high magnification, does not 
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allow for an unambiguous distinction between structurally connected, true branching sites 
and independent filaments that incidentally join to form a branch. In some cases, the latter 
difficulty could be overcome by recording STEM images at a nominal magnification of 
500.000-fold, yielding a closer view of the protein interface at the branching site (Figure 
13). However, the monitored area is extremely small and thus this approach is not feasible to 
examine the frequency of branching events.
LD incorporation leads to an increase in filament width
Image processing was used to quantitatively assess the effects of LD incorporation on 
the geometry of hybrid filaments. A statistically highly significant increase of the average 
width of approximately 10% in hybrid filaments compared to F-actin filaments corroborates 
the incorporation of LD into the filaments. Moreover, the width distribution showed a more 
pronounced variation, which reflects the irregular contour of the hybrid filaments. Because 
LD incorporation occasionally led to local disruptions in hybrid filaments, diameters smaller 
than known for F-actin filaments were also found. If only hybrid filament segments that lacked 
lateral protrusions were considered, the average diameter as well as the width distribution 
did not significantly differ from F-actin filaments. This finding supports the notion that the 
corresponding smooth segments in hybrid filaments are composed exclusively of monomeric 
actin subunits and that the increase in average width can be attributed to the incorporation 
of LD moieties.
To further characterize the nature of the protruding structure, we measured the maximal 
width, the width without the protrusion at the same site, and the width of the respective 
protrusion and compared the values to the average width of F-actin filaments. The diameter 
of the hybrid filament backbone was similar to that of smooth F-actin filaments. In addition, 
the vast majority of the lateral protrusions (~ 90%) had dimensions corresponding to those of 
actin subunits (Kabsch et al. 1985) (Fowler and Aebi 1983). Therefore, these measurements 
substantiated our predictions of a transient incorporation of LD via one of its subunits during 
early stages of actin polymerization (Table 4). Based on the dimensions alone, we cannot 
rule out that the LD incorporates into the filament in other orientations, for example, along 
the long pitch helical strand. However, LD incorporation in an orientation that conflicts the 
inherent polarity and symmetry of the F-actin filament would cause an even more severe 
impairment of the filament geometry and is therefore rather unlikely.
LD incorporation interferes with crossover spacing
Electron microscopic analysis of hybrid filaments revealed that the incorporation of 
cross-linked LD interferes with the global helical parameters of the F-actin filament. As 
a consequence, regular crossovers of the two strands were often missing or spaced further 
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apart in hybrid filament segments displaying lateral protrusions (Figures 10, 12 and 13). 
This finding provides further evidence that spontaneously formed LD can only be transiently 
incorporated into filaments.
Furthermore, because of the irregular spacing of manifest crossovers, which resulted from 
the random incorporation of cross-linked LD, meaningful mass-per-length measurements (see 
below) were not feasible. In contrast, filament segments without apparent LD incorporation 
displayed distinct crossovers and the crossover spacing was comparable to that of F-actin 
filaments.
The role of phalloidin in hybrid filaments
In order to prevent subunit exchange during the copolymerization of actin and cross-linked 
LD protomers, all polymerization reactions were carried out in the presence of phalloidin. 
In the absence of phalloidin, hybrid filaments were not detected in the pellet fraction of 
cosedimentation assays, either because they were not formed or did not abide high-speed 
sedimentation (data not shown). It is possible that if protomer exchange is allowed to take 
place, incorporated LD readily dissociates and remains present in the polymerization reaction 
at a concentration that is sufficiently high to prevent efficient polymerization. Alternatively, 
phalloidin stabilization of the monomeric protomers is required to provide a basic filamentous 
framework that will tolerate the presence of LD despite its interference with the filament 
geometry.
Although phalloidin stabilization is crucial for the integrity of hybrid filaments, it is 
doubtful whether phalloidin is bound in hybrid filament segments where the morphology 
indicates LD incorporation. A number of studies have addressed the localization of phalloidin 
binding sites in filamentous actin (Vandekerckhove et al. 1985; Barden et al. 1987; Miki et 
al. 1987; Drubin et al. 1993; Faulstich et al. 1993; Lorenz et al. 1993; Heidecker et al. 1995; 
Steinmetz et al. 1998; Belmont et al. 1999; Blondin et al. 2001; Shvetsov et al. 2002; Orlova 
et al. 2004; Oda et al. 2005), but nothing is known about the interactions of phalloidin 
with LD or LD-containing segments of hybrid filaments. It is generally agreed that for the 
formation of a tight complex with actin, phalloidin requires an actin nucleus containing at 
least three hydrolyzed ADP-P
i
/ADP-actin subunits in a conformation that is distinct from 
G-actin (Barden et al. 1987; Orlova et al. 1995; Oda et al. 2005). In addition, studies by 
Faulstich and colleagues suggested that the phalloidin-binding site in the F-actin filament 
involves regions near the actin C-terminus (Faulstich et al. 1993). In the LD, this region 
is involved in forming the antiparallel interface between the two subunits. Therefore, and 
because the contacts to neighboring subunits are also distinct from those in F-actin filaments, 
it seems unlikely that phalloidin can bind at sites of LD incorporation. Consistent with this 
notion, actin filament morphology was altered by the copolymerization of actin that was 
derivatized at the C-terminal Cys374 with tetramethylrhodamine and unmodified G-actin 
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(Kudryashov et al. 2004). Employing an undecagold-tagged phalloidin, which has been 
shown to stoichiometrically decorate F-actin filaments and can be visualized by STEM 
(Steinmetz et al. 1998), in an experimental setup where incorporated native LD is preserved 
by 1,4-PBM cross-linking throughout polymerization, would provide further insight whether 
LD-incorporation is compatible with phalloidin binding in hybrid filaments. 
Hybrid filaments do not lend themselves to mass-per-length analysis
Analytical dark-field scanning transmission microscope (STEM) has become a versatile 
tool for measuring the masses of large biological macromolecules independent of their 
shape (reviewed in Engel and Colliex 1993). Because in many cases it has been instrumental 
in determining the subunit stoichiometry of oligomeric protein complexes such as e.g. 
the aquaporins maltoporin (Lepault et al. 1988) and aerolysin (Wilmsen et al., 1992), we 
reasoned that STEM measurements should provide quantitative information on the amount 
of LD that can be copolymerized with actin into hybrid filaments. Our initial assumption that 
the incorporation of dimeric LD protomers would lead to an increase of the mass-per-length 
(MPL) was not confirmed (see Table 2). Rather, the average MPLs and Gaussian peaks for 
hybrid filaments did not significantly differ from those of conventional F-actin filaments 
(Figure 9), which were in good agreement with previously reported values (Steinmetz 
et al. 1998). Several factors, or maybe a combination thereof, should be considered that 
might explain the absence of a significant MPL increase. First, the maximal number of 
LD protomers which are tolerated in the hybrid filament might not be sufficient to yield a 
detectable difference, as the increase in mass with respect to the MPL measured in F-actin 
filaments needs be at least ~ 3 kDa/nm (S. Müller, personal communication). Furthermore, 
the low-contrast dark-field STEM images did not allow reliable boxing of hybrid filament 
segments with a high frequency of lateral protrusions (Figure 14). As a consequence, 
hybrid filament segments without apparent LD incorporation were included in the MPL 
measurements. Because the incidence of LD incorporation was also highly irregular (see 
above), the proportion of measurements representing LD-containing filament segments is 
probably rather low.
In addition, as discussed above, LD incorporation interferes with formation of regular 
crossover repeats and most likely with the filament twist. Thus, it is conceivable that the 
number of actin subunits per crossover, which is 13 for F-actin filaments (Steinmetz et al. 
1997), is altered and results in a reduced MPL value. Overall, the randomized LD incorporation 
and its structural consequences are incompatible with significant MPL measurements.
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The role of antiparallel dimers in actin patterning
Since the first atomic structure of monomeric actin complexed to DNase I has been reported 
in 1990 (Kabsch et al. 1990), a number of crystal structures have been obtained that represent 
mostly complexed or chemically modified actin (e.g. (Hesterkamp et al. 1993; Bubb et al. 
1995; Reutzel et al. 2004; Klenchin et al. 2006; Lassing et al. 2007). The similarity of the 
complexed actin structures demonstrates that the overall structure of monomeric actin is not 
significantly affected by a multitude of actin-binding proteins and toxins. The first crystals 
induced from pure actin by gadolinium were described in the 1980s (Aebi et al. 1980; Aebi 
et al. 1981; Smith et al. 1983).
Besides other actin contacts, these 2-D actin crystals called ‘sheets’ and ‘tubes’ include 
a unit cell structure and symmetry similar to that of the LD (Millonig et al. 1988), which 
renders them suitable structures to examine structural aspects of the LD.
Figure 14. STEM dark-field image for MPL analysis. Lateral protrusions cannot be discerned in unstained 
hybrid filaments. Boxed areas measuring 80 x 80 pixel were used for MPL analysis. Bar, 100 nm.
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Possibly because of its transient nature and its geometry, which seems to be incompatible 
with that of the helical F-actin filament, the structural information available on antiparallel 
actin dimers is very limited and thus, the significance of LD-mediated processes is poorly 
understood. The crystallographic structure of a dimeric polylysine-actin-latrunculin A 
complex at 3.5-Å resolution with characteristics similar to the LD has been reported a few 
years ago (Bubb et al. 2002). An antiparallel actin dimer was also observed in the asymmetric 
unit of ECP-actin crystals (Klenchin 2006). The increasing number of crystal structures with 
actin contacts other than those that exist in mature F-actin filaments support the notion that 
unconventional forms of actin play a role in actin patterning (Klenchin et al. 2006; Lassing 
et al. 2007). Considering the structural plasticity inherent to different forms of actin, one 
could imagine that different intermediates dynamically transform from one form to another 
with ongoing polymerization and are eventually funneled into a pathway that yields mature 
F-actin filaments in vitro (Galkin et al. 2002; Orlova et al. 2004). This dynamic behavior 
provides a plausible explanation for the seemingly paradox contribution of an antiparallel 
dimer in the F-actin filament symmetry (Bubb et al. 2002; Pederson and Aebi 2002; Reutzel 
et al. 2004) and reconciles different structural intermediates with the Holmes model of the 
actin filament (Holmes et al. 1990; Lorenz et al. 1993).
In cells, it has been speculated that the flexibility of incorporated antiparallel dimers 
facilitates the binding of the Arp2/3 complex (Lassing et al. 2007), which leads to branched 
actin structures at angles ranging from 35° to 90° as seen by cryoelectron tomography 
studies  (Medalia et al. 2002). As the indications for a role of the LD in actin patterning are 
accumulating, the need for tools that are suitable to specifically study this form of actin both 
in vitro and in vivo becomes evident. Therefore, we are aiming at raising antibodies that 
recognize distinct forms of actin by using peptide nanoparticles as a platform for immunization 
(Raman et al. 2006; Raman 2007)(Schroeder et al., JMB, manuscript accepted). An antibody 
that recognizes the LD and not other forms of actin would undoubtedly be of great value in 
dissecting its role in actin assembly and supramolecular patterning.
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1.6 Conclusions and outlook
The LD, an antiparallel dimeric actin species that transiently occurs at the onset of actin 
polymerization, is by itself polymerization incompetent and incompatible with the helical 
geometry of mature F-actin filaments. However, copolymerization of 1,4-PBM cross-linked 
LD with monomeric Ca-ATP-G-actin at defined ratios produced hybrid filaments with 
stably incorporated LD. Ultrastructural analysis by electron microscopy revealed that LD 
incorporation significantly interferes with the morphology of synthetic F-actin filaments. 
Although there is an upper limit for the incorporation of LD, the degree of structural disorder 
in hybrid filaments correlates with the amount of LD present.
At closer inspection, filament segments comparable to F-actin filaments and segments 
with morphological and geometrical disorders could be discerned. Lateral protrusions in 
the latter led to an increase in width on the scale of an actin subunit. This is consistent 
with the notion that the protrusions represent free LD subunits that are jutting out from the 
filaments, as it has been predicted for the unconventional ʻLD-pathway  ʼ in the course of 
actin polymerization. Moreover, lateral protrusions and the increased occurrence of branches 
in negatively stained hybrid filament specimens provides further evidence for an essential 
role of the LD in filament branching. Because the branches in hybrid filament preparations 
occur in the absence of the Arp2/3 complex or any other ligand, one might argue that the 
Arp2/3 complex acts through stabilizing a branch-inducing actin arrangement rather than 
initiating the actin branching.
Prominent local disorders of the filament geometry confirm that actin filaments represent a 
highly flexible structure including variable subunit contacts. The question whether phalloidin 
binds at sites of LD incorporation is still open, although one might assume that the subunit 
interactions required for phalloidin binding are not established and thus, dissociation of 
disordered filament segments is likely to occur. Labeling of hybrid filaments with undecagold-
tagged phalloidin and subsequent dark field STEM analysis might shed some light on this 
issue. Alternatively, dissociation of hybrid filaments could be minimized by stabilizing 
hybrid filaments with a mild fixative, provided it does not affect their morphology.
Last but not least, hybrid filaments represent supramolecular actin assemblies that 
comprise the otherwise transient LD. Thus, they can be used to test the specificity of 
antibodies raised against distinct forms of actin, such as the LD. Other supramolecular actin 
structures that similarly display actin subunits in an antiparallel orientation, for example 
gadolinium-induced 2-D crystalline actin sheets and paracrystalline actin bundles, are less 
suitable, either because they are considerably more sensitive to mechanical stress and readily 
fall apart or the antiparallel subunit arrangement is less accessible.
In summary, the hybrid filaments hold large potential not only for studying the role of the 
LD in actin patterning, but also for analysis of LD-specific antibody reagents.
Chapter 2
Peptide Nanoparticles
A potent immunogen for the production
of monospecific antibodies 
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2.1 Introduction
2.1.1 Bionanoparticles
During the last years, the research on nanosized particles (size ≤ 100nm) has intensified 
considerably, mainly because numerous promising applications have emerged.
Of particular interest are biology-inspired, protein-based nanoparticles which hold 
potential for biological, pharmaceutical and medical applications such as gene delivery, 
drug targeting, antigen display and vaccination (Allen and Cullis 2004; Kiser et al. 1998; 
Langer 1998; Savic et al. 2003). In this context, globular nanoparticles are frequently used 
as carriers of active ingredients that, in the ideal case, can be directly piloted to a specific 
location or even to a distinct cellular domain. Another advantage of globular nanoparticles 
over larger or differently shaped carriers is their comparatively high surface to volume ratio, 
which facilitates the transportation of high concentrations of ingredients.
Several bionanoparticles are based on self-organizing building blocks that are known 
from nature. For instance, multiple ferritin molecules (Ensign et al. 2004; Kramer et al. 
2004) or heat shock protein subunits (Flenniken et al. 2005; Flenniken et al. 2006) can 
build up well-defined protein cages. Moreover, specific polypeptide chains are capable to 
self-assemble into precisely defined symmetric virus capsids or virus-like particles (VLP) 
(Georgens et al. 2005; May et al. 2002). Virus capsids and VLP hold the particular advantages 
that they are uniform in size, applicable in a robust, well-defined manner (Crick and Watson 
1956; Johnson and Chiu 2000; Liljas 1999) and highly amenable to genetic and chemical 
modifications (Lee and Wang 2006). 
Some decades ago it was already suggested that VLP could serve as a suitable platform 
to repetitively display copies of a specific antigen, which might improve the effectiveness 
of vaccines (Aebi et al. 1977; Buhle and Aebi 1984; Kistler et al. 1978). Consistent with 
this notion, immunization experiments with VLP yielded a strong immune response and 
high titers of specific antibodies (Bachmann and Zinkernagel 1996; Baschong et al. 2003; 
Zinkernagel 1996).
In the following Chapter 2.1.2, a novel class of self-assembling peptide nanoparticles, 
which were originally designed by Burkhard and colleagues in the late 1990s (Raman et 
al. 2006), will be described in more detail. In particular, we tested the suitability of specific 
nanoparticles to provide a platform for repetitive antigen display. For this purpose, the 
nanoparticles were genetically modified to express actin epitopes on their surface. Most 
animals with ʻloaded  ʼ nanoparticles developed a significant immune response against 
otherwise poor antigens and both, polyclonal and monoclonal antibody reagents could be 
established.
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2.1.2 Self-assembling peptide nanoparticles
The basic, unmodified peptide nanoparticle has been computationally designed to self-
assemble from 60 single polypeptide chains into highly organized spherical particles of a 
size with regular polyhedral symmetry (Raman et al. 2006). The basic assembly steps of the 
core polypeptide and a model of the resulting nanoparticle are presented in Figure 15.
The core polypeptide chain is composed of two very stable coiled coil oligomerization 
domains (Burkhard et al. 2002; Guo et al. 2000) with different oligomerization states, which 
are joined by a short linker segment (Figure 15 A). The N-terminal oligomerization domain 
(green) corresponds to a slightly modified pentameric coiled coil domain of the cartilage 
oligomeric matrix protein (COMP) (Malashkevich et al. 1996) and the C-terminal domain 
(blue) comprises a de novo designed minimal trimeric coiled coil sequence (Burkhard et al. 
2002; Burkhard et al. 2000a; Burkhard et al. 2000b). A rigid α-helical linker made up of two 
glycine residues connects the two oligomerization domains (Figure 15 B).
Figure 15. General architecture of peptide nanoparticles. In (A), the peptide building block, which is composed 
of a pentameric coiled coil domain of COMP with five-fold symmetry (green), a linker segment (cyan) and a de 
novo designed coiled coil domain with three-fold symmetry (blue), is displayed such that the internal symmetry 
elements of the two domains are superimposed onto the symmetry axes of the nanoparticle. The intrahelical 
disulfide bridge between the helices is displayed in red. In (B), the complete coiled coil domains are displayed 
as cylinders. Additional symmetry objects generated by the five-fold and the three-fold rotational symmetry 
elements are displayed in lighter shades of green and blue, whereas the original molecule is displayed in dark 
green and blue. The rotational symmetry axes are displayed as red lines in (A) and (B). (C) Computer model of 
the assembled peptide nanoparticle. This figure has been adapted from Raman et al. 2006.
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Moreover, inter- and intrahelical salt bridges and hydrophobic interactions stabilize 
the coiled coils. At the 3  ʼend of the pentameric and 5  ʼend of the trimeric oligomerization 
domain, two cysteine residues were introduced to allow intramolecular disulphide bonding.
Hence, under oxidizing conditions the spatial orientation of the two helical oligomers 
within a polypeptide chain is assured without disorganizing their geometry (Raman 2007). 
To facilitate the downstream purification process, a His-tag was inserted at the N-terminus 
of the polypeptide chain.
To examine the immunogenic potential of self-assembling peptide nanoparticles, we 
grafted different actin-related antigenic determinants onto the C-terminus of the core 
polypeptide by genetic engineering. Therefore, nanoparticles can be considered a repetitive 
antigen display system conducive to raising a strong immune response.
2.2 Aims of project
The specific aims of the study presented below are i) to characterize recombinant NPs that 
carry an actin epitope, and ii) to demonstrate their immunogenic potential by establishing 
antibodies that react with different forms of actin.
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2.3 Material and methods
Most of the methods applied are presented in the publication in Chapter 2.4.3.
Direct immunoelectron microscopy on peptide nanoparticles
Before use, aggregates were removed from nanoparticle preparations by centrifugation 
at 16.000 g for 15 min. Nanoparticles were applied to gently glow-discharged copper grids 
and excess liquid was blotted with filter paper. Then the grids were placed upside-down 
onto a droplet of 5 nm gold-coupled actin loop antibody 5B4 (5B4-Au) or a 5 nm gold-
coupled unrelated antibody, washed with aqua bidest. and subsequently negatively stained 
with uranyl acetate. Serial dilutions were tested for each antibody.
After careful washing, the specimens were processed for electron microscopy as described 
in Chapter 1.3.
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2.4 Results 1
2.4.1 Production of recombinant nanoparticles
The de novo designed polypeptides, which serve as building blocks for peptide 
nanoparticles (see Chapter 2.1.2), were recombinantly expressed in E. coli and then purified 
under denaturing conditions via metal affinity chromatography. Refolding was carried out by a 
stepwise dilution of urea under reducing conditions to prevent the formation of intermolecular 
disulfide bridges and thus promote the self-assembly of spherical nanoparticles. In a final 
dialysis step, oxidizing conditions allowed the formation of the disulfide bridges. 
Consistent with the computer model shown in Figure 15 C, CTEM of negatively stained 
specimens revealed that the refolded core polypeptides self-assemble into spherical particles 
(Figure 16). The predominant species of particles exhibits a diameter of ~ 30 nm, warranting 
the term ʻnanoparticleʼ.
Figure 16. CTEM micrograph of negatively stained, ʻbare  ʼpeptide nanoparticles. Core polypeptides self-
assemble into spheric nanoparticles with a diameter of ~ 30 nm. Bar, 50 nm; frame size of inset: 68 nm.
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Because the nanoparticles presented in Figure 16 have been assembled from unmodified 
core polypeptides, they are considered ʻbare  ʼ(NP). Core polypeptides that were genetically 
functionalized with actin-related epitopes, were expressed, purified and refolded accordingly 
(see below).
2.4.2 Peptide nanoparticles are potent immunogens
2.4.2.1 Characterization of the actin point mutation G245D
In order to elucidate whether functionalization renders nanoparticles into potent 
immunogens, we genetically engineered an epitope which corresponds to amino acid residues 
239 - 251 of human β-cytoplasmic actin with an additional mutation of Gly245 to Asp245, 
onto the core polypeptide. 
A highly tumorgenic cell strain that expresses this single point mutated β-actin was 
established by neoplastic transformation of diploid KD fibroblasts in vitro (Leavitt and 
Kakunaga 1980). It has been shown that the expression of G245D variant β-actin in 
fibroblast cell lines caused their tumorgenic transformation (Vandekerckhove et al. 1980). 
For example, stable transfection of Rat-2 fibroblasts produced a tumorgenic strain termed 
Rat-2 sm9 (Leavitt unpublished).
The SDS-PAGE of total cell extracts in Figure 17 A revealed that Rat-2 sm9 expresses a 
~ 42 kDa protein with a slightly reduced electrophoretic mobility compared to endogenous 
β-actin.
Figure 17. G245D mutant β-cytoplasmic actin. (A) Whole cell extracts prepared from Rat-2 fibroblasts and 
Rat-2 sm9 cells were subjected to SDS-PAGE and stained with Coomassie brilliant blue. In Rat-2, the band 
corresponding to wild type endogenous actin is more pronounced than in Rat-2 sm9 where an additional band 
with a slightly reduced mobility is seen. (B) Immunoblotting with a polyclonal antibody that specifically binds 
to the G245D variant actin. The mutant actin is only present in the transfected cells and not in untransfected 
Rat-2 or HeLa cells. The serum is specific for G245D actin variant and does not react with purified rabbit 
skeletal muscle actin (Act). The molecular masses in kDa of two standard proteins are indicated on the right.
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The staining intensity of the  mutant actin was comparable to that of the endogenous 
actin. Compared to the levels of β-actin in untransfected Rat-2, endogenous actin appeared 
to be slightly reduced in Rat-2 sm9. This finding suggests that expression of the variant actin 
led to a down regulation of the endogenous actin.
To confirm that this band represents the G245D variant of actin, we performed 
immunoblotting assays with whole cell extracts from both transfected and untransfected 
cell lines using a polyclonal antiserum that specifically recognizes only the G245D mutant 
(Leavitt et al. 1987). As documented in Figure 17 B, immunoblot analysis revealed that the 
G245D-specific serum detects a single band in Rat-2 sm9 cells that is absent in untransfected 
Rat-2 and HeLa cells. Similarly, the antibody did not react with purified skeletal muscle 
actin. Reprobing the membrane with an antibody that reacts to all actin isoforms confirmed 
that similar amounts of actin were present in Rat-2 and HeLa cell extracts and that the 
endogenous actin migrates slightly faster than the G245D variant (data not shown).
2.4.2.2 Polypeptides containing actin-related sequences self-assemble into 
nanoparticles
Because the synthetic 13-mer peptide containing the G245D mutation had proven to 
be highly immunogenic in standard immunization procedures and had produced a highly 
specific antiserum, we reasoned that this epitope would be suitable to test the immunogenic 
potential of ʻloaded  ʼnanoparticles. For this purpose, we genetically grafted the sequence 
corresponding to the amino acid residues 239 - 251 of human β-cytoplasmic actin with either 
a glycine or an aspartate residue at position 245 onto the C-terminus of the nanoparticle core 
peptide. Recombinant expression, purification and refolding were carried out as described 
in Chapter 2.3.
To confirm that the epitopes did not interfere with particle assembly, we examined the 
preparations after refolding by CTEM. Electron micrographs in Figure 18 illustrate that 
both, polypeptides expressing either wild type or the mutant actin epitope at the C-terminus, 
were able to self-assemble into nanoparticles. The ʻloaded  ʼnanoparticles displayed a similar 
morphology, measuring ~ 30 nm in diameter. Nanoparticles containing the β-cytoplasmic 
actin wild type epitope were termed NP-Gly (Figure 18 A), according to the glycine residue 
in position 245, whereas nanoparticles containing the mutated actin epitope were termed 
NP-Asp (Figure 18 B), indicating the exchange to an aspartic acid residue.
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2.4.2.3 Demonstration of actin-related peptides on peptide nanoparticles
Even at closer inspection, CTEM did not reveal morphological differences between core 
nanoparticles lacking an epitope (NP), NP-Gly and NP-Asp (see Chapter 2.4.2.2). Hence, 
it remained unclear if multiple copies of the actin-related epitopes were exposed on the 
surface of NP-Gly and NP-Asp, as was predicted by modeling. To address this question, 
we performed biochemical experiments using the previously established G245D-specific 
polyclonal antiserum termed HuT-14.
Because the N-terminus of the core polypeptide contains a histidine tag, NP-Gly, NP-Asp 
and NP were separated by SDS-PAGE, blotted and probed with a monoclonal His antibody. 
As expected, the immunoblot in Figure 19 A shows that under denaturing conditions the 
His antibody detected the polypeptide chains in ʻbare  ʼ(NP) and ʻloaded  ʼ(NP-Gly, NP-Asp) 
nanoparticles tested. Consistent with the presence of an extra epitope, the monomeric species 
from NP-Gly and NP-Asp moved comparatively slower on SDS-PAGE than the monomeric 
NP core polypeptide.
Subsequently, we tested if the specific HuT-14 polyclonal antibody could recognize the 
epitopes under native conditions. For immunoprecipitation (IP), the polyclonal antiserum 
HuT-14 (characterized in Chapter 2.4.2.3) was covalently bound to Protein A Sepharose 
beads (PA) and then the PA-HuT-14 slurry was incubated with assembled NP-Gly, NP-Asp 
Figure 18. Peptide nanoparticles expressing actin-related epitopes. Epitopes corresponding to amino acids 
239 - 251 residues of human β-cytoplasmic actin were engineered to the C-terminus of the core polypeptide 
chains that serve as building blocks for peptide nanoparticles. Following self-assembly, samples were applied 
to gently glow-discharged cooper grids and negatively stained with 2% uranyl acetate. (A), NP-Gly expressing 
a C-terminal sequence corresponding to human wild type β-cytoplasmic actin (SYELPDG
245
QVITUG). (B), 
NP-Asp expressing the corresponding actin sequence but with a G245D mutation (SYELPDD
245
QVITUG) in 
actin.
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and NP. Subsequently, the immunoprecipitated complexes were collected by centrifugation 
and carefully washed. After releasing complexes from the beads by heat denaturing in SDS 
sample buffer, the IP samples were analyzed by SDS-PAGE and immunoblotted with a His 
antibody (see Chapter 2.3).
As documented in Figure 19 B, HuT-14 precipitated exclusively NP-Asp, which contains 
the mutated actin epitope. Bands that represent the monomeric, dimeric and higher oligomeric 
forms of the NP-Asp polypeptide were detected by the His monoclonal antibody. However, 
both NP-Gly as well as NP were not effectively immunoprecipitated by the G245D-specific 
HuT-14 and appeared to be largely absent.
Figure 19. Actin-related epitopes on exposed peptidic nanoparticles. (A), Immunoblot analysis of NP-Gly, 
NP-Asp and NP with an His-tag antibody. The additional actin-related sequence in NP-Gly and NP-Asp 
lead to a reduced electrophoretic mobility of the corresponding polypeptide under denaturing conditions. 
(B), Immunoblot analysis of immunoprecipitated nanoparticles. HuT-14-antiserum was covalently bound to 
Protein A Sepharose (PA) and then the slurry was incubated with NP, NP-Gly and NP-Asp. Immunoprecipitated 
complexes were separated on SDS-PAGE and blotted. Probing with an His antibody showed that only NP-Asp 
were immunoprecipitated by HuT-14. NP-Gly, nanoparticles expressing an epitope derived from human β-
cytoplasmic actin; NP-Asp, nanoparticles expressing a G245D mutant actin epitope; NP, core nanoparticles 
without epitope. The molecular masses of standard proteins in kDa are indicated on the right.
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In addition, we carried out immunoprecipitation experiments with a polyclonal antiserum 
that was raised against the human wild type β-cytoplasmic actin (ʻGlyʼ) peptide. This 
antiserum immunoprecipitated predominantly NP-Gly and to a significant lesser extend NP-
Asp. However, NPs lacking an actin-epitope were not detected (data not shown).
In summary, the data presented show that recombinant polypeptide chains expressing 
specific actin-related epitopes at the C-terminus self-assemble into homogenous populations 
of peptide nanoparticles. Although the monomeric polypeptides exhibited a slightly different 
electrophoretic mobility depending on the epitope sequence, the assembled particles could not 
be distinguished by CTEM. Immunoprecipitation studies with an antibody that specifically 
recognizes the G245D point mutation suggested that the antibody has access to the mutated 
actin epitope in assembled NP-Asp under native conditions, and thus, the epitopes are likely 
to be exposed on the nanoparticle surface.
2.4.2.4 Immunization with ʻloaded  ʼnanoparticles yields specific polyclonal antiserum
The apparent surface-exposure of the grafted actin-epitope and their repetitive, ordered 
arrangement implied from the polypeptide design, suggested that nanoparticles might be a 
suitable repetitive antigen display system that is able to induce a strong immune response in 
a host organism. To test this hypothesis, NP-Asp and NP-Gly were used to immunize rabbits 
for the production of polyclonal, monospecific antibodies. The antisera that were purified 
from different bleedings were tested for reactivity by immunoblot experiments. The highly 
specific Hut-14, which had been raised previously against a synthetic peptide containing the 
G245D mutation, served as positive control to confirm that signals correspond to mutant 
actin (data not shown).
As illustrated in Figure 20, crude serum from the final bleed after a standard immunization 
with NP-Asp reacted at a 1:10.000 dilution very strongly with a single band in Rat-2 sm9 
whole cell extracts. The ʻAspʼ-antiserum did not react with endogenous β-cytoplasmic actin 
in whole cell extracts of Rat-2, Rat-2 sm9 or with purified α-skeletal muscle actin.
Immunization of rabbits with NP-Gly produced a ʻ Glyʼ-antiserum, which reacted with wild 
type and with mutant actin, albeit with a significantly reduced affinity (data not shown).
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In conclusion, the data indicate that epitope-presenting nanoparticles are potent 
immunogens that elicit a strong immune response. In the following we grafted a sequence 
corresponding to a structural feature that is conserved in all actins, onto the C-terminus of 
nanoparticles and used them for the production of monoclonal antibodies.
Figure 20. Specificity of the polyclonal antiserum raised against NP-Asp. Purified skeletal muscle actin and 
whole cell extracts of Rat-2 and Rat-2 sm9 cells were analyzed by immunoblotting with a 1:10.000 dilution 
of the antiserum produced in rabbits immunized with NP-Asp. The antiserum specifically detects the G245D 
actin variant expressed in Rat-2 sm9 and showed no reactivity with β-cytoplasmic actin in Rat-2 cells, or with 
skeletal muscle actin.
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Summary
The role of actin in transcription and RNA processing is now widely accepted but the 
form of nuclear actin remains enigmatic. Monomeric, oligomeric or polymeric forms of 
actin seem to be involved in nuclear functions. Moreover, uncommon forms of actin like 
the ʻlower dimer  ʼhave been observed in vitro. Antibodies have been pivotal in revealing the 
presence and distribution of different forms of actin in different cellular locations. Because 
of its high degree of conservation, actin is a poor immunogen and only few specific actin 
antibodies are available. To unravel the mystery of less common forms of actin, in particular 
those in the nucleus, we chose to tailor monoclonal antibodies (mAb) to recognize distinct 
forms of actin. To increase the immune response, we used a new approach based on peptide 
nanoparticles, which are designed to mimic an icosahedral virus capsid and allow the 
repetitive, ordered display of a specific epitope on their surface. Actin sequences representing 
the highly conserved ʻ hydrophobic loopʼ, which is buried in the F-actin filament, were grafted 
onto the surface of nanoparticles by genetic engineering. After immunization with ʻloop 
nanoparticlesʼ, a number of  mAbs were established that bind to the hydrophobic loop both 
in vitro and in situ. Immunofluorescence studies on cells revealed that F-actin filaments were 
only labeled once the epitope had been exposed. Our studies indicate that self-assembling 
peptide nanoparticles represent a versatile platform that can easily be customized to present 
antigenic determinants in repetitive, ordered arrays and elicit an immune response against 
poor antigens.
Introduction
Remodeling of the actin cytoskeleton plays an important role in many physio-pathological 
processes including embryonic development, tissue repair and carcinogenesis. The dynamics 
of the temporally and spatially tightly controlled actin network depends on the interplay of 
monomeric actin associated with distinct actin binding proteins (ABPs) and filamentous 
actin (F-actin) organized into higher order structures. Conventional F-actin filaments have 
not yet been identified in living, untreated nuclei, indicating that for its nuclear functions, 
actin might assume distinct oligo- or polymeric forms (Jockusch et al. 2006). Support for 
such “unconventional” actin assemblies has been gained from studies with antibodies that 
recognize distinct states of actin. For example, Gonsior and colleagues describe a monoclonal 
antibody, 2G2, which was raised against an actin-profilin complex, that recognizes a distinct 
form of actin in the nucleus (Gonsior et al. 1999). Another monoclonal antibody that reveals 
distinct actin structures in the nucleus and the cytoplasm, was established by immunizing 
mice with a chemically cross-linked, antiparallel actin dimer (Schoenenberger et al. 2005). 
Compared to phalloidin, which only binds to actin subunits in an F-actin conformation, 
antibodies are clearly more versatile tools in that they recognize different states and 
suprastructures of actin.
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As actin is a highly conserved protein throughout all eukaryotic phyla, it is rather difficult 
to obtain specific anti-actins with affinities sufficient for use in immunoprecipitation, 
immunoblotting or immunocytochemical analyses. Early studies used actin purified from 
vertebrate skeletal or smooth muscle to immunize rabbits for the production of antisera. 
Although the immunogen differed only in a few amino acids from the endogenous actins 
of the vaccinated animal, specific antibodies were obtained in some cases (Lazarides and 
Weber 1974; Jockusch et al. 1978). These antibodies proved very useful in demonstrating 
the presence and localization of actin filaments in cultivated mammalian cells as they 
crossreacted with muscle as well as with nonmuscle actins from different species. In addition, 
they stimulated a plethora of studies on cellular architecture and mobility (Lazarides and 
Weber 1974). Subsequently, peptides corresponding to the N-terminal region, which has a 
slightly higher variability than the rest of the molecule (Vandekerckhove and Weber 1979), 
were successfully used to generate selected, isoform-specific monoclonal antibodies (Skalli 
et al. 1986; Gimona et al. 1994). However, even when technical developments designed 
to improve the immune response, such as specific immunization protocols, macrophage-
activating carriers and adjuvants or specific myeloma strains for the production of monoclonal 
antibodies, are implemented, the production of a reliable anti-actin with high specificity for 
different forms of actin remains a challenging enterprise. 
Modern immunization strategies involve live attenuated, whole inactivated, recombinant 
subunit protein, live vector DNA, and combinatorial vaccines (for reviews see (Cho 2003; 
Zinkernagel 2003)). Compared to attenuated or whole inactivated vaccines, which are not 
devoid of risk factors, subunit vaccines based on recombinant proteins can be considered 
safe. They may suffer from poor immunogenicity owing to incorrect folding of the target 
protein or its poor presentation to the immune system. One class of subunit vaccines that are 
readily recognized by the immune system are Virus-like particles (VLPs), highly organized 
spheres that self-assemble from structural envelope proteins of virus particles (for reviews 
see (Ludwig and Wagner 2007; Roy and Noad 2008)). When derived from the original 
pathogen, the repetitively arranged epitopes of the VLPs mimic viral antigens in a highly 
authentic conformation. In addition, VLPs have been used as carrier and presentation system 
for the repetitive display of B-cell epitopes from foreign pathogens. 
The concept of improving antigenicity through presenting an antigen in an ordered, 
repetitive array (Baschong et al. 2003) is being increasingly employed to obtain high titers 
of specific antibodies. A case for this concept was made more than 25 years ago, when 
trying to produce high-titer/high-affinity monospecific antibodies against the different 
capsid proteins of bacteriophage T4 (Aebi et al. 1977). Subsequently, targeted expression of 
antigenic determinants on the surface of virus capsids or bacterial envelopes was achieved 
by recombinant DNA technology (Sanchez and Holmgren 1989; Greenwood et al. 1991; 
Lomonossoff and Johnson 1996; Porta et al. 1996; Lee et al. 2003). Alternatively, antigens 
were grafted onto in vitro assembled repetitive arrays of proteins (Domingo et al. 2001) or 
Chapter 2       Peptide Nanoparticles - A potent immunogen 
       for the production of monospecific antibodies 
                        
57
stoichiometrically bound to the surface of a virus capsid in the form of antigen-carrying 
proteins (Ren et al. 1996). Engineering antigens as repetitive supramolecular arrays is now 
leading the way to novel strategies for therapeutic vaccines for chronic diseases (Bachmann 
and Dyer 2004).
So far, viral capsid structures have mostly been used as repetitive antigen display systems. 
Here we report the application of nanoparticles (Raman et al. 2006), which are formed through 
self-assembly of a single designed polypeptide, as a novel platform for the repetitive display 
of poorly immunogenic actin epitopes. The design principle of the peptide nanoparticles 
suggests immunization properties similar to those of VLPs. However, compared to VLPs 
the nanoparticle polypeptide can be easily customized at the N-and C- terminus by genetic 
engineering and recombinantly expressed in E. coli. To achieve a repetitive antigen display 
on the nanoparticle surface, a peptide sequence that corresponds to the hydrophobic loop of 
actin was added at the C-terminus of the backbone polypeptide. The resulting nanoparticles 
were used as immunogen to produce monoclonal antibodies that specifically react with the 
actin epitope on the nanoparticle carrier as well as with the hydrophobic loop in cellular 
actin networks. Our studies show that the repetitive antigen display offered by the peptide 
nanoparticle carrier increases the immunogenic potential of otherwise poor antigens.
Materials and Methods
Reagents
Alexa Fluor 568-phalloidin, Alexa Fluor 488- and Alexa Fluor 633 carboxylic acid, 
succinimidyl ester were purchased from invitrogen Molecular Probes. DRAQ5 cell permeant 
DNA probe was obtained from Alexis Biochemicals.
Cells
HeLa and Rat2 fibroblasts (Leavitt et al. 1985) were grown in Dulbeccoʼs minimal 
essential medium supplemented with 2 mM L-glutamine, 100 IU/ml penicillin, 100 µg/ml 
streptomycin, and 10% FCS (DFCS) at 37°C, in a humidified atmosphere containing 5% 
CO
2
. Cells were subcultured weekly up to 10 passages.
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Construction of NP and NP-loop expression plasmids
The sequence encoding the nanoparticle peptide (NP; Figure 1A) was ligated into the 
BamHI/EcoRI restriction sites of mpPEP-T expression vector which corresponds to pPEP-
T (Brandenberger et al. 1996) lacking the oligomerization domain. Oligonucleotides 
encompassing residues 263 to 274 of human β-cytoplasmic actin with additional modifications 
(Figure 1B) were cloned into the XmaI/EcoRI restriction sites of the NP expression construct. 
The resulting constructs are termed NP-L/C and NP-L/S. 
Expression and purification of NP peptides
A culture of transformed E. coli BL21 DE3 pLys was grown in LB (containing 20 μg/ml 
ampicillin and 30 μg/ml chloramphenicol) at 37°C at 190 rpm until OD
600
 0.5 - 0.6 was 
reached. Expression of the peptide was induced by 1 mM IPTG for 3-4 hrs. After pelleting, 
the cells were resuspended in lysis buffer  (8 M urea, 100 mM NaH
2
PO
4
, 10 mM Tris, 5 
mM β-Mercaptoethanol, pH 8.0) and sonicated. Non-solubilized cellular fragments were 
removed by centrifugation (40 min at 17.000 rpm) and the supernatant was incubated with 
nickel beads (Sigma-Aldrich) for 2 hrs at room temperature (RT) and then loaded onto a 
Ni-NTA column. Unspecifically bound proteins were removed by washing buffer (8 M urea, 
100 mM NaH
2
PO
4
, 10 mM Tris, 5 mM β-Mercaptoethanol) with decreasing pH, pH 6.3, 5.9, 
5.0. Finally, the NP peptide was eluted from the resin using the elution buffer (8 M urea, 100 
mM NaH
2
PO
4
, 10 mM Tris, 5 mM β-Mercaptoethanol, pH 8.0 containing 1 M Imidazole). 
The fractions containing the purified peptide were combined and dialyzed overnight against 
8 M urea, 20 mM Tris/HCl, 150 mM NaCl, 10% glycerol, 2 mM DTT, 1 mM EDTA, pH 7.5. 
Protein concentration was determined by Bradford assay (Bio-Rad) and purity analyzed by 
17% SDS-polyacrylamide gels.
Self-assembly of nanoparticles
Protein concentration was adjusted to 0.1 mg/ml and dialyzed overnight at RT against 
assembly buffer (8 M urea, 20 mM Tris/HCl, 150 mM NaCl, 10% glycerol, 2 mM DTT, pH 
7.5). Refolding and self-assembly was achieved by sequential dialysis in assembly buffer 
with reducing urea concentrations.
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Production of monoclonal antibodies
Monoclonal antibodies (mAbs) were generated by i.p. injection of 7-week old  BALB/c 
mice with 50 µg NP-L/C nanoparticles mixed with 50 µl Pam
3
Cys-Ser-(Ly)
4, 
Hydrochloride 
(Calbiochem) on day 1, 21, and 42. 4, 3, and 2 days before fusion, i.p. booster injections of 
50 µg NP-L/C without Pam
3
Cys-Ser-(Ly)
4, 
Hydrochloride were administered. After fusion, 
cloning and selection, antibody-producing hybridomas were screened for their binding 
to NP-L/C peptide by immunoblotting. Eleven out of 41 strongly reactive clones from 
two independent fusion events were subcloned. Isotype analysis revealed all established 
hybridomas to produce mAbs of the IgG2b subtype. Supernatants were grown either 
according to standard protocols or in serum-free medium (ISF-1, Biochrom, Berlin). MAbs 
were used as culture supernatant or purified by immunoaffinity chromatography using anti-
mouse IgG-agarose (Sigma).
Immunoprecipitation
Purified mAb 1F1 was coupled to protein A sepharose CL-4B (Amersham Biosciences) 
following the suppliers protocol. After several washes with coupling buffer (20 mM sodium 
phosphate, pH 7.0), antibody-protein A sepharose beads were incubated with NP-L/C and 
NP, respectively, on a rocker for 1 hr at 4°C. After multiple wash steps with coupling buffer, 
the supernatant was removed and the pellet was resuspended in 5x SDS sample buffer, boiled 
for 5 min at 95°C, vortexed and pelleted again. The supernatants were separated on 17% 
SDS-polyacrylamide gels and further processed for immunblotting. 
Indirect Immunofluorescence
For immunofluorescence, cells were grown on glass coverslips for 24 - 48 hrs to 
subconfluency. Coverslips were rinsed twice with PBS before fixation. Different fixation 
protocols were used as indicated. Cells were either fixed for 10 min with freshly prepared 
3% formaldehyde in PBS, for 15 min with formalin solution (Sigma), or for 15 min with 
-20°C MeOH. In some cases, cells were extracted for 5 min with 2% octyl-POE (n-
octylpolyoxyethylene, Alexis) in modified Hanks  ʼbuffer (MHB; (Small and Celis 1978)) 
containing 0.12% glutaraldehyde prior to fixation by 1% glutaraldehyde for 20 min (Baschong 
et al. 2001). After several washes in MHB, aldehyde groups were quenched by two times 10 
min incubations with 0.5 mg/ml NaHB
4
 in MHB on ice. Appropriate dilutions of the primary 
antibody were incubated for 1 hr at RT. After several washes in PBS, coverslips were placed 
on a drop of Alexa Fluor 488-conjugated anti-mouse IgG (H and L chain, Alexis; 1/800) 
secondary antibody solution and incubated for 1 hr at RT. In some cases, Alexa Fluor 568-
phalloidin (1/250; Molecular Probes) and/or DRAQ5 (1/250; Alexis Biochemicals) were 
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incubated together with the secondary antibody.
Confocal images were obtained using a 63x or 100x oil objective on a Leica TCS SP 
laser scanning confocal microscope. Digitized confocal images were processed by Leica 
software, Imaris 4.1 (Bitplane AG) and Adobe Photoshop 7.0.
Immunoelectron microscopy
For immunogold labeling, ultrathin sections of LR White embedded HeLa cells were 
mounted on 200 mesh carbon/parlodion coated copper grids. After blocking unspecific 
binding sites by two 5 min incubations in 2% BSA/PBS, grids were incubated on droplets 
of 1F1 antibody solution in a humidified chamber for 2 hrs at RT. Then the grids were 
rinsed with PBS, blocked with 2% BSA/PBS for two times 5 min, and incubated with a 10 
nm gold-conjugated goat anti mouse IgG secondary antibody (BBInternational) for 1 hr at 
RT. After washing in PBS and distilled water, grids were stained with 6% uranyl acetate 
for 1 hr, rinsed with distilled water and then counterstained with lead-citrate for 2 min. For 
control experiments, the primary antibody was omitted (data not shown). Stained specimens 
were examined in a Hitatchi H7000 transmission electron microscope operated at 100 kV. 
Micrographs were recorded on Kodak® electron image film SO-163.
Fluorescent labeling of antibodies and nanoparticles
Antibody solutions in PBS were labeled for 3 hrs at RT with a 6-fold molar excess of Alexa 
Fluor 633 carboxylic acid, succinimidyl ester according to the manufacturerʼs protocol. The 
labeling reaction was stopped by adding 1 M hydroxylamine HCl. The free Alexa Fluor 633 
was removed by gel filtration chromatography (Sephadex G50) and overnight dialysis in 
PBS. The labeling of NP and NP-L/S with Fluor 488 carboxylic acid, succinimidyl ester was 
carried out accordingly in 20 mM Hepes, 150 mM NaCl, 10% glycerol, pH 7.5. Uncoupled 
Alexa Fluor 488 was also removed by gel filtration (Sephadex G50), followed by overnight 
dialysis in 20 mM Hepes, 150 mM NaCl, 10% glycerol, pH 7.5.
Acquisition of fluorescence images
Fluorescence images were recorded using a fluorescence confocal laser scanning 
microscope (ZEISS LSM 510 META, ZEISS AG). Solutions (5 µl) of fluorescently labeled 
peptidic nanoparticles were added to special chambered quartz glass holders (Lab-Tek, 8-
well, NUNC A/S). Acquisition of images was performed with a water immersion objective 
(40x, 1.2 NA, C-Apochromat) focusing the laser onto the bulk of the aqueous solution. 
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The sample was excited simultaneously with a 433 and a 633 nm laser using a main and a 
secondary dichroic mirror to exclude any excitation light in the detection channel. For the 
emitted light, one channel was configured for detecting the Alexa 488 dye (LP 505), and the 
other channel was configured for detecting the Alexa 633 dye (LP 650). In order to obtain 
high quality images of double-labeled particles, images with a size of 512 x 512 pixels, using 
8-bit color depth, and a scan speed of 0.96 s/pixel were collected. To increase intensity the 
pinhole diameter of Alexa 488 and the Alexa 633 channel was set to 146 µm and 185 µm, 
respectively.
Fluorescence cross-correlation spectroscopy 
Fluorescence cross-correlation spectroscopy (FCCS) has been described in great detail 
elsewhere (Schwille et al. 1997; Rigler et al. 1998). The cross-correlation curve is obtained 
by correlating the individual intensities emitted in the green (488 nm laser), and the red (633 
nm laser) channel. The corresponding cross-correlation function can be written as
Equation 1
where N
g
, N
r
, N
gr
, and T
D.gr
 describes the number of molecules labeled with the green dye, the 
number of molecules labeled with the red dye, the number of molecules labeled with both red 
and green dye, and the diffusion time of the double labeled species, respectively. The number 
of double labeled species, which is given by equation 4 when T = 0, can be expressed as
 Equation 2
which can simply be rearranged to
 Equation 3
with N
AC,g
, N
AC,r
, and N
CC
 being the total number of molecules detected in the green channel, 
the red channel, and the apparent number of molecules in the cross-correlation channel, 
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respectively. Equations 1 to 3 are only true if no cross-talk from one channel to the other 
occurs. Measurements were performed with a Confocor2 (ZEISS AG) by exciting the sample 
with both the 488 and the 633 nm laser line, and using a beam line using a bandpass (BP 505-
550 nm) and a longpass (LP 650 nm) for the green and the red detector channel, respectively. 
A small quantity (5 µl) of the sample was pipetted to special chambered quartz glass holders 
(Lab-Tek, 8-well, NUNC A/S) and acquisition of data from the sample was assured by 
focusing the laser beam 200 µm above the glass surface. Repeated (15 times) measurements 
of 3 seconds duration were performed in order to remove data with too high intensities. 
Auto- and cross-correlation curves were fitted with a Marquardt-Levenberg algorithm using 
the supplied ZEISS software package. Diffusion times for the used dyes Alexa 488 (20 
µs) and Alexa 633 (45 µs) were measured and used for all subsequent fitting of correlation 
curves. The diffusion times of Alexa 633-labeled mAbs was determined to 380 µs. NP-L/S 
labeled with Alexa 488 correspond to a diffusion time of 1160 µs.
For binding tests, mAbs and nanoparticles were incubated together for 1 hr with gentle 
shaking at RT prior to FCCS analysis. 
Actin preparation
Rabbit skeletal muscle G-actin was purified from acetone powder (Spudich and Watt 1971) 
with an additional gel filtration step on a Superdex S200 column (Amersham Biosciences) 
equilibrated in buffer A (2.5 mM imidazole, 0.2 mM CaCl
2
, 0.2 mM ATP, 0.005% NaN
3
, 
pH 7.4). Fractions from gel filtration columns were analyzed by SDS-PAGE. The protein 
concentration of fractions containing the respective G-actin purified to homogeneity was 
determined spectrophotometrically by absorbance at 290 nm using a molar extinction 
coefficient of 2.66 x 104 M-1cm-1.
Cosedimentation assay
Purified rabbit skeletal muscle G-actin was precleared by centrifugation at 250.000 g for 
1 hr at 4°C. The G-actin solution was carefully removed and polymerization was induced 
by adding 100 mM KCl or phalloidin and 100 mM KCl at a molar ratio of 2:1 for 3 - 5 hrs 
at 4°C. After centrifugation for 1 hr at 100.000 g at 4°C, the supernatant was removed and 
the pellet was washed with buffer F (buffer A containing 100 mM KCl) by centrifugation at 
100.000 g for 15 min at 4°C. The pellets were resuspended in the initial reaction volume of 
buffer F and incubated for at least 2 hrs at 4°C to obtain a homogenous suspension of F-actin 
filaments. 
For incubation of prepolymerized F-actin filaments with mAb 5B4, aggregates were removed 
from the purified antibody solution by centrifugation at 100.000 g for 1 hr at 4°C immediately 
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before incubation with the resuspended F-actin pellet fraction. MAbs were added to ~ 5 µM 
F-actin solution to a final concentration of ~ 0.12 µM. After 1 hr incubation on a roller 
at 4°C, the mixtures were centrifuged at 100.000 g for 1 hr at 4°C. Aliquots of the input 
(T), the supernatant (S) and the resuspended pellet (P) were separated by 15% SDS–PAGE 
and analyzed by immunoblotting. Actin was detected with a commercially available actin 
polyclonal Ab (A2066, SIGMA) followed by an alkaline phosphatase-conjugated goat anti-
rabbit IgG secondary antibody. The presence of 5B4 heavy and light chains was visualized 
with an alkaline phosphatase-conjugated goat anti-mouse IgG secondary antibody.
Results
Peptide nanoparticles as platform for the repetitive display of antigenic determinants
To improve the antigenicity of a distinct actin epitope we took advantage of the repetitive 
and ordered display of the corresponding actin sequence on the surface of a peptide 
nanoparticle platform. The basic building block of the nanoparticles is a polypeptide that was 
computationally designed to form a regular icosahedron (Burkhard et al. 2000; Burkhard et al. 
2001). In contrast to the original nanoparticles (Raman et al. 2006) which were assembled from 
a synthetic peptide, we produced nanoparticles from recombinantly expressed polypeptides. 
As shown in Figure 21 A, the recombinant core peptide of a nanoparticle is composed of 
two linked oligomerization domains, each containing particular coiled-coil heptad repeat 
patterns: an N-terminal 36 amino acid segment largely corresponding to the assembly 
domain of cartilage oligomerization matrix protein (COMP; green), which oligomerizes into 
pentamers (Kajava 1996), linked by a two amino acid linker sequence (black) to a de novo 
designed trimerization domain (blue). Compared to the minimal trimeric coiled coil domain 
in the synthetic polypeptide, the recombinant nanoparticle core polypeptide was extended 
at the C-terminus by the addition of 21 coiled-coil forming residues in order to ensure the 
protrusion of the C-terminus on the surface of the nanoparticle (Figure 21 C). 
Following expression in E. coli, the polypeptide was purified under denaturing conditions 
using metal affinity chromatography. Refolding and self-assembly into nanoparticles was 
induced by a stepwise dilution of urea. According to the design principles and assuming an 
icosahedral symmetry of the nanoparticles, each particle should be composed of 60 copies 
of the polypeptide, with the C-termini at the particleʼs periphery. Consequently, peptide-
based epitopes, which are inserted at the C-terminus through genetic engineering, are likely 
to be exposed on the particle surface. The surface-exposure of multiple copies of antigenic 
determinants in combination with the regular icosahedral symmetry that the nanoparticles 
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are designed to adopt (Figure 21 C), suggest that ʻloaded  ʼnanoparticles might represent an 
ideal repetitive antigen display system for eliciting an immune response.
In order to examine the immunogenic potential of such loaded nanoparticles, we have 
introduced a peptide epitope, which corresponds to residues 263 to 274 of the highly 
conserved human β-cytoplasmic actin molecule (Figure 21 B, red), at the C-terminus of the 
core polypeptide. We chose an actin sequence because its high degree of homology throughout 
different phyla and the reluctance of the immune system to react to self-antigens render it 
a challenging antigen. Actin is an abundant, highly dynamic protein in eukaryotic cells that 
assumes different forms within the cell, most prominently monomeric and filamentous (F-
actin). As shown in the model of the F-actin structure (Figure 21 B; (Holmes et al. 1990; 
Lorenz et al. 1993)), the sequence from amino acid 263 to 274 forms a distinct structure, the 
so-called ʻhydrophobic loopʼ, which inserts into a hydrophobic pocket formed by a subunit 
of the opposite filament strand, and thus plays an important role in filament stability as well 
as in polymerization. Grafting the sequence that corresponds to the hydrophobic loop onto 
the nanoparticles allows us to test whether this platform is feasible for generating antibodies 
Figure 21. Design of peptide nanoparticles as a platform for repetitive actin epitope display. (A) Domain 
structure of the core polypeptide. The N-terminal histidine tag is followed by 36 amino acids that correspond to 
the slightly modified pentameric coiled coil domain of COMP (green). The second, C-terminal oligomerization 
domain consists of a de novo designed, 46 amino acid, trimeric coiled coil sequence (blue), which is linked to the 
pentameric domain by two glycine residues. (B) In the Holmes model of the F-actin filament structure (Holmes 
et al. 1990; Lorenz et al. 1993), the hydrophobic loop (red) corresponding to residues 262 to 274 in actin, 
inserts into a pocket formed at the interface between two adjacent subunits of the opposite strand. Aminoacids 
263 to 274 were grafted onto the C-terminus of the core polypeptide downstream of a glycine/cysteine linker 
(black). The resulting polypeptide termed NP-L/C contains two closely spaced cysteine residues, whereas the 
NP-L/S polypeptide contains serines at these positions. Exchanged amino acids are indicated by asterisks. (C) 
Computer model of the assembled NP-L/C nanoparticle with icosahedral symmetry.
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that recognize a distinct structural element. In order to further stabilize the loop structure, 
we exchanged the glycine residue in the core polypeptide by a cysteine to allow for disulfide 
bonding with the cysteine residue of the epitope sequence near the C-terminus. The resulting 
construct was expressed, purified and refolded into NP-L/C particles, which were used for 
immunization of mice as described in Materials and Methods. In a second construct termed 
NP-L/S, the two cysteine residues near the C-terminus were replaced by serine. 
Assembly of peptides containing actin loop epitopes into nanoparticles 
Based on the in silico predictions shown in Figure 21 C and on previous data obtained 
with a synthesized core polypeptide (Raman et al. 2006), we would expect the recombinant 
polypeptides to assemble into a homogenous population of spherical particles. As illustrated 
by the electron micrograph in Figure 22, self-assembly of the core polypeptide produced 
mostly spherical nanoparticles. The nanoparticles exhibited a fairly uniform morphology 
with an outer diameter of approximately 30 nm for negatively stained samples. Based on 
the computer model, a diameter of 20.3 nm was predicted for native nanoparticles. Electron 
micrographs revealed a minor fraction of the core polypeptide to form smaller structures. We 
cannot distinguish whether they represent assembly intermediates or fragments of dissociated 
nanoparticles.
Figure 22. Transmission electron micrographs of peptide nanoparticles. After refolding of recombinantly 
expressed polypeptides, samples were adsorbed on carbon-coated grids and negatively stained with 2% uranyl 
formate. Core polypeptides assemble into single, spherical nanoparticles (NP). They are fairly homogenous in 
size with a diameter of ~ 30 nm. The frame size of the inset is 68 nm. NP-L/C particles display a tendency to 
aggregate under oxidizing conditions. Replacing the cysteine residue of the actin loop epitope by serine in the 
NP-L/S polypeptide yielded single homogenous nanoparticles with a diameter of ~ 25 nm. 
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Under oxidizing conditions, nanoparticles without an epitope were monodisperse 
with little tendency to aggregate. In contrast, electron micrographs revealed extensive 
aggregation of negatively stained NP-L/C (middle panel). Only a minor fraction of the 
polypeptides assembled into single spherical structures that appeared to be slightly smaller 
than nanoparticles. Because the NP-L/C polypeptide contains two cysteine residues near 
the protruding C-terminus, it is likely that at high protein concentrations, disulfide bonds 
are formed also between particles, causing their aggregation. To test this hypothesis, we 
produced NP-L/S particles where both cysteines at the C-terminus were replaced by serine 
residues, under oxidizing conditions. Electron micrographs of negatively stained NP-L/S 
(right panel) reveal individual spherical nanoparticles with outer diameters ranging from 20 
to 25 nm. Based on the computer model, the diameter of particles that carry the actin epitope 
was calculated to be 23.3 nm. Similar to the ʻ bare  ʼnanoparticles, smaller structures were also 
observed in negatively stained NP-L/S samples. Dynamic light scattering measurements of 
NP-L/S particles revealed a largely monodisperse size distribution of nanoparticles with a 
hydrodynamic diameter that is consistent with the EM data (data not shown).
Characterization of monoclonal antibodies raised against NP-L/C
For the production of monoclonal antibodies (mAb), mice were repeatedly immunized 
intraperitoneally with 50 µg purified NP-L/C particles per injection following the protocol 
described in Materials and Methods. Hybridoma supernatants were initially tested by an 
ELISA assay using purified rabbit skeletal muscle actin and a dot blot assay against NP-L/C 
polypeptide (data not shown). A number of reactive hybridoma clones from independent 
fusions were identified. Isotype determination revealed that all clones produced IgG2b 
antibodies. To characterize the epitope specificity under denaturing conditions, we carried out 
immunoblots with individual hybridoma supernatants. Figure 23 A shows a representative 
blot of refolded NP-L/S and NP-L/C, purified rabbit skeletal muscle actin and total cell 
extracts from HeLa cells probed with the randomly selected mAb 1F1. In NP-L/S and NP-
L/C preparations, the antibody reacts with a band migrating at approximately 15 kDa. The 
electrophoretic mobility of this band correlates with the calculated molecular mass of the 
monomeric forms of the NP-L/C and NP-L/S polypeptide (approximately 14 kDa). The 
additional bands detected by 1F1 most likely correspond to dimeric and higher oligomeric 
species of the respective polypeptides. Probing a parallel blot with an antibody against the 
histidine tag present at the N-terminus revealed the same pattern, indicating that these bands 
represent full-length polypeptides (data not shown). To demonstrate that the 1F1 mAb is 
directed against the actin epitope sequence and not against the core polypeptide, we loaded 
purified skeletal muscle actin and a total cell extract of HeLa cells on the gel. 1F1 bound 
to the 42 kDa actin band and to a corresponding band in the cellular extract. Similar results 
were obtained with six different hybridoma lines (data not shown).
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The immunoblotting experiments indicated that the mAbs obtained from immunization 
with NP-L/C recognize the denatured actin epitope sequence engineered onto the C-terminus 
of the core polypeptide in NP-L/C and NP-L/S, as well as in its native context. Under 
denaturing conditions, the cysteine residue corresponding to Cys272 in actin do not seem to 
be essential for antibody specificity.
Figure 23. Immunochemical characterization of mAb 1F1 specificity. (A) Purified NP-L/C and NP-L/S 
particles, purified skeletal muscle actin (Act), and total protein extracts from HeLa cell were separated on 15% 
SDS-polyacrylamide gels, blotted and probed with mAb 1F1. The antibody reacts with monomeric, dimeric 
(arrowheads) and oligomeric species of NP-L/S and NP-L/C polypeptides under denaturing conditions. 1F1 
does not react with the core polypeptide NP (see panel B). The 1F1 epitope is also detected in purified actin. In 
HeLa cell extract, a single band with an electrophoretic mobility comparable to that of actin is recognized. (B) 
Immunoprecipitation of NP-L/S nanoparticles. Protein A sepharose beads (PA) were saturated with 1F1 and 
then incubated with NP or NP-L/S nanoparticles under native conditions. Immunoprecipitated complexes were 
separated on a 15% SDS-polyacrylamide gel. Purified NP, NP-L/S, and 1F1 mAb were loaded as controls. The 
blot was probed with 1F1 and immunoreactive bands were revealed by an alkaline phosphatase-conjugated 
secondary anti-mouse IgG. The secondary Ab does not cross-react with NP nanoparticles but reveals the heavy 
and light chains of the mAb, both in the immunoprecipitate and in the control lane with purified 1F1. The 
molecular masses (in kDa) of standard proteins are indicated on the right.
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To examine the exposure of the epitope on the particle surface, we carried out 
immunoprecipitation experiments with assembled particles and subsequently blotted 
the immunoprecipitated complexes (Figure 23 B). Because the NP-L/C particles tended 
to aggregate, monodisperse NP-L/S particles were used for these experiments. Protein A 
sepharose beads were saturated with purified 1F1 mAb and then incubated with NP or NP-
L/S under nondenaturing conditions. Precipitates, as well as directly applied NP and NP-
L/S particles and purified 1F1, were separated on SDS-PAGE and subsequently blotted. As 
illustrated in Figure 23 B, immunoblotting showed that protein A-bound 1F1 only precipitated 
the particles carrying the actin epitope (NP-L/S) and not the ʻempty  ʼparticles (NP). Directly 
loaded samples confirmed that 1F1-reactive bands were only seen in NP-L/S and not in NP.
In addition to the 1F1 mAb, we tested the specificity of four other hybridomas, 5B4, 
4A7, 3E3 and 6E2, that were independently established after immunizing mice with NP-L/C 
particles, in biochemical assays. All mAbs specifically bound to nanoparticles carrying the 
actin epitope and detected actin in whole cell extracts under denaturing conditions (data not 
shown). 
Binding of 1F1 mAb to NP-L/S visualized by fluorescence microscopy 
The specificity of the binding between 1F1 and the NP-L/S in solution was determined 
by using both fluorescence microscopy and fluorescence cross-correlation spectroscopy 
(FCCS). For this purpose, purified antibodies and the peptide nanoparticles were labeled with 
the fluorescent dyes Alexa 633 and Alexa 488, respectively. An unrelated mAb of the same 
isotype as 1F1 was used as control. A fluorescent micrograph of a mixture of labeled mAbs and 
labeled NP-L/S is shown in Figure 24 A. The image reveals a fairly even distribution of NP-L/
S particles (green dots in Figure 24 A) and antibodies (red dots in Figure 24 A). Fluorescence 
micrographs as well as FCCS data indicate that both antibodies and peptide nanoparticles 
aggregated slightly, despite pre-clearing by highspeed centrifugation or filtration (data not 
shown). A similar distribution was observed in images of a sample containing a mixture of a 
labeled control mAb and labeled NP-L/S (Figure 24 B). In contrast to the unspecific control 
antibody, which did not colocalize with the NP-L/S (merged image in Figure 24 B), there is a 
significant amount of dots that colocalized in the mixture containing 1F1 and NP-L/S (orange 
dots in the merged image of Figure 24 A). There is a number of dots that apparently do not 
colocalize in Figure 24 A, probably because not all labeled 1F1 and NP-L/S were exactly 
in the respective focal plane. Because the resolution of the light microscope is diffraction-
limited to about 300 nm, colocalization only reveals that the differently labeled molecular 
species are close in space, whereas individual molecular interactions cannot be resolved. In 
addition, the confocal fluorescence micrographs are acquired with a photon multiplier tube 
detector that does not have single molecule sensitivity, i.e. individual nanoparticles are too 
small to be visualized. Hence, the conclusions drawn from the images in Figure 24 are based 
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Figure 24. Specific binding of mAb 1F1 to NP-L/S nanoparticles visualized by fluorescence microscopy. 
Images were collected by focusing the laser beam in the bulk of small droplet (10 µl) containing an aqueous 
solution of (A) labeled 1F1 and NP-L/S, and (B) an aqueous solution of labeled IgG2b control antibody and 
NP-L/S (negative control). Antibodies were labeled with Alexa 633, whereas the NP-L/S was labeled with 
Alexa 488. Fluorescence micrographs in the left and middle panel show images obtained in the green and red 
detection channel, respectively. The superposition of the green and red images is presented in the right panel. 
Colocalized, white/yellow particles (brightest particles are marked by white arrows) represent binding events 
of 1F1 mAb to NP-L/S. No colocalization was observed with the 633-control mAb (B, right panel).
on a qualitative assessment of the interaction between the specific antibody and the NP-L/S 
particles.
Binding of 1F1 to NP-L/S is confirmed by fluorescence cross-correlation spectroscopy 
In addition to the acquisition of fluorescence micrographs, binding of 1F1 mAb to NP-L/S 
was evaluated by FCCS. This single-molecule detection fluorescence spectroscopic technique 
is based upon the diffusion properties of fluorescently labeled species and is able to provide 
a yes or no answer if binding between two differently labeled partners, here an antibody and 
a nanoparticle, occurs. It allows for the determination of the concentration and dynamics of 
each individual, labeled protein as well as the double-labeled protein complexes, which in 
Chapter 2       Peptide Nanoparticles - A potent immunogen 
       for the production of monospecific antibodies 
                        
70
our case correspond to the binding of Alexa 633-1F1 emitting in the red to Alexa 488-NP-L/S 
particles emitting in the green. An unspecific Alexa 633-mAb of the same isotype incubated 
with Alexa 488-NP-L/S particles served as negative control. Figure 25 A depicts the cross-
correlation curves obtained from incubations of the specific 1F1 mAb with NP-L/S particles 
(black curves) and the control incubations with the unspecific mAb (blue curves). Mixing 
the specific 1F1 with NP-L/S leads to a significantly higher cross-correlation amplitude in 
comparison to the negative control. Binding becomes more overt in the normalized cross-
correlation curves shown in Figure 25 B. The diffusion time derived for the 1F1-nanoparticle 
complex is 1962 µs (black curve) which correlates well with its approximate molecular 
weight (about 1000 kDa), whereas the corresponding diffusion time in the negative control 
experiment was 1046 µs. This difference, together with the significantly smaller amplitude 
obtained in measurements with the control mAb, indicate that 1F1 specifically binds to NP-
L/S. Furthermore, a significant fraction of the auto-correlation curve recorded in the red 
detector channel corresponds to the diffusion time characteristic for the specific 1F1-NP-L/S 
complex formation (1950 µs). This fraction could not be detected with control mAb. The 
reason for the amplitude in the cross-correlation curve of the negative control experiment 
could be related to non-specific binding, but also to emission cross-talk which leads to an 
apparent increase in the cross-correlation amplitude. 
Figure 25. Binding of 1F1 mAb to NP-L/S examined by fluorescence cross-correlation spectroscopy. Left 
panel depicts the cross-correlation curves of a mixture of the Alexa 633-labeled 1F1 mAb and NP-L/S labeled 
with Alexa 488 (in black), and cross-correlation curves of a mixture of a control IgG2b mAb labeled with 
Alexa 633 and NP-L/S labeled with Alexa 488 (in blue). Corresponding normalized cross-correlation curves 
are presented in the right panel. Experimental data are shown as solid lines whereas the corresponding fit is 
depicted as a dotted line.
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These results clearly indicate that specific binding between the 1F1 mAb and the NP-
L/S particles occurs whereas binding of an unrelated antibody to NP-L/S particles is very 
low and can thus be considered non-specific. In support of this notion, control experiments 
performed with mixtures of labeled 1F1 mAb and ʻbare  ʼ nanoparticles without an actin-
derived epitope (NP) failed to show any antibody-antigen interactions (data not shown).
1F1 detects the hydrophobic loop epitope in situ
To determine whether the mAbs raised against nanoparticles displaying the hydrophobic 
actin loop sequence recognize the actin epitope in its native environment, we labeled 
Rat2 fibroblasts, which establish an extensive network of actin stressfibers, by indirect 
immunofluorescence and compared the staining pattern of 1F1 (Figure 26, upper panels) and 
Figure 26. Cellular localization of the 1F1 and 5B4 epitope. (A) In Rat-2 fibroblasts that were fixed with 4% 
formaldehyde and permeabilized with 0.2% Triton X-100, 1F1 and 5B4 display a fine punctate staining pattern 
throughout the cytoplasm and the nucleus. Filopodial extensions at the cell periphery are prominently labeled. 
(Aʼ) Counterstaining of the cells with 568-phalloidin revealed the F-actin stress fibers and shows that both 
antibodies do not bind to filamentous actin under these conditions. The inset shows the merged image of the 
area indicated by the arrow at higher magnification. Actin at the tips of filopodial extensions is labeled by 5B4, 
but not by 568-phalloidin.  Bar inset, 5 µm. (B) Fixation of rat2 fibroblasts with -20°C MeOH denatures stress 
fibers and permits binding of both mAbs to filamentous actin. Bar, 10 µm.
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5B4 (lower panels) to that of phalloidin-positive filamentous actin. In Rat2 cells fixed with 
4% paraformaldehyde and then permeabilized with 0.2% triton-X100 (Figure 26 A), 1F1 
and 5B4 showed a fine disperse, slightly punctate staining throughout the cell. Consistent 
with the previously reported distribution of non-filamentous actin in the cytoplasm and the 
nucleus (Schoenenberger et al. 2005). 1F1 and 5B4-labeling was also found in both cellular 
compartments. Moreover, a pronounced staining of filopodial extensions at the cell periphery 
was observed in some cases. The staining pattern was clearly distinct from that of filamentous 
actin revealed by phalloidin (Figure 26 Aʼ ). However, when Rat2 cells were fixed with -20°C 
methanol (Figure 26 B), which results in partial denaturation and precipitation of cellular 
structures, the antibody labeling appeared to be more stressfiber-like. This finding suggests 
that MeOH had to some extent unmasked the binding site of 1F1 (and 5B4) in filamentous 
actin. 
The accessibility of the 5B4-binding site in isolated F-actin filaments was studied by 
highspeed cosedimentation assays (Figure 27). As expected, pre-polymerized F-actin 
filaments were pelleted by centrifugation at 100.000 g (left panel), whereas purified 5B4 
immunoglobulin remained in the supernatant. A similar distribution was observed when 5B4 
was incubated together with F-actin filaments prior to centifugation (right panel). The faint 
band representing small amounts of 5B4 light chain in the pellet fraction might represent 
antibody reacting with the free ends of filaments. The data from cosedimentation experiments 
support the notion that the epitope recognized by 1F1 and 5B4 is buried in filamentous 
actin.
Figure 27. 5B4 does not bind to native F-actin filaments. The interaction of purified 5B4 with phalloidin-
stabilized F-actin filaments was analyzed by high-speed cosedimentation assays. Blots of the total protein 
input (T), the supernatant (S) after centrifugation and the resulting pellet (P) were probed with a polyclonal 
actin antibody. Left panel, phalloidin-stabilized F-actin filaments were completely pelleted by the applied 
centrifugal forces. Middle panel, high-speed centrifugation does not the pellet the purified antibody. Right 
panel, the majority of the antibody remained in the supernatant after cosedimentation with F-actin filaments. 
The molecular masses (in kDa) of standard proteins are indicated on the right. hc, heavy chain, lc, light 
chain.
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Subcellular distribution of the 1F1 epitope
To further investigate the subcellular distribution of the hydrophobic loop antigen at the 
ultrastructural level, we carried out post-embedding indirect immunoelectron microscopy on 
ultrathin sections of HeLa cells and neonatal rat heart tissue (Figure 28). We chose HeLa cells 
because of their relatively large nucleus compared to the total cell volume and cardiac muscle 
tissue because of the abundance of actin filaments that are highly organized in sarcomeres. 
The sections were labeled with 1F1 and then incubated with a 10 nm colloidal gold-
conjugated goat anti mouse IgG. Control incubations without the primary antibody showed 
that there was virtually no background labeling of HeLa cells or cardiac tissue under the 
experimental conditions chosen (data not shown). Consistent with the immunofluorescence 
labeling of Rat2 cells shown above, gold particles were detected throughout the cytoplasm 
(c) and the nucleus (n) in both cell types. The distribution of the gold particles appeared to be 
random, without an evident association with any distinct structure. In particular, there was no 
conspicuous labeling of thin filaments in the cardiac muscle tissue (Figure 28 B), supporting 
the notion that the antigen is concealed in the F-actin filament. Immunogold labeling of 
HeLa cells and cardiomyocytes confirmed that mAbs raised against NP-L/S particles detect 
the hydrophobic loop of actin primarily in non-filamentous actin where it is exposed. 
Figure 28. Cellular distribution of the 1F1 epitope at the ultrastructural level. Ultrathin sections of HeLa 
cells  (A) and neonatal rat cardiomyocytes (B) were labeled post-embedding with 1F1 and a 10 nm gold-
conjugated secondary antibody (enlarged, pseudocolored red). Immunogold labeling confirms that the actin 
conformation recognized by 1F1 is present in the cytoplasm (c) and the nucleus (n). A distinct labeling of thin 
filaments in the sarcomeres of cardiomyocytes is not evident.
Chapter 2       Peptide Nanoparticles - A potent immunogen 
       for the production of monospecific antibodies 
                        
74
Discussion
Repetitive surface display on peptide nanoparticles turns conserved actin sequences into 
potent immunogens
Antibodies that recognize distinct structural elements are important tools to examine the 
distribution, assembly, and ultimately the function of supramolecular actin structures. Because 
actin is an extremely conserved molecule, peptides used for immunization are likely to be 
almost identical to the actin of the host and therefore, self-tolerance will prevent the induction 
of a strong immune response. Consequently, the production of specific actin antibodies has 
proven notoriously difficult. In those cases where the epitope has been mapped, antibodies 
raised against actin or peptides thereof predominantly recognize regions of the more variable 
aminoterminus (Skalli et al. 1986; Gimona et al. 1994). A small number of highly interesting 
antibodies have been obtained by using distinct forms of actin as immunogen rather than 
peptides corresponding to specific actin sequences. For example, immunization with actin 
complexed to profilin led to a mAb termed 2G2, which binds to a non-sequential actin epitope 
(Gonsior et al. 1999).
Besides several forms of denatured actin, 2G2 recognizes a specific conformation of 
native actin, which is present in the nucleus of certain cell types and specified by compaction 
of the antibody-reactive region into a coherent patch. Another antibody that reveals distinct 
forms of nuclear and cytoplasmic actin has been obtained by immunizing mice with a 
covalently cross-linked antiparallel actin dimer (Schoenenberger et al. 2005). Furthermore, 
autoantibodies that recognize predominantly filamentous actin have been found in patients 
with type1 autoimmune hepatitis (Silvestrini and Benson 2001; Granito et al. 2006).
The ability of actin to polymerize into highly ordered, two-stranded helical filaments is 
an intrinsic property of all actins and thus sequences involved in the establishment of F-
actin filaments are amongst the most conserved. Moreover, sequences that are involved in 
subunit contacts along and between the axial strands are in general not readily accessible 
for antibody binding. For example, amino acids 263 to 274 which form the ʻhydrophobic 
loopʼ, represent a highly conserved, distinct structural feature that lies buried in the filament. 
Because it presumably is a difficult antigen, we chose this particular sequence to test the 
immunogenic potential of peptide nanoparticles.
The display of peptides or proteins in an ordered, repetitive array is known to enhance 
their immunogenic potential. For example, pattern recognition by the immune system is 
efficiently stimulated by the highly ordered and repetitive structure of virus-like particles 
(VLPs). A number of VLPs, such as Tobacco mosaic virus (TMV; (Palmer et al. 2006; Smith 
et al. 2006)) human papilloma virus and Hepatitis B VLPs, have been modified to function 
as scaffolds for the surface display of peptide epitopes  (Jennings and Bachmann 2008). 
Repetitive antigen display systems as B-cell epitope carriers have so far largely involved 
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viral capsid structures. As an alternative, we have recently designed a novel tool for repetitive 
antigen display: using different protein oligomerization domains we have designed peptide 
nanoparticles with predicted icosahedral symmetry similar to viral capsids (Raman et al. 
2006). 
Like VLPs, the polyhedral symmetry of peptide nanoparticles represents an ideal ʻrig  ʼ
for repetitive antigen display, but nanoparticles offer additional advantages. In particular, 
the expression vector used in this study can easily be customized with an antigenic epitope 
at either end of the sequence as both, the N-terminal and the C-terminal ends of the peptide 
sequence extend from the nanoparticle surface. Hence, an antigenic peptide sequence at the 
C-terminus of the construct will be repetitively displayed at the surface of the nanoparticle. 
It has previously been shown that such a repetitive antigen display will substantially increase 
the level and specificity of antibodies in response to a given antigen (Baschong et al. 2003).
The backbone peptide chain of the first generation nanoparticles was produced by solid-
phase peptide chemistry (Raman et al. 2006). In this study, we have generated an expression 
vector which allows not only C-terminal modification of the peptide by genetic engineering, 
but also the easy and fast recombinant expression of the epitope-tagged peptides in E. coli. 
Furthermore, a hexahistidine tag at the N-terminus facilitates downstream purification of 
nanoparticle peptides. The ultrastructural morphology of basic nanoparticles assembled from 
recombinantly expressed backbone peptide is comparable to that of nanoparticles assembled 
from the synthetic peptide. The size of both types of negatively stained nanoparticles was 
determined to be approximately 25 nm in diameter. After taking into account artifacts 
introduced by sample preparation and negative staining, this number corresponds well to the 
diameter of 20.3 nm calculated from the computer model. For negatively stained NP-L/S, 
which carry the hydrophobic loop epitope at the C-terminus of the backbone polypeptide, 
the average diameter was 22.1 nm. Thus, the NP-L/S appear to be not only smaller than the 
calculated 23.3 nm, but also smaller than the nanoparticle without the epitope. It is possible 
that the epitope affects the folding and assembly of the core polypeptide in such a manner 
that it differs from the modelled icosahedral structure. Our ongoing biophysical analyses 
with other nanoparticle constructs indicate that in fact the number of peptide chains that 
assemble into a single nanoparticle may differ from the 60 peptide chains that are expected 
to form an T1 icosahedron. Nevertheless, the immunoprecipitation experiments and FCCS 
using NP-L/S indicate that the epitope is indeed exposed on the surface of these particles.
That folding and assembly of nanoparticles are sensitive to the nature of the epitope 
is further confirmed by the introduction of an additional cysteine at the base of the actin 
loop sequence, which resulted in the aggregation of NP-L/C particles under oxidizing 
conditions. It is possible that during assembly this cysteine residue is buried whereas the 
C-terminal cysteine is fully exposed in high density on the surface of the nanoparticles, and 
thus, disulfide bonding more readily occurs between the C-terminal cysteines of neighboring 
particles even at low concentration. This aggregation may even have played an adjuvant 
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role in the overall immune response raised against NP-L/C particles by promoting a local 
inflammatory response. However, administration of disperse peptide nanoparticles carrying 
a profilin epitope effectively triggered the immune response (Murk et al., manuscript under 
revision). In addition, recent studies demonstrate that 25 nm-nanoparticle vaccines were 
significantly more efficient than 100 nm-particles in stimulating adaptive immunity (Reddy 
et al. 2007). 
Immunization with NP-L/C allowed the establishment of several different hybridoma 
cell lines. The subclass of the mAbs were all of the IgG2b isotype indicating that using 
nanoparticles as a platform for repetitive antigen display shifts the immune response towards 
a less inflammatory T helper type 2-like response (Chackerian et al. 2006).
Antibody specificity
To demonstrate the specific binding of monoclonal loop antibodies to the actin epitope 
exposed on NP-L/S particles at the molecular level, we used fluorescence correlation 
spectroscopy. The advantage of this emerging technique is that interactions between molecules 
can be determined through their correlated motion in equilibrium solution, independent 
of molecular orientation. A number of recent studies have used fluorescence correlation 
spectroscopy to measure antigen-antibody interactions (Lagerkvist et al. 2001; Grunwald et 
al. 2005; Ruan and Tetin 2008). The combination with a confocal microscope will not only 
improve signal to noise ratios in spectroscopic measurements, but also allows simultaneous 
confocal imaging of the labeled specimen. Confocal images (Figure 24) of Alexa 488-labeled 
particles and Alexa 633-labeled antibodies revealed that some aggregation had occurred in 
both specimens even at optimized concentrations. Although individual nanoparticles, not to 
mention the significantly smaller antibodies, are below the limits of resolution, aggregation 
resulted in dot sizes that were within the resolution of the light microscope. Correct 
conclusions about the number of antibodies bound or binding constants are difficult because 
the fluorescence intensity of labeled particles is modified by intermolecular quenching and 
thus, determination of the actual number of fluorescently labeled epitopes very ardous. 
Another reason for the difficulty to determine stoichiometry and binding affinity is related 
to the fact that the number of fluorophores coupled to an antibody cannot be stanardized. 
For instance, it has been shown that when IgGs, which contain two independent epitope 
binding sites, statistically carry one fluorophore, approximately one third of the molecules 
are not labeled and will lead to a significant reduction of the cross-correlation amplitude. 
Nanoparticles, which are assembled from presumably sixty peptides, are even more prone 
to being nonuniformly labeled. Morevover, because of the close spacing of the epitopes 
with respect to the dimensions of the antibody, there will be significant steric hindrance. 
Although we do not know how many antibodies are bound to an individual particle, merged 
images of labeled loop antibodies versus control antibodies clearly demonstrate a specific 
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interaction between loop antibodies and NP-L/S. The specificity was further confirmed by 
using nanoparticles with an unrelated epitope (data not shown). 
Improvement of labeling protocols and careful optimization of the instrumentation will 
be necessary to achieve the highest cross-correlation signal and for further characterization 
of the NP-L/S interactions with the loop antibodies.
Antibodies raised against loop nanoparticles detect cellular actin
Immunolabeling of HeLa cells with mAbs raised against NP-L/C revealed that the loop 
epitope, which corresponds to aa 262 - 274 in actin, is also recognized in its native structure 
in situ. According to the F-actin filament model (Holmes et al. 1990), the hydrophobic loop 
structure is involved in contacts between axial strands and thus is buried in the filament 
(Figure 21 B). Moreover, a detachment of the hydrophobic loop 262 - 274 from the monomer 
surface, and its perpendicular extension and insertion into protomers of the opposite strand 
is required for F-actin filament formation and stability. As a consequence of this protected 
location, loop mAbs 1F1 and 5B4 predominantly recognized non-filamentous actin with a 
more accessible loop structure in the cytoplasm of formaldehyde fixed cells. This staining 
pattern is similar to the one observed with the previously published actin mAb 1C7 that 
binds to amino acids 194 - 202, which also lie buried within the filament (Schoenenberger 
et al. 2005). However, treatment with ice-cold methanol at least partially uncovered the 
loop epitope and revealed a stressfiber-like pattern in 1F1 and 5B4 labeled cells. In contrast, 
the epitope recognized by 1C7 is involved in subunit contacts along the helical strands 
and remains shielded even after methanol treatment. Intriguingly, 1F1 seems to bind to the 
hydrophobic loop in non-filamentous and filamentous actin under these conditions, although 
the loop is predicted to undergo a conformational change to stabilize the filament in the 
prevailing Holmes model (Holmes et al. 1990).
Our data show that by grafting an actin-related epitope onto the surface of designed peptide 
nanoparticles we were able to tailor antibodies that bind to a specific actin structure in situ. 
To substantiate that a nanoparticle-induced immune response is generally applicable for 
isolating antibodies against refractory antigens, we recently employed this innovative method 
to produce profilin1-specific mAbs, which can be used elucidate the different functions of 
profilin isoforms (Murk et al., manuscript under revision). Therefore, nanoparticles could 
serve as a highly versatile and convenient platform for the development of synthetic subunit 
vaccines.
Chapter 2       Peptide Nanoparticles - A potent immunogen 
       for the production of monospecific antibodies 
                        
78
Acknowledgments
We gratefully acknowledge the help of Rosmarie Sütterlin (M.E. Müller Institute 
for Structural Biology, University of Basel) with immunofluorescence. This work was 
supported by a grant from the Swiss National Science Foundation (to CAS), the Deutsche 
Forschungsgemeinschaft (BMJ) and the M.E. Müller Foundation.
79
Chapter 2       Peptide Nanoparticles - A potent immunogen 
       for the production of monospecific antibodies
2.6 Immunoelectron microscopy of peptide nanoparticles
2.6.1 Immunoelectron microscopy of peptide nanoparticles yielded ambiguous 
results
To further characterize the binding of antibodies to nanoparticles at the ultrastructural 
level, we attempted to employ immunogold electron microscopy.
Direct immunogold labeling of nanoparticles in solution with 5B4-Au yielded gold 
particles attached not only to the nanoparticles but also to the EM-grid itself (Figure 29). 
Hence, actual binding events could not be distinguished from background noise.
Figure 29. Direct immunogold-labeling in solution. Gold particles, indicating the mAb 5B4 were found 
associated with nanoparticles (enlarged and pseudocoloured red) but also randomly adsorbed to the grid 
(enlarged and coloured black).
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To get more conclusive results for immunogold labeling of nanoparticles, we pursued 
several strategies to improve the specificity of this technique.
For direct immunogold labeling of nanoparticles on the EM-grid, NP-L/S and NP were 
applied to gently glow discharged copper EM-specimens. Subsequently, the specimens were 
incubated on droplets of serially diluted, gold-coupled mAb 5B4 (5B4-Au) and a gold-
coupled unrelated mAb. After careful washing, labeled specimens were processed for CTEM 
as described in Chapter 1.3.
Incubation with moderate concentrations of 5B4-Au yielded gold particles attached to 
the nanoparticles and also to the EM-grid. Similar to the direct labeling in solution, actual 
binding events and background noise could not be distinguished (data not shown).
5B4-Au was further titrated in order to establish conditions where unspecific binding to 
the grid was minimal. Immunogold labeling of different nanoparticles with 5B4-Au and the 
gold-conjugated unrelated mAb under these conditions is illustrated in Figure 30. Despite 
the presence of multiple epitopes per particle, binding events on NP-L/S were rather scarce 
(Figure 30 A). Moreover, a similar number of binding events was observed with NP that do 
not carry the loop epitope (Figure 30 B), and even with the unrelated mAb (Figure 30 C), 
gold particles were associated with NP-L/S.
This finding suggests that the interaction between 5B4-Au with adsorbed NP-L/S is not 
strong enough to be significant. Alternatively, epitopes on adsorbed NP-L/S are not sufficiently 
exposed to be accessed by specific antibody. Independent on the amount of antibody applied, 
we detected at the most six gold particles on individual, assembled nanoparticles, Since NP-
L/S have a diameter of less than 30 nm (see Chapter 2.5) and the approximate size of IgGs 
is 12 nm (Taschner et al. 2001), the number of binding events could have been limited by 
spatial hindrance of the antibody.
Figure 30. Direct immunogold-labeling of peptidic nanoparticles. (A) NP-L/S labeled with 5nm colloidal gold 
conjugated 5B4 actin loop mAb (5B4-Au). (B) The same gold-conjugated mAb binds to NP. (C) NP-L/S labeled 
with 5nm colloidal gold-conjugated unrelated mAb. Gold particles are enlarged and pseudocolored red.
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Figure 31. Immunogold-labeling of nanoparticles. In (A) and (B) the structure of the recognized nanoparticle 
is clearly. However, in (C) and (D) small clusters of gold dots could represent nanoparticles covered by bound 
antibodies or aggregates of antibodies alone.
Thus, only a delimited number of antibody-gold complexes were capable to bind to the 
epitopes on the nanoparticles. This is consistent with the significantly larger number of gold 
particles detected on aggregated nanoparticles, such as on NP-L/C (data not shown). 
Moreover, as displayed in Figure 31, small cluster of gold-labeled antibody have 
dimensions similar to those of nanoparticles. Hence, in many cases it remained unclear if 
there was a nanoparticle underneath the gold or if the gold dots represent only aggregates of 
antibody.
In contrast to other labeling strategies, such as indirect immunogold labeling of 
nanoparticles in solution and on the specimen as well as direct immunogold labeling in 
solution, direct immunogold labeling of nanoparticles on the specimen was the only technique 
with which unspecific bound gold particles could be eliminated from the background of the 
specimen.
In order to achieve a high density of nanoparticles and thereby reduce background noise 
caused by unspecific adsorption of the antibodies, we also tried immunogold labeling on 
embedded and thin-sectioned nanoparticles, as was shown for viruses and VLP previously 
(e.g. (Canto-Nogues et al. 2001; Chiu et al. 2006)). Therefore, we pelleted NP-L/S particles 
by high-speed centrifugation.
However, the soft nanoparticle pellets easily disintegrated and could not be embedded. 
In conclusion, we suggest that immunogold labeling was not an appropriate technique 
to visualize and verify the specific binding of antibodies with peptide nanoparticles. Due 
to the small difference in size between nanoparticles and antibodies, the number of specific 
binding events was too little to distinguish from unspecific binding. 
However, immunogold labeling of viruses and virus-like particles (VLPs) is a commonly 
used technique. In contrast to our nanoparticles, the previously immunogold labeled viruses 
and VLPs span at least 50 nm and remained visible even with a larger number of gold 
particles attached (e.g. (Brookman et al. 1995; Berg et al. 2005)). Apart from biochemical and 
immunofluorescence studies, visualization of specific interactions of antibodies with peptide 
nanoparticles yielded more convincing results using FCCS (Schroeder et al. manuscript 
accepted; JMB; Chapter 2.5).
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2.7 Conclusions and outlook
As documented in Chapter 2.4, immunization with peptide nanoparticles carrying 
epitopes that mimic distinct structural elements of the actin molecule yielded antibodies that 
specifically recognize these particular epitopes in vitro and in situ. 
Currently, we aim at producing antibodies that exclusively recognize the LD. For this 
purpose, we genetically engineered three novel, designed peptides onto the C-terminus of the 
core polypeptides. These peptides were designed to mimic surface areas and surface charges 
that occur at the interface of LD subunits and are specific to the antiparallel arrangement 
of the subunits. Because the amino acid sequence of the chosen epitopes do not occur in 
monomeric actin, we suggest that these constructs are suitable to produce antibodies that 
exclusively react with LD.
Chapter 3
Raver1
An integral component of muscle contractile elements
and a potential ligand for actin
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3.1 Introduction
3.1.1 Raver1 – a heterogeneous nuclear ribonucleoprotein
By screening a yeast two-hybrid library for new ligands of the actin-binding proteins 
(ABPs) vinculin/metavinculin, Huettelmaier and coworkers identified a hitherto unknown 
protein, which they termed raver1 (Huttelmaier et al. 2001). Computational analysis 
revealed that rat raver1 is composed of 748 amino acids (Mr 80 kDa), which include one 
Rev-like nuclear export sequence (NES), two nuclear localization signals (NLS), and three 
amino-terminal RNA recognition motifs (RRMs). Within the RRMs, raver1 shares some 
conserved motifs with proteins of the heterogeneous nuclear ribonucleoprotein (hnRNP) 
family (Huttelmaier et al. 2001; Jockusch et al. 2003). Thus, in the absence of any other 
homologues, raver1 is currently considered to be an hnRNP.
3.1.2 Cellular distribution of the dual compartment protein raver1
Raver1 is ubiquitously expressed in all cell lines and tissues tested (Huttelmaier et al. 
2001). Striated muscle and organs with a high content of epithelia express the highest levels 
of raver1, whereas comparatively low amounts are found in brain, lung and spleen tissue 
(Zieseniss 2005). Expression of raver1 is not restricted to specific developmental stages. 
Although considered an hnRNP, raver1 is not confined to the nucleus, but is also present in 
the cytoplasm. Specifically, it is predominantly nuclear in undifferentiated cells and more 
evenly distributed throughout the nucleus and the cytoplasm after differentiation (Huttelmaier 
et al. 2001).
The majority of nuclear raver1 is localized in perinucleolar bodies, where it colocalizes 
with the hnRNP polypyrimidine tract binding protein (PTB), which is involved in RNA 
splicing of certain actin binding proteins (ABP), such as α-actinin and tropomyosin 
(Valcarcel and Gebauer 1997). Consistent with an association of raver1 with PTB, native 
protein complexes containing raver1 and PTB could be isolated from undifferentiated C2C12 
myoblasts (Zieseniss 2005). Intriguingly, actin was also a constituent of this complex.
During the differentiation of myoblasts to myotubes, raver1 was seen to redistribute 
from the nuclear to the cytoplasmic compartment (Huttelmaier et al. 2001), indicating that 
translocation possibly depends on the differentiation stage and/or the transcriptional activity 
of cells (Huttelmaier et al. 2001; Zieseniss 2005; Zieseniss et al. 2007). However, studies 
with C2C12 myoblasts and heterokaryon HeLa cells showed a continuous shuttling of raver1 
between the cytoplasm and the nucleus (Huttelmaier et al. 2001).
The localization of cytoplasmic raver1 was intensively studied in isolated myotubes, 
and in striated as well as smooth muscle tissues (Huttelmaier et al. 2001; Zieseniss 2005; 
Zieseniss et al. 2007). Immunofluorescence and immunoelectron microscopy revealed a 
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distinct labeling pattern of raver1 in the cytoplasm, which was similar in myotubes and 
different striated muscle tissues. In myotubes, raver1 colocalized with vinculin/metavinculin 
and α-actinin at microfilament attachment sites (Huttelmaier et al. 2001). Likewise, raver1 
was abundant at the microfilament attachment sites in sarcomers and costamers of skeletal 
muscle tissues (Zieseniss 2005; Zieseniss et al. 2007). However, in heart tissue raver1 was 
predominantly detected at intercalated discs (Huttelmaier et al. 2001), but also at the I-bands 
(Zieseniss 2005; Zieseniss et al. 2007).
In Chapter 3.3, the detailed localization of raver1 in different types of muscle tissue 
revealed by immunofluorescence and immunoelectron microscopic analyses is presented. In 
the following Chapter 3.4, this published study was extended to immunolabeling of raver1 
in different cultured cell lines and in nuclei from Xenopus laevis oocytes.
3.1.3 Raver1 - a potential ligand for actin
Despite a distinct distribution of raver1 in cells and tissues, and biochemical evidence 
for its interaction with specific ABPs and PTB, the function of raver1 remains unknown. 
Interestingly, a number of findings suggest that actin might be a possible target protein for 
raver1. For instance, raver1 accumulates at the I-band of sarcomers where F-actin filaments 
are the predominant structure. In addition, both proteins have some binding partners in 
common. Consistent with the notion of a direct interaction of raver1 and actin in the nucleus, 
preliminary data suggest that both proteins are constituents of the same nuclear complex.
Actin has been shown to play a role in the nuclear export of retroviral RNAs but also of 
host proteins such as protein kinase inhibitor (Hofmann et al. 2001; Hofmann et al. 2006). 
Similarly, raver1 has been suggested to be involved in the translocation machinery that escort 
proteins to their specific microfilament adhesion sites into the cytoplasm (Huttelmaier et al. 
2001; Jockusch et al. 2003). 
Another common feature of raver1 and actin is their involvement in the readout of genetic 
information. Nuclear actin has been recently identified as a component of the transcription 
apparatus (reviewed by (Grummt 2006)), which implies an important role of actin in RNA 
processing, whereas raver1 through its interaction with PTB, is involved in mRNA stability. 
Genes whose alternative splicing is regulated by PTB include α-tropomyosin (TM), β-TM 
and α-actinin, which are binding partners of actin in the sarcomere (reviewed in (Wagner 
and Garcia-Blanco 2001)). 
Preliminary evidence for a direct interaction of raver1 and actin in vitro has recently been 
provided (Zieseniss 2005). For a more detailed analysis, we carried out cosedimentation 
assays with purified rabbit skeletal muscle actin and recombinantly expressed raver1. The 
results of the biochemical and microscopic analysis of the protein complexes are summarized 
Chapter 3.4.
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3.2 Material and methods
Most of the methods applied will be included in the publication in Chapter 3.3.
Preparation of Xenopus laevis oocyte nuclei
Mature (stage VI) oocytes were surgically removed from female X. laevis (Jarnik and 
Aebi 1991) and kept in modified Barth saline (10 mM HEPES containing 88 mM NaCl, 
1 mM KCl, 0.82 mM MgSO
4
, 0.33 mM Ca(NO
3
)
2
, 0.41 mM CaCl
2
, 100 U/ml penicillin-
streptomycin, pH 7.5; MBS) at 4°C. Oocytes were defolliculated by treatment with 5 mg/ml 
collagenase (Sigma, St. Louis, MO) in calcium-free MBS for 3 hrs at RT. 
For CTEM, nuclei were manually dissected from stage VI oocytes and collected in low 
salt buffer (10 mM HEPES containing 1 mM KCl, 0.5 mM MgCl
2
, pH 7.5; LSB), fixed for 
15 min in LSB containing 4% formaldehyde, and then processed for thin-section electron 
microscopy as described elsewhere (Fahrenkrog et al. 2002; Paulillo et al. 2005). 
Cosedimentation of raver1 and actin
Purified skeletal muscle G-actin (see Chapter 1.3) and recombinant full-length raver1 
protein (R1-FL) and a carboxy-terminal raver1 fragment (R1-ΔN), which were expressed 
in insect cells, were precleared from aggregates by ultracentrifugation at 100.000 g for 1 hr 
at 4°C. The upper fraction of the corresponding supernatants was removed and the protein 
content was determined by measuring UV absorption.
For cosedimentation, G-actin and raver1 fragments were mixed at final concentrations of 
3 µM and 2 µM, respectively, and incubated on a roller for 1 hr at 4°C. Subsequently, high-
speed pelleting and SDS-PAGE analysis were performed as described in Chapter 1.3. The 
SDS-PAGE gels were silver stained as published (Ansorge 1985). 
For cosedimentation of prepolymerized F-actin filaments and R1-FL or R1-ΔN, G-
actin was first polymerized in the presence of 100 mM KCl and a two-fold molar excess of 
phalloidin over F-actin. The resulting filaments were separated from non-polymerized actin 
by high-speed pelleting according to Chapter 1.3. The pellets were resuspended in actin 
filament buffer and used for cosedimentation assays with R1-FL or R1-ΔN. The experimental 
conditions were similar to those described for cosedimentation with G-actin, except that 
actin filament buffer was used for washing and resuspension of the filament pellets.
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Abstract
Raver1, a ubiquitously expressed protein was originally identified as a ligand for 
metavinculin, the muscle specific isoform of the microfilament-associated protein vinculin. 
The protein resides primarily in the nucleus, where it colocalizes and may interact with 
the polypyrimidine-tract binding protein PTB, which is involved in alternative splicing 
processes. During skeletal muscle differentiation, raver1 translocates to the cytoplasm 
and eventually targets to the Z-line of sarcomeres. Here, it colocalizes with metavinculin, 
vinculin and alpha-actinin, all of which have biochemically been identified as raver1 ligands. 
To obtain more information on the potential role of raver1 in muscle structure and function, 
we investigated its distribution and fine localization in striated and smooth muscle of mouse. 
Three monoclonal antibodies that recognize epitopes in different regions of the raver1 protein 
were employed in immunofluorescence and immunoelectron microscopy. Our results show 
that cytoplasmic accumulation of raver1 is not confined to skeletal muscle, but occurs also 
in heart and smooth muscle. Unlike vinculin and metavinculin, cytoplasmic raver1 is not 
restricted to costameres, but also represents an integral part of the sarcomere. In isolated 
myofibrils and in ultrathin sections of skeletal muscle, raver1 was found concentrated at the 
I-Z-I band. In addition, a minor fraction of raver1 was present in the nuclei of all three types 
of muscle. These data indicate that during muscle differentiation raver1 might link gene 
expression with structural functions of the contractile machinery of muscle.
Introduction
Muscle contraction critically depends on the precise interplay of myofibrils anchored to 
and associated with structural as well as regulatory proteins. This is best demonstrated for 
striated muscle, where the contractile apparatus is organized into regular repeating units, 
the sarcomeres, whose integrity is essential for proper muscle function. Metabolic labeling 
and transfection studies have shown that fully differentiated muscle, in spite of its rigid 
appearance, is a highly dynamic structure with a constant turnover of individual components 
albeit at different rates (Zak et al. 1977; Martin 1981; Michele et al. 1999; Littlefield et 
al. 2001). Even proteins previously perceived as static components of the Z-disc such as 
alpha-actinin or myotilin are in a continuous exchange with a cytoplasmic pool (Wang et al. 
2005). Furthermore, muscle is able to respond to changes in mechanical strain by altering the 
equilibrium between protein synthesis and degradation (Janmey 1998; Ruwhof and van der 
Laarse 2000; Russell et al. 2000). However, it is still poorly understood how the turnover of 
individual components is achieved while muscle function is being maintained.
Some of the muscle proteins exhibit a dual residency, at the sarcomere and in the nucleus. 
They have been suggested to function as messengers that link gene expression to myofibril 
signalling pathways. Indeed, there is increasing evidence that sarcomeric constituents may 
appear at different subcellular locations in response to different stimuli, both within the 
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sarcomere as well as in other cellular compartments, such as the nucleus (reviewed in (Clark 
et al. 2002; Lange et al. 2006)). These findings imply that the sarcomere not only provides 
the structural basis for muscle contraction, but also serves as a communicative platform 
where signals are both, perceived and transmitted, allowing for functional plasticity of 
muscle tissue.
A candidate messenger protein in muscle differentiation or maintenance is raver1 (Figure 
32 A), a ubiquitously expressed 80 kDa protein that contains three RNA-recognition motifs 
(RRMs) with a high sequence homology to members of heterogeneous ribonucleoprotein 
family (Huttelmaier et al. 2001; Jockusch et al. 2003). In most cell types, raver1 is found in 
the nucleus, but displays nucleocytoplasmic shuttling presumably mediated by two nuclear 
localization signals at the N- and C-termini and a putative export sequence located within 
the central leucine-rich region. In the nucleus, raver1 may associate with another hnRNP, 
the polypyrimidine tract binding protein (PTB), a potent regulator of alternative splicing 
of several genes (Valcarcel and Gebauer 1997). Direct binding of raver1 to PTB has been 
demonstrated in vitro and both proteins colocalize in the perinucleolar compartment (PNC), 
an RNA-dependent structure that is characterized by the accumulation of PTB (Ghetti et al. 
1992). Furthermore, raver1-PTB complexes can be immunoprecipitated from vertebrate cells 
(Huttelmaier et al. 2001). While direct RNA binding of raver1 has yet to be demonstrated, 
the protein may assist in PTB-mediated splicing events in smooth muscle (Gromak et al. 
2003; Spellman et al. 2005). Apart from its association with PTB in the nucleus, raver1 
interacts with the microfilament-associated proteins vinculin, its muscle-specific splice 
variant metavinculin and alpha-actinin (Huttelmaier et al. 2001). In fact, raver1 was originally 
identified through its interaction with metavinculin in a yeast two hybrid screen. During 
myotube formation of C2C12 cells, nuclear raver1 was shown to translocate to the cytoplasm 
and eventually associate with myofibrils at the position of the Z-line. In differentiated skeletal 
muscle, raver1 colocalized with its cytoplasmic ligands (meta)vinculin and alpha-actinin at 
the region of sarcomeric Z-lines and costameres (Huttelmaier et al. 2001).
To gain further information on raver1 and its role in muscle differentiation, we embarked 
on a detailed analysis of the localization of raver1 in skeletal, heart and smooth muscle 
of the mouse. To this end, we generated and characterized three monoclonal antibodies 
against different regions of the raver1 protein and employed them in immunofluorescence 
and immunoelectron microscopy. Our data reveal that raver1 is associated with cytoplasmic 
contractile elements in all three muscle types. Furthermore, raver1 is not restricted to 
costameres, but the protein is a prominent component of the I-Z-I region in striated muscle 
and the intercalated disc in heart. In addition, nuclear localization of raver1 was noted for all 
tissues examined.
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Figure 32. Characterization of monoclonal antibodies against different raver1 epitopes. (A) Schematic 
representations of full-length raver1 and two complementary deletion constructs used in this study. The first 
and last amino acids of each construct are given. RNA recognition motifs are shown as black boxes, nuclear 
localization signals are indicated in grey. A central leucine-rich region (putative NES) is depicted as a hatched 
box. Arrows indicate the binding positions of the monoclonal antibodies 5G6, 5D5 and 7D3. (B) The epitope 
recognized by 5G6 comprises amino acids 25 - 30 of raver1 as revealed by pepscan analysis. (C) Reactivity of the 
raver1 antibodies with recombinant raver1 and its deletion fragments (SDS-PAGE, left panel) in immunoblots. 
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5G6 (centre panel) recognizes full-length raver1, a bouquet of its degradation products and raver1∆C, while 
7D3 (right panel) and 5D5 (not shown) react with full length raver1 and raver1∆N. (D) Reactivity of the raver1 
antibodies with cell extracts. Equal amounts of proteins from murine C2C12 and human HeLa were subjected 
to SDS-PAGE, blotted and incubated with 5G6 (left), 5D5 (right) and 7D3 (not shown). While the C-terminal 
antibodies recognize raver1 protein in samples of both cell types, 5G6 detects only murine raver1. (E) Part of 
the amino acid sequence of raver1 comprising the epitopes for 5G6 (left) and 7D3/5D5 (right) from different 
species. Note that the C-terminal sequence is highly conserved among vertebrate raver1 proteins, whereas the 
5G6 epitope is only conserved in mouse and rat.
Materials and methods
Raver1 antibodies 
Three monoclonal antibodies of the IgG type were generated. The antibody 5G6 was 
raised against an N-terminal fragment of raver1 (Huttelmaier et al. 2001). In the present 
study, the epitope of this antibody was mapped by pepscan analysis. Peptides (15mers) of 
the raver1 sequence with an overlap of twelve amino acids between consecutive peptides 
were spot-synthesized on a cellulose membrane (Frank and Overwin 1996) and analyzed for 
antibody binding as described (Mayboroda et al. 1997). Two additional antibodies (5D5 and 
7D3) were raised against a C-terminal peptide (EPSPEGSY, corresponding to amino acids 
718 - 727) of the protein, following standard protocols. The antibodies obtained were tested 
in solid phase binding assays (enzyme-linked immunosorbent assay) on recombinant protein 
and in immunoblots using total extracts of HeLa and C2C12 cells subjected to SDS-PAGE. 
HRP-coupled goat anti-mouse antibodies (Sigma) were used as secondary antibodies in both 
assays.
The raver1 antibodies were purified from hybridoma culture supernatants by affinity 
chromatography using anti-mouse IgG agarose (Sigma) columns. Binding and elution of 
antibodies was performed according to the supplier’s protocol. 500 µl fractions were collected 
and immediately neutralized to pH 7.0 with 1 M Tris pH 9.5. Aliquots were analyzed by SDS-
PAGE. Fractions containing high antibody concentrations were pooled and dialyzed against 
PBS overnight. The concentration of purified antibody was calculated from the absorption at 
OD280 nm using an extinction coefficient of 1.35.
Cryosectioning and immunofluorescence labeling
Freshly isolated murine tissues (extensor digitorum longus, heart, uterus, urinary bladder) 
were mounted on egg white and cork (Jockusch and Voigt 2003) with Polyfreeze tissue-
freezing medium (Polysciences Inc.). To prevent contraction, muscles were fixed with 
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minutien pins. Specimens were frozen in melting isopentane, prechilled in liquid nitrogen and 
stored at -80°C. They were sectioned (5 - 10 μm) in a cryostat microtome at -20°C, mounted 
on glass slides and dried for at least 30 min. After washing with PBS, the sections were 
briefly (10 - 20 s) incubated with 1% Triton X-100 and then fixed with 4% formaldehyde for 
20 min. After additional washing steps, they were permeabilised with 0.2% Triton X-100 at 
room temperature (RT) for 30 min. For indirect immunofluorescence, unspecific background 
labeling was first quenched by incubation with 5% bovine serum albumin and 0.25 mg/ml 
Fab fragments (goat anti-mouse IgG, Dianova) in PBS at RT for 1 hr. The sections were 
then washed in PBS and incubated with the monoclonal raver1 antibodies (cell culture 
supernatants) at RT for 1 hr, washed three times in PBS and then incubated with goat anti-
mouse Cy3 (diluted 1:200, Jackson Immuno Research). Samples were counterstained for 
F-actin and DNA with FITC-conjugated phalloidin (Sigma) and DAPI, respectively. Finally, 
samples were extensively washed in PBS, mounted in Mowiol, and examined with a Zeiss 
Axiophot microscope equipped with epifluorescence optics.
Preparation and staining of myofibrils
Skeletal muscles were dissected from adult mice and incubated in Ringer’s solution (100 
mM NaCl, 2 mM MgCl
2
, 5 mM EGTA, 10 mM NaH
2
PO
4
, 0.1% glucose, 20 μM leupeptin, 
pH 7.4) on ice for 30 min. The tissue was transferred to rigor buffer (100 mM KCl, 2 mM 
MgCl
2
, 2 mM EGTA, 0.3 mM DTT, 20 μM leupeptin pH 7) using 5 ml per 0.5 g of tissue. 
After homogenisation using a dounce homogeniser, samples were incubated for 10 min on 
ice under constant agitation, centrifuged at 1.500 g for 30 min and resuspended in 10 volumes 
of ice-cold rigor buffer. These steps were repeated three times. Isolated myofibrils were 
stored in rigor buffer containing 50% glycerol at -20°C until use. For immunofluorescence, 
the myofibrils were allowed to adhere to glass slides for 1 min, rinsed with PBS and fixed 
with 4% formaldehyde for 10 min. After washing the samples were blocked with 5% 
bovine serum albumin in PBS at RT for 2 hrs, to reduce background labeling and stained 
for immunofluorescence as described above. Sarcomeric alpha-actinin was stained using a 
monoclonal antibody (Sigma).
Immunoelectron microscopy 
For immunogold labeling, ultrathin sections were mounted on 200 mesh carbon/parlodion-
coated copper grids. After blocking unspecific binding sites by two 5 min incubations in 
2% BSA/PBS, grids were incubated on droplets of raver1 antibody solutions in a moist 
chamber at RT for 2 hrs. The optimal antibody concentrations were determined by titration 
experiments. For direct labeling, purified raver1 antibodies were conjugated to colloidal 
gold (Slot and Geuze 1985). For indirect labeling, grids were rinsed with PBS after primary 
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antibody incubation, blocked with 2% BSA in PBS for two times 5 min, and then incubated 
with a secondary 10 nm gold-conjugated goat anti mouse IgG (BBInternational) for 1 hr at 
RT. After washing in PBS and dH
2
O, grids were stained with 6% uranyl acetate for 1 hr, rinsed 
with dH
2
O and then counterstained with lead-citrate for 2 min. For control experiments the 
primary antibody was omitted (data not shown). Electronmicrographs of stained specimens 
were recorded with either a Hitachi H 7000 (Hitachi Ltd., Tokyo, Japan) on Kodak® electron 
image film SO-163 or digitally with a Philips Morgagni 268D (Philips Electron Optics BV, 
Eindhoven, Netherlands) transmission electron microscope operated at an acceleration 
voltage of 100 kV and 80 kV, respectively.
Gel electrophoresis and immunoblotting
Total protein extracts from C2C12 and HeLa cells were obtained as described (Huttelmaier 
et al. 2001). Equal amounts of total protein were loaded onto 10% polyacrylamide gels. After 
electrophoresis, samples were transferred onto nitrocellulose membranes and analyzed for 
raver1 proteins following standard procedures as described (Huttelmaier et al. 2001).
Recombinant protein expression and purification
Recombinant raver1 proteins were expressed using the Bac-to-Bac™-system according 
to the manufacturer’s (Invitrogen) protocol. Briefly, cDNAs encoding full-length raver1, 
raver1∆C (amino acids 1 - 441) and raver1∆N (amino acids 442 - 748) were cloned into 
a modified pFastBac™ donor plasmid harbouring an additional FLAG tag sequence 
downstream of the histidine tag and transformed into E.coli DH10Bac cells. Recombinant 
bacmid DNA was isolated and transfected into sf9 (Spodoptera frugiperda) cells. The virus-
containing supernatant was harvested and used for the infection of High Five™ insect cells. 
Cells were collected by centrifugation at 500 g for 5 min, washed with PBS containing 
leupeptin (20 μM) and stored at -70°C. His-tagged proteins were purified from insect cells 
according to the manufacturer’s instructions (Qiagen) with slight modifications as described 
(Witt et al. 2004). Fractions containing the protein of interest were dialyzed against storage 
buffer (50 mM sodium phosphate buffer, pH 7.2, containing 0.2 mM EGTA, 4 μM pepstatin 
A, 40 μM leupeptin, Trasylol (2.8 mg/ml in H
2
O) and 14.3 mM β-mercaptoethanol) and 
stored on ice until use. 
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Results
Characterization of raver1 antibodies
In the present study three monoclonal antibodies, directed against different regions in 
the raver1 sequence (Figure 32 A) were employed to analyze the subcellular distribution of 
raver1 protein in muscle. The 5G6 antibody was raised against a recombinant MBP-tagged 
N-terminal raver1 fragment (amino acids 1 - 625) for the initial characterization of raver1 
(Huttelmaier et al. 2001). We mapped the epitope of this antibody by pepscan analysis (Frank 
and Overwin 1996) and found that it recognizes a series of four 15mer peptides (Figure 32 B). 
From the minimal sequence overlap the epitope ETVDRR was deduced, which corresponds 
to amino acids 25 - 30 of raver1. The antibodies 5D5 and 7D3 were raised against a C-
terminal synthetic peptide (EPSPEGSY, comprising amino acids 718 - 727) and specifically 
recognized this peptide in ELISA and immunoblot assays (data not shown). 
All three antibodies were tested for their reactivity with recombinant raver1 proteins 
in immunoblot assays (Figure 32 C and data not shown). Full-length raver1 and the two 
complementary deletion constructs raver1∆C (amino acids 1 - 441) and raver1∆N (amino 
acids 442 - 748) were purified from insect cells and subjected to SDS-PAGE (left panel), 
revealing major protein bands of 80 kDa for full-length raver1, approximately 51 kDa for 
raver1∆C and approximately 35 kDa for raver1∆N. Degradation was only noted for the 
full-length protein. In immunoblots, antibody 5G6 recognized full-length raver1 and its 
proteolytic fragments as well as the N-terminal fragment raver1∆C (Figure 32 C, middle). In 
contrast, antibodies 5D5 and 7D3 bound to the C-terminal construct raver1∆N in addition to 
the full-length protein, but failed to detect any degradation products (Figure 32 C, right and 
data not shown). This indicates that the full-length protein is degraded from its C-terminus.
When tested on cell extracts (Figure 32 D), all three antibodies recognized a protein 
band of approximately 80 kDa in murine C2C12 cells. In (human) HeLa cells, however, 
endogenous raver1 protein was only detected by the C-terminal antibodies (Figure 32 D, 
right and data not shown). Consistent with this finding, a comparison of known raver1 
sequences reveals that the 5G6 epitope is not highly conserved among vertebrate species, 
whereas the epitope recognized by 5D5 and 7D3 is present in man, mouse, rat and Xenopus 
raver1 (Figure 32 E).
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Figure 33. Localization of raver1 in skeletal muscle of the mouse (extensor digitorum longus). 
Immunofluorescence analysis of frozen sections (A, B left panels) stained for raver1 with 5G6 (A) 5D5 (B) 
and 7D3 (not shown) revealed a striated pattern for each antibody. Higher magnifications (insets) of well 
stretched muscle tissue (boxed regions) suggest that raver1 is localized as a doublet embracing the Z-lines. 
Bars, 10 μm.
Identification of raver1 as a myofibril component
In striated muscle, the raver1 ligand vinculin is restricted to attachment sites of the 
contractile apparatus to the sarcolemma, such as costameres and intercalated disks (Tokuyasu 
et al. 1981; Koteliansky and Gneushev 1983; Pardo et al. 1983; Witt et al. 2004), whereas 
alpha-actinin, another raver1 binding partner, is additionally present in the Z-disc (Tokuyasu 
et al. 1981; McKenna et al. 1986). 
We therefore wanted to determine whether raver1 was confined to the costamere or 
constitutes an integral part of sarcomeric structures. Frozen longitudinal sections of skeletal 
muscle from adult mice (extensor digitorum longus) yielded an identical staining pattern 
with all three raver1 antibodies (Figure 33 and data not shown). Raver1 was present as a 
doublet in the I-Z-I region, which was identified in the corresponding phase contrast image. 
Notably, these doublets could only be seen in well relaxed or stretched muscle. In contracted 
muscle, raver1 appeared as a single band colocalizing with the Z-line, which may account 
for the staining observed in our previous investigation (Huttelmaier et al. 2001).
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To further ascertain the localization of raver1 in muscle, myofibrils were isolated from 
murine skeletal muscle and labelled with raver1 antibodies yielding identical staining pattern 
(Figure 34 A and data not shown).
Figure 34. Identification of raver1 as an integral component of skeletal muscle myofibrils. In phase contrast 
images of myofibrils isolated from mouse skeletal muscle (A and B, left panels), I-bands (arrows) and Z-lines 
(arrowheads) are well discernible. Immunostaining of myofibrils for raver1 (5G6, A) and alpha-actinin (B) 
reveals that raver1 concentrates as a doublet in the I-Z-I region whereas alpha-actinin clearly marks the Z-
line. Bars, 5 µm. (C, D). Electron micrographs of ultrathin sections of mouse skeletal muscle directly labelled 
with 10 nm gold-conjugated raver1 antibody 5G6 (C) and 7D3 (D) show prominent labelling of the I-band with 
some accumulation in the vicinity of the Z-line. Fewer gold particles are also found at the M-band (M in D) and 
within the nucleus (C). In both pictures, gold is enlarged and pseudocoloured red. Bars, 200 nm.
Chapter 3               An integral component of muscle contractile elements
                and a potential ligand for actin
97
Again, raver1 was present as a doublet flanking the Z-disc on both sides as was evident 
from comparison with the corresponding phase contrast images (Figure 34, left) and the 
staining of myofibrils for alpha-actinin (Figure 34 B) or actin (data not shown).
The sarcomeric localization of raver1 was further examined by immunoelectron 
microscopy (Figures 34 C and D). Gold particles were mainly distributed along the Z-disc in 
the I-Z-I region, but were occasionally also found at the M-line (Figure 34 D). Additionally, 
sections including the nucleus revealed raver1 also as an intranuclear component (Figure 34 
C).
Figure 35. Subcellular localization of raver1 in cardiomyocytes. Frozen longitudinal sections (A, B) of mouse 
heart muscle were analysed for raver1 by 5G6 (A) and 7D3 (B) and counterstained with either FITC-conjugated 
phalloidin (A) or DAPI (B) to visualize the filamentous actin cytoskeleton or nuclei, respectively. Left panels 
(A, B) represent the corresponding phase contrast images. (A, B centre panel): Raver1 is present in a striated 
pattern in cardiac sarcomeres (inset in A represents a higher magnification of the boxed area) and in intercalated 
discs (arrowheads in A). A comparably weak raver1 signal which is mainly obscured by sarcomeric striations 
is detected in the centrally located nuclei of cardiac cells (asterisks in B, placed immediately right to nuclei) 
which were counterstained by DAPI (right panel). Bars: 10 μm. (C, D) Ultrathin sections of neonatal rat heart 
muscle, indirectly labelled with 7D3 and 10 nm gold (enlarged and pseudocoloured red). The sarcomeric (C, 
D) and nuclear (D) localization of raver1 seen at the light microscopic level is confirmed. M: M-band, N: 
nucleus, Z: Z-line, Bars, 200 nm.
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Localization of raver1 in cardiac muscle
To study the distribution of raver1 in cardiac muscle, immunolabelling experiments were 
performed on murine ventricular heart tissue (Figure 35). Frozen sections were stained with 
5G6 (Figures 35 A) and 7D3 (Figure 35 B). In longitudinal sections, a distinct sarcomeric 
banding pattern was observed that colocalized with the Z-discs of cardiomyocytes (Figure 
35 A). Distinct doublets were not as well resolved as in skeletal muscle (compare inset 
in Figure 35 A with Figure 33). In addition, a strong raver1 signal was also present at the 
intercalated discs connecting cardiomyocytes (arrowheads in Figure 35 A). Raver1 staining 
in cardiomyocyte nuclei was weak (asterisks in Figure 35 B) and often obscured by the 
sarcomeric signals. A similar reduction of nuclear signal intensity has already been described 
during the differentiation process of skeletal muscle (Huttelmaier et al. 2001). Ultrastructural 
analyses by immunoelectron microscopy with 7D3 confirmed the dual residency of raver1 
(Figures 35 C, D). Immunogold labelling was prominent at the I-Z-I region (Figure 35 C) 
and in the nucleus (Figure 35 D). These data reveal that the localization of raver1 at the 
sarcomeric boundary and in the nucleus is a common feature of striated muscle.
Analysis of raver1 distribution in smooth muscle
We also investigated the subcellular distribution of raver1 in smooth muscle, where the 
contractile apparatus is not organized in sarcomeres. Sections of murine urinary bladder 
(Figure 36 A) and uterus (Figure 36 B) were analyzed with 7D3 or 5D5, respectively. The 
smooth muscle cells of the urinary bladder (Figure 36 A, top left) were readily distinguished 
from adjacent connective tissue by strong cytoplasmic staining for raver1 (Figure 36, top 
right), and by the bright staining of filamentous actin by phalloidin (Figure 36, bottom left). 
A comparison of these images with DAPI staining (Figure 36, bottom right) clearly showed 
that raver1 was also present smooth muscle nuclei (Figure 36, A arrows). Increased raver1 
staining was also noted for the smooth muscle layer of blood vessels (Figure 36 A, boxed 
areas). Sections of the uterine smooth muscle (Figure 36 B, top left) confirmed the presence 
of raver1 in myofibrils (Figure 36 B, top right), which were identified by phalloidin staining 
(Figure 36 B, bottom left) and the characteristic elongated shape of their nuclei (Figure 36 B, 
bottom right). The presence of raver1 in smooth muscle myofibrils was evident (see Figure 
36 B), but the resolution of the immunofluorescence images was not good enough to claim 
unambiguously its presence in smooth muscle nuclei. 
At the ultrastructural level, the distribution of raver1 was examined in ultrathin sections 
of urinary bladder labelled with 5D5 (Figure 37). Indirect immunogold labelling revealed 
that raver1 was present in both, nuclei and cytoplasm. In some instances, an association 
of raver1 with cytoplasmic filamentous structures that could represent microfilaments was 
observed. 
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Figure 36. Immunolocalization of raver1 in smooth muscle. (A) Urinary bladder. The phase contrast image 
(upper left) shows smooth muscle (left), identified by the intense staining of filamentous actin by phalloidin 
(left lower panel) and connective tissue (right), separated by the dotted line. The position of a blood vessel is 
indicated (boxed area). Immunostaining with 7D3 (upper right) reveals a cytoplasmic concentration of raver1 
in the smooth muscle layers of the urinary bladder and the blood vessel. Less prominent raver1 staining was 
observed in smooth muscle nuclei (arrows) identified by DAPI staining (lower right). Cells of the connective 
tissue show primarily a nuclear localization of raver1. (B) Mouse uterus. The smooth muscle fibres seen in the 
phase contrast image (upper left) and recognized by their fibrillar actin staining with phalloidin (lower left) 
are intensely stained for raver1 with 5D5. Nuclei were identified by DAPI staining (lower right), but a nuclear 
localization of raver1 could not be determined at the resolution of such images. Bars, 20 μm.
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Figure 37. Immunoelectron microscopic analysis of raver1 in smooth muscle tissue. (A and B) Ultrathin 
sections of smooth muscle from mouse urinary bladder (A) and mouse aorta (B) were labelled with 5D5 and 
a 10 nm gold-conjugated secondary antibody (enlarged, pseudocoloured red). Raver1 is seen present in the 
nuclei (N) and the cytoplasm (C) of both types of smooth muscle cells. Bars, 200 nm
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Discussion
We have previously observed that during skeletal muscle differentiation the hnRNP-like 
protein raver1 translocates from the nucleus to microfilament attachment sites in differentiated 
skeletal muscle at the sarcolemma (Huttelmaier et al. 2001). Based on these findings, 
we analyzed the subcellular distribution of raver1 in skeletal muscle in more detail and 
expanded our investigation to heart and smooth muscle. We demonstrate that the cytoplasmic 
accumulation of raver1 and its association with contractile elements is a common feature of 
all three types of muscle. In addition, a minor fraction of the protein was always present 
in the nucleus. A detailed analysis of stretched myofibrils and ultrathin sections of skeletal 
muscle showed that raver1, like alpha-actinin but unlike vinculin, is not restricted to the 
costameres. Instead, it is also an integral sarcomeric component, mainly localized in the I-
Z-I region. In heart muscle, raver1 was also found as a prominent component of intercalated 
discs, which are also rich in vinculin, metavinculin and alpha actinin (Tokuyasu et al. 1981; 
Witt et al. 2004).
Immunolabelling of myofibrils (Figure 34) revealed that the distribution of raver1 does 
not exactly correspond to that of its ligand alpha-actinin. As expected, the latter is strictly 
confined to the Z-disc (Tokuyasu et al. 1981; McKenna et al. 1986), whereas raver1 flanks 
this structure being thus mainly located in the I-regions. This partial overlap in situ may 
either reflect a true differential localization of the two proteins, or, alternatively, it could be 
the consequence of steric hindrance of antibody binding caused by additional proteins. In 
vitro, raver1 directly interacts with vinculin and alpha-actinin and complexes containing all 
three proteins can be recovered from cell extracts by immunoprecipitation (Huttelmaier et 
al. 2001). Based on our immunolabelling analyses, a direct interaction between raver1 and 
alpha actinin in situ might be possible, but cannot be proven.
As revealed by immunoelectron microscopy, raver1 was occasionally also found at 
the M-band (Figures 34 and 35). Different locations within the sarcomere have also been 
described for other proteins such as obscurin (Young et al. 2001) and FHL2/DRAL (Lange 
et al. 2002), but at present it is not clear whether translocations of such proteins occur within 
the sarcomere, or whether there are distinct subpopulations of these components present at 
different sites (Lange et al. 2006).
The dual localization of raver1 in the nuclear and sarcomeric compartment of muscle, 
together with its structural organization, based on which it was identified as a member of 
a protein family engaged in RNA modification, suggests that raver1 may also have a dual 
function. Since raver1 harbours three RRMs and affects PTB-mediated RNA splicing in 
vitro (Gromak et al. 2003) it has been speculated that raver1 could be involved in processing 
and delivery of specific mRNAs to the sarcomere and thus mediate site-specific synthesis of 
sarcomeric proteins (Jockusch et al. 2003). Such sarcomeric localization has been reported 
for the mRNAs of vimentin, desmin and vinculin (Morris and Fulton 1994). However, direct 
RNA binding of raver1 remains to be shown. Alternatively, the RRMs may act as binding 
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modules mediating protein-protein interactions and could be involved in vinculin binding 
(Huttelmaier et al. 2001). 
However, other possibilities need to be considered. It is commonly accepted that the 
functional plasticity of muscle critically depends on intracellular communicators, which 
translate mechanical signals into altered protein activities or gene expression profiles. For 
example, a signalling complex involving the kinase domain (TK) of the giant sarcomeric 
protein titin regulates nuclear translocation of MURF-2. Nuclear MURF-2 interacts with the 
transactivation domain of serum response factor (SRF), which indirectly leads to suppression 
of SRF-dependent muscle gene expression (Lange et al. 2005). MURF-2 thus represents a 
member of a constantly growing, heterogeneous group of proteins that may translocate from 
the sarcomere to the nucleus to perform a sensory or messenger function. Other examples of 
such proteins are for example myopodin (Weins et al. 2001; Sanchez-Carbayo et al. 2003), 
myopalladin (Bang et al. 2001) and CARP (Jeyaseelan et al. 1997; Bang et al. 2001; Miller et 
al. 2003). However, for most proteins the physiological consequences of these translocations 
remain to be shown (Lange et al. 2006). 
At present, we cannot determine whether raver1 exerts primarily structural, transport, 
signalling or regulatory functions in muscle. Raver1 knock-out mice are viable and fertile 
and myofibrils isolated from these animals are morphologically indistinguishable from their 
wild type counterparts (B. Kleinhenz and H.H. Arnold, personal communication). Even 
though we recently identified a raver1-related protein (raver2, Kleinhenz et al. 2005) the 
possibility of mere functional redundancy is rather unlikely, since raver2 is not expressed in 
muscle tissue. Furthermore, genetic analyses do not indicate any other raver isotypes.
In summary, these facts argue against a purely structural function of raver1. Apparently, 
the protein is not required for initial sarcomere formation and maintenance. However, the 
possibility remains that raver1 in costameres and intercalated disks contributes to proper 
muscle function by modulating either the molecular architecture of microfilament attachment 
sites or signalling pathways that target these attachment sites. Further studies, involving 
physiological analyses of animals, muscle and isolated myofibrils on raver1-depleted mice 
are required to clarify these issues.
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3.4 Localization of raver1 in tissues and cells by immunoelectron microscopy
For an extended characterization of raver1 distribution, we have performed additional 
immunoelectron microscopy studies on a variety of different muscle tissues, cultured cell 
lines and isolated oocyte nuclei.
3.4.1 Raver1 in rodent muscle tissues
The immunogold labeling studies that were carried out on ultrathin sections of rodent 
muscle tissue are summarized in Table 6.
Table 6. Immunoelectron microscopic analysis of rodent muscle tissues
with raver1 antibodies; nd, not done.
Raver1 antibody
N-terminal C-terminal
Striated muscle
Rat neonatal heart nd +
Murine adult heart nd +
Murine skeletal muscle + +
Smooth muscle
Murine aorta + +
Murine urinary bladder nd +
Murine uterus + +
Chapter 3               An integral component of muscle contractile elements
                and a potential ligand for actin
105
Immunofluorescence labeling of mouse uterine smooth muscle tissue with 5D5 revealed 
raver1 to be present predominantly in the cytoplasm of myofibrils, whereas in the nucleus, 
raver1 appeared to be absent (Zieseniss 2005; Zieseniss et al. 2007). However, at the 
ultrastructural level, raver1 was shown to localize to both, the cytoplasm as well as the 
nucleus (Figure 38 A). An association with distinct structures was not evident in any cellular 
compartment. Instead, raver1 appeared to be randomly distributed. 
A similar distribution of raver1 in the nucleus and the cytoplasm was also observed in 
neonatal rat heart labeled with the raver1 antibody 5G6, which binds to an N-terminal epitope 
in raver1 (Figure 38 B). 
Previous immunofluorescence studies with raver1 antibody 7D3, which binds to the C-
terminal region of raver1, revealed a pronounced labeling of the sarcomeric I-regions resulting 
in a typical cross-striation pattern (Zieseniss et al. 2007). However, at the ultrastructural 
level, labeling with the 5G6 antibody did not reveal accumulation in a distinct band of the 
sarcomere.
In summary, observations at the ultrastructural level supplement previous 
immunofluorescence microscopy studies (Huttelmaier et al. 2001; Jockusch et al. 2003; 
Zieseniss 2005; Zieseniss et al. 2007). In particular, the data support the dual residency of 
raver1 in the nucleus and cytoplasm in all types of muscle tissues tested. In striated muscle, 
antibodies against the C-terminal region of raver1 revealed an accumulation of raver1 at the 
I-bands of sarcomers at the cellular and ultrastructural level, leading to a distinct striated 
pattern (Zieseniss et al. 2007).
Figure 38. Localization of raver1 in muscle tissues by indirect immunoelectron microscopy. Ultrathin 
sections of (A) mouse uterine smooth muscle and (B) neonatal rat heart were labeled with the raver1 antibodies 
5D5 and 5G6, respectively. Gold particles (enlarged, pseudocoloured red) were seen in both, the cytoplasm 
(C) and the nucleus (N).
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Raver1 antibody
N-terminal C-terminal
Cultured cells 
HeLa nd +
Rat2 nd +
C2C12 + +
Rat aortic smooth muscle cells + +
NVCM nd +
Isolated nuclei
Xenopus oocyte nuclei + +
3.4.2 Distribution of raver1 in cultured cells
As listed in Table 7, immunolocalization studies at the ultrastructural level were carried 
out on a number of cultured cell lines, on primary rat neonatal ventricular cardiomyocytes 
(NVCM) (Pinson 1990), primary rat aortic smooth muscle cells, and on isolated nuclei from 
Xenopus laevis oocytes (Reichelt et al. 1990; Jarnik and Aebi 1991).
Table 7. Indirect immunoelectron microscopic studies on ultrathin sections of cultured 
cells and isolated Xenopus laevis oocytes with raver1 antibodies; nd, not done.
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Immunogold labeling of ultrathin sections from different cultured cell lines with raver1 
antibodies showed that raver1 was evenly distributed in the cytoplasm (C) and the nucleus 
(N) in all cells tested (Figure 39). An association of raver1 with distinct cellular structures 
was not evident. In Rat2 fibroblasts, raver1-associated gold particles were less frequent than 
in HeLa cells (Figure 39 A, B). The highest levels of raver1 were detected in aortic smooth 
muscle cells using 5G6, which binds to the N-terminus of raver1 (Figure 39 C).
Figure 39. Localization of raver1 in cultured cells by indirect immunoelectron microscopy. (A) Rat2 cells 
were reacted with raver1 antibody 7D3, (B) HeLa cells with 5D5 and (C) aortic smooth muscle cells with 5G6. 
Gold particles (enlarged, pseudocoloured red) were seen in both, the cytoplasm (C) and the nucleus (N) of all 
cells tested.
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3.4.3 Raver1 localizes to the nuclear face of oocyte nuclei
In order to study a potential role of raver1 in nucleocytoplasmic transport, the distribution 
of raver1 at the nuclear envelope was examined at the ultrastructural level by pre-embedding 
labeling of nuclei from X. laevis oocytes. For this purpose, nuclei were manually dissected 
(Reichelt et al. 1990; Jarnik and Aebi 1991) and incubated with 8 nm colloidal gold-coupled 
raver1 antibodies 5G6, 5D5 and 7D3. Subsequently, the nuclei were fixed, thin-sectioned 
and processed for CTEM analysis. 
As illustrated in the electronmicrograph in Figure 40, incubation of nuclei with 5D5 
antibody yielded the most pronounced labeling of the nuclear envelope (NE), with the 
majority of gold particles residing at the nuclear face (NF). The schematic representation of 
the nuclear pore complex (NPC) shown in Figure 40 B illustrates that in cross section, the 
distal ring (DR), nuclear ring (NR), and cytoplasmic ring (CR) are generally located between 
-120 nm to -50 nm, -50 nm to 0 nm, and 0 nm to 60 nm from the central plane, respectively 
(Fahrenkrog et al. 2002; Beck et al. 2004). Because raver1 appeared to reside at a consistent 
location with respect to the NPC, we measured the vertical distance of the gold particles 
from the central plane of the NE. The corresponding histograms are presented in Figure 40 
C.
In total, 145 gold particles were scored, 97.9% of which were located at the NF and only 
2.1% of gold particles were found on the cytoplasmic face (CF) of the NE. The vast majority 
of gold particles on the NF (97.1%) were associated with the DR of the nuclear basket. A 
similar distribution was observed with gold-conjugated 7D3 antibody, where 85.7% of the 
56 scored gold particles were located at the NF. Again, these gold particles accumulated at 
the DR. Labeling with gold-conjugated 5G6 antibody, which recognizes an epitope at the 
N-terminus of raver1, revealed a corresponding distribution of gold particles. 
In summary, immunogold electron microscopy with three different raver1 antibodies 
suggests that raver1 interacts with the NPC of Xenopus oocyte nuclei. At the NPC, raver1 
seems to preferentially associate with the DR of the nuclear basket. However, because the 
nucleoplasm is not structurally preserved during pre-embedding labeling experiments, the 
distribution of raver1 throughout the nucleus remains unresolved. 
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Figure 40. Raver1 at the NPC of nuclei from X. laevis oocytes. Isolated nuclei were pre-embedding labeled 
with the 8 nm gold-coupled raver1 antibodies 5D5 and 5G6, and processed for CTEM. (A) The gold particles 
(enlarged, pseudocoloured with red) either antibody were seen predominantly at the DR of the NPC. Asterisks 
indicate raver1 directly located at the DR of longitudinal cross-sectioned NPCs. CF; cytoplasmic face, NF; 
nucleoplasmic face. (B) Schematic cross-section through the NPC from Xenopus laevis oocyte nuclei. The 
dashed line represents the central plane of the nuclear envelope. CR, cytoplasmic ring; NR, nuclear ring, DR, 
distal ring. (Adapted from Stoffler et al. 1999). (C) Quantification of the gold particles.
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Construct Amino acids
Mw [kDa] 
RRM NLS
R1-FL 748     (1 – 748) 86 3 2
R1-ΔN 306 (442 – 748) 35 --- 1
3.4.4 Raver1 is a ligand for actin in vitro
Because previous studies suggested that raver1 might be a direct binding partner for actin 
(Huttelmaier et al. 2001) and more recent data indicates that the presence of raver1 induces 
bundling and networking of prepolymerized F-actin filaments in vitro (Zieseniss 2005), we 
wanted to examine the interaction of actin with raver1 in more detail.
In the study presented below, we examined the interaction of i) recombinantly expressed 
full-length raver1 protein (R1-FL) and ii) a C-terminal raver1 fragment (R1-∆N) with highly 
purified rabbit skeletal muscle actin. In particular, we incubated G-actin and prepolymerized 
F-actin filaments with R1-FL and R1-∆N, respectively, and analyzed their interaction by 
high-speed cosedimentation and subsequent SDS-PAGE analysis. In addition, high-speed 
pellets were examined at the ultrastructural level to visualize the effects of raver1 on the 
supramolecular organization of actin.
The basic molecular characteristics of R1-FL and R1-∆N are summarized in Table 8. 
Table 8. Molecular characteristics of recombinantly expressed full-length raver1 (R1-
FL) and a C-terminal raver1 fragment (R1-ΔN). Both constructs comprise N-terminal 
polyhistidine tags; RRM, RNA-recognition motif; NLS, nuclear localization signal.
In the standard actin sedimentation assay (see Chapter 1.3), G-actin exclusively remains 
in the supernatant (data not shown). Similarly, control experiments with recombinantly 
expressed R1-FL alone showed that after high-speed centrifugation, the 86 kDa raver1 and 
numerous degradation products remained in the supernatant (Figure 41 A, left). It should be 
noted that recombinant R1-FL and the R1-ΔN fragment, could only be produced in insect 
cells and both proteins were difficult to efficiently purify, as well as extremely prone to 
degradation. Cosedimentation of mixtures of G-actin and R1-FL at high speed resulted in a 
partial redistribution of both, actin and R1-FL to the pellet fraction (Figure 41 A, middle), 
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suggesting that a pelletable supramolecular structure was formed by the association of raver1 
with actin. If prepolymerized, phalloidin-stabilized F-actin filaments were incubated with 
R1-FL, virtually all of the actin was pelleted. This finding indicates, that the interaction 
with raver1 did not result in a depolymerization of preformed filaments. Consistent with the 
results obtained for R1-FL alone (Figure 41 A, right), approximately half of the R1-FL and 
interestingly most of the degradation products remained in the supernatant. As revealed by 
electronmicrographs of negatively stained samples of the resuspended pellet fraction, the 
interaction of R1-FL with F-actin filaments led to their bundling (Figure 41 B). 
To narrow down which region of the raver1 molecule interacts with actin, we performed 
cosedimentation assays with R1-ΔN, a ∼ 35 kDa fragment corresponding to the C-terminus 
of raver1. High-speed centrifugation of R1-ΔN by itself left the fragment in the supernatant 
(Figure 41 A, left, S). If purified G-actin was mixed with R1-ΔN, most of the raver1 fragment 
and a significant fraction of the G-actin were found in the pellet (Figure 41 A, right, P). 
Currently, we do not know if in (S), the weak band at ∼ 35 kDa represents raver1 fragment 
or a characteristic actin degradation product. In addition, the origin of the higher molecular 
weight band is unclear but might represent an aggregated form of R1-ΔN. Because the partial 
cosedimentation with G-actin was observed for the full-length and the C-terminal raver1 
fragment, one might conclude that raver1 interacts with G-actin via its C-terminal region. 
It is also possible that this interaction induces the polymerization of actin into filaments 
that are pelleted. However, CTEM analysis of the cosedimented pellet fraction (Figure 
41 B) revealed that pellets mainly consisted of unstructured protein aggregates (left) and 
filamentous structures (Figure 41 B, right) were rarely detected.
If prepolymerized, phalloidin-stabilized F-actin filaments were mixed with R1-ΔN (Figure 
41 C), basically all of the raver1 fragment was pelleted together with the actin filaments. 
Electron microscopy analysis of the pellet fraction revealed that the presence of R1-ΔN 
induced the bundling of F-actin filaments (Figure 41 D), similar to the bundling activity 
observed for the full-length protein (Figure 41 B). 
Together, the results from cosedimentation assays and the ultrastructural inspection 
corroborates the preliminary finding that raver1 interacts with actin in vitro (Zieseniss 2005). 
Furthermore, the bundling of prepolymerized F-actin filaments indicates that raver1 contains 
at least one binding site for filamentous actin, which appears to be located in the C-terminal 
part of the molecule.
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Figure 41. Interaction of actin with R1-∆N. Aliquots of the total protein inputs (T), the supernatants after 
high-speed centrifugation (S) and the resuspended pellets (P) were subjected to a 12% SDS-PAGE and silver 
stained. In addition, aliquots of the resuspended pellets were negatively stained and analyzed by CTEM. (A, 
left panel) R1-∆N remained entirely in the supernatant (S), whereas (A, right panel) R1-∆N cosedimented with 
G-actin, forming mainly unstructured aggregates (B, left panel) and a minor fraction of filamentous structures 
(B, right panel). (C) R1-∆N was entirely pelleted with phalloidin stabilized F-actin filaments and (D) induced 
the formation of actin filament bundles. The molecular masses in kDa of standard proteins are indicated on 
the left.
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3.5 Conclusions and outlook
Cosedimentation assays and electron microscopy provide evidence that the hnRNP 
protein raver1 interacts with preformed F-actin filaments in vitro. In particular, it induced 
the formation of thick F-actin filament bundles. The number of ABPs with filament bundling 
activity is increasing (Ruzanov et al. 1999; Mulder et al. 2003, Michelot et al. 2005). At 
first sight, the nuclear localization of raver1 might appear inconsistent with its bundling 
activity, specifically since actin filaments are not observed in the nucleus under physiological 
conditions. However, we have also shown that raver1 is not only a nuclear protein, but 
is present in the cytoplasm as well. Moreover, other ABPs with bundling activity such 
as formins have also been detected in the nucleus. The actin-binding properties of the C-
terminal deletion construct R1-ΔN were comparable to that of the full-length protein. This 
result indicated that the actin binding site(s) is located in the C-terminal region of raver1. 
Similarly, the binding site for alpha-actinin has been allocated to the C-terminal region, 
whereas binding of raver1 to its cytoplasmic ligands (meta)vinculin is mediated by the N-
terminal region of the molecule (Hüttelmaier et al. 2001; Zieseniss 2005). Our data support 
and extend previous observations, which suggested that recombinantly expressed raver1 
binds directly to actin in vitro (Zieseniss 2005). 
Isolation of protein complexes containing actin, raver1 and PTB from undifferentiated 
C2C12 myoblasts, where raver1 primarily resides in the nucleus suggested that the interaction 
with actin might occur in the nucleus (Zieseniss 2005). Consistent with this notion, hnRNP 
U, another member of the hnRNP family, has been shown to cooperate with nuclear actin for 
productive transcription (Kukalev et al. 2005). Using three monoclonal antibodies that react 
with N- and C-terminal epitopes of raver1, our immunoelectron microscopy studies revealed 
a distinct nuclear localization of raver1 in Xenopus oocytes. Specifically, raver1 distinctly 
accumulated at the distal ring of the NPC baskets. Although actin has also been found to 
associate with the NPC as well as with a network of ʻpore-linked filamentsʼ, which extend 
from the nuclear envelope deep into the nucleus (Hofmann et al. 2001; Kiseleva et al. 2004), 
the colocalization of raver1 and actin at the NPC remains to be investigated. In addition, 
structure of the nucleoplasm is not preserved during the pre-embedding labeling procedure, 
so that the localization of raver1 within the nucleus is not revealed. Hence, we were not able 
to confirm the localization of raver1 in perinucleolar bodies, which was previously described 
by immunofluorescence (Huttelmaier et al. 2001).
Nuclear actin was seen to play an important role in the nuclear export of e.g. retroviral 
RNAs (Hofmann et al. 2001). Likewise, raver1 has been considered to act as chaperone for 
mRNAs, accompanying them on their journey from the nucleus to the cytoplasm (Jockusch et 
al. 2003). Hence, one could speculate that both proteins might be coexported (possibly with 
specific mRNA cargo) to a common cytoplasmic destination, such for instance to the I-bands 
of skeletal muscle sarcomers (Huttelmaier et al. 2001; Zieseniss 2005; Zieseniss et al. 2007). 
However, a functional interplay of raver1 and actin in the nucleus and combined nuclear 
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export of both proteins is still hypothetical and has to be elucidated in future experiments. 
To study the nuclear export of raver1 and a potential translocation mechanism for raver1 
and actin to the cytoplasm, proteins involved in the nuclear export of actin, such as exportin6 
(Stuven et al. 2003; Bohnsack et al. 2006), could be probed for their ability to interact with 
raver1 in colocalization and coimmunoprecipitation experiments. 
In addition, other candidate target proteins to be studied are those present at the basket 
of NPCs, which are thought to participate in nuclear protein export, such as for instance the 
tumor promoter region protein Tpr and specific nucleoporins (Frosst et al. 2002; Krull et al. 
2004). 
A major drawback in studying the interactions of raver1 with different target proteins 
lies in the difficulties expressing recombinant raver1 and fragments thereof. The protein 
used for our in vitro studies was produced in insect cells at low yield. In addition, purified 
raver1 showed a strong tendency to aggregate and was extremely prone to proteolytic 
degradation. However, to further characterize the interaction with actin, it is essential to 
carry out systematic binding experiments with recombinantly expressed raver1 fragments. 
Therefore, one imminent task is to explore alternative expression systems.
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